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ABSTRACT
Cannabis use initiated during adolescence may precipitate lasting consequences
on the brain and behavioral health of the individual. However, research on the risk factors
for cannabis use during adolescence has been largely cross-sectional in design. Despite
the few prospective studies, even less is known about the neurobiological predictors. This
dissertation improves on the extant literature by leveraging a large longitudinal study to
uncover the predictors of cannabis use in adolescent samples collected prior to exposure.
All data were drawn from the IMAGEN study and contained a large sample of
adolescents studied at age 14 (N=2,224), and followed up at age 16 and 19. Participants
were richly characterized using psychosocial questionnaires, structural and functional
MRI, and genetic measurements. Two hypothesis-driven studies focused on amygdala
reactivity and two data-driven studies across the feature domains were completed to
characterize cannabis use in adolescence.
The first study was cross-sectional and identified bilateral amygdala hyperactivity
to angry faces in a sample reporting cannabis use by age 14 (n=70). The second study
determined this amygdala effect was predictive of cannabis use by studying a sample of
cannabis-naïve participants at age 14 who then used cannabis by age 19 (n=525). A doseresponse relationship was observed such that heavy cannabis users exhibited higher
amygdala reactivity. Exploratory analyses suggested amygdala reactivity decreased from
age 14 to 19 within the cannabis sample, although statistical significance was not found.
In the third study, data-driven machine learning analyses predicted cannabis
initiation by age 16 separately for males (n=207) and females (n=158) using data from all
feature domains. These analyses identified a sparse set of shared psychosocial predictors,
whereas the identified brain predictors exhibited sex- and drug-specificity. Additional
analyses predicted initiation by age 19 and identified a sparse set of psychosocial
predictors for females only (n=145). The final study improved on drug-specificity by
performing differential prediction analyses between matched samples of participants who
initiated cannabis+binge drinking vs. binge drinking only by age 16 (males n=178;
females n=148). A sparse subset of psychosocial predictors identified in the third study
was reproduced, and novel brain predictors were identified. Those analyses were unique
as they compared two machine learning algorithms, namely regularized logistic
regression and random forest analyses.
These studies substantiated the use of both hypothesis- and data-driven prediction
analyses applied to large longitudinal datasets. They also addressed common issues
related to human addiction research by examining sex-differences and drug-specificity.
Critically, these studies uncovered predictors of use in samples collected prior to
cannabis-exposure. The identified predictors are therefore disentangled from
consequences of use. Results from all studies inform etiological mechanisms influencing
cannabis use in adolescence. These findings can also be used to stratify risk in vulnerable
adolescents and inform targets for interventions designed to curb use.
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CHAPTER 1: INTRODUCTION AND LITERATURE REVIEW
Drug use is one of the most common and chronic behavioral health issues facing
society, yet little is know about the neurobiological, genetic, and psychosocial predictors
of use. Individuals who struggle with substance use disorders typically begin drug
experimentation in adolescence. Therefore, it is important to identify predictive profiles
during this period of development when individuals are most vulnerable to initiating drug
use. Here, the literature specifically concerning adolescent cannabis use will be reviewed
in light of the psychosocial and neurobiological changes that occur during adolescence.
Special focus will be given to the animal and human studies that reported on the
correlates and consequences of cannabis use in adolescence. In light of those studies, it is
suggested that cannabis initiation during early adolescence is related to differences in the
neurobiology and psychosocial functioning later in life.
Cannabis use has become a topical matter of public health in light of the risks
associated with early initiation and chronic use. Recreational cannabis use for adults is
now legalized in many different parts of the United States and abroad. Moreover, recent
trends in adolescent use indicated that cannabis is now the second most popular drug used
by adolescents (as indicated by any lifetime use), surpassing cigarettes in 2011 (Johnston
et al., 2018). Despite these trends, the scientific evidence related to the biobehavioral
predictors of cannabis use remains unclear. An important gap in the literature is the lack
of longitudinal studies with multimodal assessments aimed at uncovering the predictors
of cannabis use. The identification of these predictors will inform pathways to cannabis
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initiation, stratify risk in vulnerable adolescents, and supply targets for proactive
interventions tailored to mitigate use and attenuate the consequences of use.
1.1 Adolescent Development
Psychosocial Development
The World Health Organization defines adolescence as the period of development
between ages 10-19 (www.who.init), although some argued for an extension into age 24
(Sawyer et al., 2018). Adolescence is a developmental period characterized by substantial
psychosocial and neurobiological changes (Spear, 2000a). Throughout this period,
adolescents experiment with various new behaviors, environments, and reinforcers in
order to learn new skills necessary for independence. Childhood behavioral patterns that
previously sustained the individual are replaced by adult-like behaviors developed
through experimentation with independence.
Adolescents also experience a drive to emigrate from the natal family
environment, incorporate more peers into their social networks, and increase time spent
outside of adult supervision (Spear, 2000a). Increased interactions with peers provide
opportunities for the adolescent to experiment with and learn social skills necessary for
adulthood. And from an evolutionary biology perspective, motivation to emigrate from
the home to associate with peers is advantageous in facilitating the identification of
reproductive partners.
Opportunities to engage in risky behaviors are likely during this phase of
development when adolescents spend more time engaged with their social network of
peers (Rose et al., 1996). Participating in similar risky behaviors yields powerful social
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reinforcement for adolescents (Kaplan et al., 1987) and can boost self-esteem (Shedler
and Block, 1990). Adolescents also reported they approach risky situations in order to
satisfy curiosity and augment the sense of arousal, intensity, and complexity of novel
experiences (Lipsett and Mitnick, 1991). While risk-taking behaviors are a common
feature of adolescence, moderating the frequency and severity of these behaviors is an
important skill that must also be learned during this period (Galvan et al., 2007).

Structural Neurodevelopment
Across early development and into adulthood, the brain undergoes a series of
changes including global and focal volume changes, increased myelination, synaptic
pruning, and receptor proliferation until the stable adult form is reached (Spear, 2000b,
2013). Throughout this process, the neural architecture supporting cognitive, affective,
motor, and sensory functions reach maturity.
From gestation to late childhood, the brain generates an excess of neurons and
synaptic connections to supply individuals with an overabundance of neural resources
(Huttenlocher and Dabholkar, 1997; Oppenheim, 1991). Following this overabundance,
synaptic pruning results in considerable gray matter volume loss as a healthy means to
promote functional neuronal efficiency. During this process, the important neural
connections established from prior experience and learning are preserved, while
redundant connections are terminated (Casey et al., 2008).
In addition to synaptic pruning, neuronal myelination also proliferates during
adolescence. Paus and colleagues reported that adolescent brain development is
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specifically characterized by a marked increase in the myelination of the corticospinal
tracts supporting voluntary movements, and the frontotemporal tracts supporting
language (Paus, 1999). Pruning and myelination processes are especially active in the
prefrontal cortex (PFC) (Gogtay et al., 2004; Whitford et al., 2007).
Work by Giedd and colleagues uncovered separate neural developmental
trajectories by sex (Giedd et al., 1999). Total brain and total gray matter volume (but not
white matter) exhibited an inverted U shape trajectory from childhood to adolescence.
Volumes increased throughout childhood and approached an inflection point that
triggered a decline in brain volume, most likely driven by pruning processes. On average,
females reached peak total brain volume at age 11 years while males peaked at age 15. In
terms of white matter volume, research by Lenroot and colleagues suggested white matter
increased steadily throughout the lifespan, but at a much faster rate in adolescence for
males than females (Lenroot et al., 2007). In a related study of white matter development
by Perrin and colleagues, authors postulated white matter sex-differences may be due to
axonal diameter, rather than myelination, as testosterone up-regulates expression of
axonal microtubules (Perrin et al., 2008).

Functional Neurodevelopment
Durston and colleagues argued that spatial-extent of brain activity characterizes
functional maturity (Durston et al., 2006). Compared to immature diffuse activity,
authors argued that focal activations indicated more efficient processing resulting from
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the strengthening of relevant connections via long-term potentiation. As such, spatialextent is an important way to characterize functional between-group differences.
In terms of the functional network structure, brain activation networks develop
into organized distributed processes from adolescence into adulthood, and prioritize
sparse “small world” network structures (i.e., spatially distant regions of the brain are
connected by a small number of connections). In a study of resting state network
structures by Fair and colleagues, a-priori defined regions of interests for the default
mode network were studied at two stages of development (Fair et al., 2009). Findings
indicated distant network nodes exhibited weak interconnectivity at age 7, but then
shifted to strong interconnectivity at age 21. For example, authors reported modest
correlated activity between the medial prefrontal cortex and the lateral parietal cortex at
age 7. After functional development, these regions exhibited strong correlated activity.
This example of functional integration among distant cortical regions is a hallmark of
functional development and reflects mature functional efficiency grounded in the changes
to the structural architecture (Churchwell et al., 2010; Giedd et al., 1999; Lenroot et al.,
2007; Perrin et al., 2008).

Brain Development and Adolescent Behavior
The current framework of adolescent neurodevelopment in relation to drug use
behaviors postulates that a divergent rate of maturation between the subcortical and
prefrontal regions of the brain might drive reward-seeking behaviors (Casey et al., 2000;
Galvan et al., 2006). In a study by Fareri and colleagues, children and adolescents exhibit
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positively correlated activity between the ventral striatum and medial prefrontal regions,
whereas adults exhibit a developmental switch to anti-correlated activity (Fareri et al.,
2015). This effect is also evident in the connectivity between the amygdala and mPFC
(Gee et al., 2013). As such, anti-correlated activity is interpreted as a sign of top-down
cognitive control whereby the prefrontal cortex down-regulates subcortical activity.
A developmental functional MRI (fMRI) study by Galvan and colleagues
indicated the bottom-up mesocortical and mesostriatal dopaminergic projections of the
midbrain reached functional maturity prior to the opposing top-down prefrontal
projections (Galvan et al., 2006). This finding is supported by animal models that
indicated dopaminergic projections to the PFC reached high levels during adolescence
(Kalsbeek et al., 1988; Leslie et al., 1991; Rosenberg and Lewis, 1994). Animal models
have also identified the three major dopamine receptor subtypes, D1, D2, and D4, reach
peak concentrations in the striatum during adolescence, whereas the concentrations in
cortical regions continued to rise throughout adulthood (Tarazi and Baldessarini, 2000).
While more research is needed, functional MRI studies of reward processing found
heightened blood-oxygen level dependent (BOLD) signals in the striatum and
ventromedial prefrontal cortex (vmPFC) specific to adolescents during receipt of reward
(Cohen et al., 2010; Leijenhorst et al., 2010). Furthermore, another study by Galvan and
colleagues reported a positive correlation between ventral striatum activation and a selfreported measure of risk-taking behaviors (Galvan et al., 2007). In sum, these findings
support the hypothesis that dopaminergic hyperactivity in adolescence may potentiate
sensation-seeking behaviors.
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1.2 Substance Use in Adolescence
Current Prevalence Rates of Alcohol, Cannabis, and Cigarette Use in Adolescence
Current prevalence rates of drug use in adolescence can be derived from the most
recent report of the Monitoring the Future Study (“MTF”, Johnston et al., 2018). The
MTF study surveyed US classroom students in grades 8 (age 13-14), 10 (age 15-16), and
12 (age 17-18) on their patterns of drug use. For the 2017 report, roughly 43,700
teenagers in 360 schools across the United States were studied. This nationally
representative dataset provides context for the need to study drug use in adolescence.
Alcohol is currently (and historically) the most commonly used substance in
adolescence. As of 2017, 23%, 42%, and 62% of teens in grade 8, 10, and 12 respectively
reported any lifetime alcohol use. Conversely, binge drinking (defined by the MTF study
as consuming five or more drinks) prevalence has reached it’s historic low and currently
stands at roughly 9%, 25%, and 45% of grades 8, 10, and 12. Despite this historic low, it
is troubling that nearly half of adolescents initiated at least one binge drinking episode
before finishing 12th grade.
Following alcohol, cannabis is the second most commonly used drug (surpassing
cigarettes in 2011) with any lifetime use reported in 14%, 31%, and 45% of grades 8, 10,
and 12. These rates have been stable over the past 10 years (2007 – 2017), and
demonstrate an improvement relative to the past 20 years when rates peaked at 23%,
42%, and 50% in 1997. Nonetheless, rates of use are consequential in that about 10% of
teens who try cannabis will become weekly users in adulthood (Hall and Pacula, 2003).
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In terms of the availability of the drug, roughly 65% of 10th graders in 2017 reported that
cannabis was “fairly easy” or “very easy” to obtain. For comparison, roughly 63% said
the same for cigarettes, indicating that cannabis is remarkably within reach for these
adolescents. It is also important to note that cannabis risk perception is at a historic low,
with only 40% of 10th graders who perceived “great risk” in regular cannabis use, and
only 20% who perceived “great risk” for occasional use (Johnston et al., 2018).
The MTF study also provided estimates on the differences in prevalence between
years 2016 and 2017. For binge drinking, there was no significant difference in use rates
from 2016—2017, providing very early evidence for the stabilization of the historically
low levels of adolescent binge drinking. For cannabis, a significant 1.3% increase in use
was observed from 2016—2017, but only when considering all grades combined. No
significant differences were observed for each grade in isolation, although trends
indicated subtle increases (Johnston et al., 2018). Thus, the significant increase across the
grades is a small effect that only reached significance with a large sample.
Finally, cigarette use is common in adolescence, although rates have declined
over time. Current prevalence of lifetime cigarette use stands at 9%, 16%, and 26% for
grades 8, 10 and 12. These numbers are a major improvement relative to 1997 when rates
were 47%, 60%, and 65% (Johnston et al., 2018). Within the context of cannabis use,
alcohol and tobacco use are highly correlated with cannabis, in addition to being highly
correlated with each other (Moss et al., 2014a). Given this association, some researchers
posit the lack of an anticipated increase in cannabis use was driven in part by the decline
in cigarette use (Miech et al., 2017).
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Psychosocial Outcomes Associated with Drug Use in Adolescence
Developmental patterns of cannabis use have indicated that early initiation is
correlated with higher levels of cannabis dependence (DSM-IV) in adulthood (Hall &
Degenhardt, 2009; Moss, Chen & Yi, 2009). Correlations have also been identified
between adolescent cannabis use and diminished socio-economic attainment (Fergusson
& Boen, 2008), and although this effect is presumably bi-directional (low-SES predicts
cannabis use), carefully controlled models have suggested a causal mechanism for
cannabis use (Melchior et al., 2017). Many of the psychosocial consequences of cannabis
use may be attenuated by delaying cannabis use until later in life (Lisdahl et al., 2013).
Therefore, the ability to predict and inform prevention strategies for cannabis use is of
substantial value to minimize psychosocial consequences later in life.
The literature linking cannabis use to mental health outcomes is inconclusive. An
earlier study reported that roughly 10% of males and 22% of females who used cannabis
in adolescence experienced depression and anxiety as adults (Patton, 2002). However, a
recent meta-analysis by Gobbi and colleagues offered an updated perspective on the
associations between adolescent cannabis use conferring risk for depression, anxiety, and
suicidality. Authors reported that adolescent use was associated with a 1.4 increase in the
odds for developing depression, 1.2 increase for anxiety (although not statistically
significant), 1.5 increase for suicidal ideation, and finally a 3.5 increase for a suicide
attempt (Gobbi et al., 2019). These findings should be interpreted within in the context of
the relatively high prevalence of lifetime cannabis use in adolescence (45% of 12th
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graders). And although those odds ratios are modest, a different meta-analysis reported
stronger odds for both depression and suicide attempt when considering more frequent
use (Silins et al., 2014). Therefore, preventing cannabis use is hypothesized to partially
lower the incidence of these disorders and experiences.
Lastly, the relationship between adolescent cannabis use and schizophrenia or
psychotic like disorders has been an active area of research. The Swedish Conscript study
(Andréasson et al., 1987), and Dunedin, NZ study (Arseneault et al., 2002) were
instrumental in catalyzing interest in these associations. Those studies each supplied
evidence that higher frequency of use (Andréasson et al., 1987) and earlier age of onset
(Arseneault et al., 2002) predicted the likelihood of developing psychosis. Since those
reports, more recent papers adjusted their risk models for confounding variables like
other drug use, family histories, and prodromal symptomology, and concluded the risk
for these disorders is still valid (Gage et al., 2016; Mustonen et al., 2018). Future studies
are needed to examine the extent to which interventions or decreasing prevalence rates of
cannabis use correlate with psychotic like disorder diagnoses.

1.3 Predictors and Correlates of Cannabis Use in Adolescence
Psychosocial Predictors
Substance use in adolescence is predicted by a set personality traits and
environmental factors. To start, novelty-seeking personality levels typically peak during
adolescence (Maggs et al., 1995; Moffitt, 1993), and are also highly predictive of
substance use (Conrod et al., 2000; Hale et al., 2003; Malmberg et al., 2012). Adolescents
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also tend to discount delayed rewards in favor of immediate rewards (Steinberg, 2008)
and display insensitivities to the aversive properties of some drugs (Cauffman et al.,
2010; Doremus-Fitzwater et al., 2010; Schramm-Sapyta et al., 2006). Taken together,
these behavioral characteristics make adolescents vulnerable to engage drug use.
For environmental factors, numerous studies have identified frequency of early
life stress (Barrett and Turner, 2006), as well as perceived level of stress (Baer et al.,
1987; Deykin et al., 1987; Johnson and Pandina, 1993; Tschann et al., 1994) as strong
predictors of drug use in adolescence. More specifically, studies indicated that physical
and/or sexual abuse during childhood is more frequent in females than males, but
nonetheless strongly predicted drug use later in life for both sexes (Liebschutz et al.,
2002). For males, severity of later drug use was inversely correlated with age at first
abuse, such that the younger the age of physical and/or sexual abuse, the more severe
substance abuse problems later in life. This dose response relationship was not evident in
females, as any history of abuse during childhood strongly predicted substance use
problems in adulthood (Liebschutz et al., 2002).
Taken together, prior life stress might promote the generation of maladaptive
coping strategies that include substance use. And while stress more generally precipitates
drug use (DeWit et al., 1999; Sinha, 2008; Tschann et al., 1994; Wills, 1986) the exact
mechanism driving this association are actively being studied (Milivojevic and Sinha,
2018). Drugs and drug-seeking behaviors may potentiate perceptual and biological
reactivity to stress (Cinciripini et al., 1989; Cobb and Van Thiel, 1982; D’Souza et al.,
2004; Heesch et al., 1995) and drive self-medication behaviors. Additionally, stress may
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impair capacity for impulse control, which is hypothesized to contribute to the
maintenance of substance use disorders (Sinha, 2009). Therefore, various forms of life
stress are key predictors to be studied as well as how they might influence the
neurobiology to confer risk for use.

Parental and Peer Influences
Correlations between adolescent cannabis use and lifetime cannabis use of the
parent has been identified (Duncan et al., 1995; Kerr et al., 2015). A recent paper by
Sokol and colleagues reported that any maternal lifetime cannabis use shifted the age of
initiation two years earlier in their adolescent offspring relative to adolescents from
parents without cannabis use histories (Sokol et al., 2018). Furthermore, O’Loughlin and
colleagues reported adolescents with one parent endorsing any lifetime use were roughly
twice as likely to use cannabis, while adolescents with two parents endorsing any lifetime
use were eight times more likely to use cannabis, relative to their peers whose parents do
not report lifetime use (O’Loughlin et al., 2018). Hence, the influence of parental lifetime
cannabis use on the initiation of use for their child is remarkable. While many factors
may partially contribute to parent-offspring transmission of drug use, possible
mechanisms include shared genetic and neurobiological predispositions.
Peer influences are also strong indicators of cannabis use. At a very basic level, an
adolescent is more likely to use cannabis if they are involved in a network of peers who
use cannabis. This finding has been consistent throughout the literature (Ali et al., 2011;
Duncan et al., 2005; Kuntsche and Jordan, 2006). Mechanisms contributing to this effect
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are hypothesized to be related to the individual differences in the reinforcing properties of
both the drug and the social context (Caouette and Feldstein Ewing, 2017). For example,
some adolescents may not find pleasure in drug use but enjoy the social reinforcement
achieved by engaging in cannabis use behaviors with their peers. In contrast, some
adolescents may not enjoy social situations but they are necessary as a means to obtain
drugs. Evidence for both these scenarios are reported in the literature. Lee and colleagues
studied motives for cannabis use in high school graduates and reported that 26%
endorsed social enhancement and bonding as their primary motive for use (Lee et al.,
2007). Buckner and colleagues designed an instrument to measure the likelihood of
cannabis use in different social situations and reported that adolescents with social
anxieties avoided social situations where cannabis is unavailable (Buckner et al., 2012).
Therefore, it is important to consider relationships with peers and social contexts as
contributing factors for cannabis use in adolescence.

Cognitive Associations with Cannabis Use
In studies on cognition in adolescent cannabis users, findings are relatively
inconclusive, with more evidence pointing to cognitive deficits in teens with heavy or
earlier onset of use. Research by Tapert and colleagues examined cognitive development
in relation to cannabis use in a longitudinal study of teens. Early reports found a decrease
in composite attention scores with cannabis use (Tapert et al., 2002). These findings were
corroborated later and suggested chronic cannabis use throughout adolescence is

13

associated with a decrease in complex attention, slow processing speeds, and reduced
verbal learning and sequencing skills (Jacobus and Tapert, 2014; Medina et al., 2007a).
In a longitudinal study by Hanson and colleagues, researchers assessed verbal
learning, working memory, visual attention, and time estimation at three time points
across one month of monitored abstinence in cannabis using teens compared to controls.
Across all measures, cannabis users showed worse performance than controls, however,
users showed a recovery effect following three-weeks monitored abstinence for all
measures except attention. These findings provided evidence that cannabis related insult
only to attention might persist into adulthood, or, at least require protracted periods of
abstinence to recover (Hanson et al., 2010). These findings have been corroborated by
Fontes and colleagues (Fontes et al., 2011), and Gruber and colleagues qualified this
finding and reported attentional deficits negatively correlated with age of initiation
(Gruber et al., 2012). Therefore, cannabis might partially impair attentional capacities in
individuals who initiate cannabis earlier than their peers.
As reflected above, an ongoing area of research is the extent to which adolescent
cognitive differences persist into adulthood. In early studies, Schwartz and colleagues
reported short-term memory impairments persist at least six-weeks after monitored
abstinence (Schwartz et al., 1989). However, in a prospective study by Fried and
colleagues, researchers analyzed cognitive performance in current users, former users,
and never-using controls, while accounting for performance levels prior to drug use.
Investigators measured IQ, memory, processing speed, and attention using an extensive
battery. Findings indicated that current cannabis users performed worse than the non14

users across all domains. However, former users had performance levels similar to neverusers despite initiating use earlier and using more cannabis than the current users.
Although that study was confounded as former users also had the highest socioeconomic
status (SES) compared to the two comparison groups (Fried et al., 2005).
Lastly, Lane and colleagues assessed motivation in adolescent cannabis users
using a reward task that allowed subjects to switch task difficulties for smaller monetary
reinforcement. Heavy users switched task difficulties at an earlier rate than non-using
peers, and earned a greater proportion of earnings from the smaller reward level.
Proportion of earnings correlated with the amount of cannabinoids present in urine
samples on the day of testing (Lane et al., 2005). This finding was also exhibited by
adults tested under acute intoxication of smoked cannabis compared to placebo (Lane and
Cherek, 2002). Thus, cannabis use is associated with impaired motivation and sensitivity
to reward, at least under acute and lingering effects. Authors concluded cannabis use
might disrupt healthy motivational processes that coordinate favorable behavioral
adaptations (Lane et al., 2005).
It is worth noting there were studies that did not find differences in cognitive
abilities related to cannabis use in adolescence (Tait et al., 2011; Takagi et al., 2011;
Teichner et al., 2000). However, the prevalence of papers that reported cannabis use
compromises cognition outnumbers those reports. Scott and colleagues reviewed the
literature on adolescent cannabis use and cognition (Scott et al., 2018). Authors reported
modest impairments on learning, working memory, delayed memory, inhibition, and
attention in adolescent cannabis users (Scott et al., 2018). Moreover, authors concluded
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that those differences generally abated following a minimum of three days monitored
abstinence (Scott et al., 2018). This conclusion was also reported in an earlier metaanalysis adult cannabis use and cognition (Grant et al., 2003). Together, these findings
indicated that cannabis cessation interventions would likely produce beneficial effects on
cognitive ability in adolescents who initiated cannabis use.

Cannabinoid Psychopharmacology & Insights from Animal Models
The primary cannabinoid (CB1) receptor is a metabotropic Gi-protein coupled
receptor located throughout the brain, with high concentrations in the cerebellum,
hippocampus (especially the CA1/CA3 and dentate gyrus), basal ganglia and amygdala
(Glass et al., 1997; Herkenham et al., 1991; Katona et al., 2001). Within these regions,
the CB1 receptor is found on presynaptic terminals of both GABAergic and
glutamatergic interneurons and participates in neuromodulatory functioning. The
endogenous ligands for these receptors are anandamide and 2‐arachidonoylglycerol,
while the primary exogenous cannabinoid responsible for psychoactive effects is delta-9tetrahydrocannabinol (THC) (Gaoni and Mechoulam, 1964; Pertwee, 2008). When the
CB1 receptor is bound by these ligands, neurotransmission is attenuated through the
inhibition of cyclic adenosine monophosphate (cAMP) and subsequent signal
transduction pathways, including the inhibition of pre-synaptic Ca2+ channels to regulate
vesicular release of neurotransmitters (Wilson et al., 2001).
Animal models have provided valuable evidence that linked adolescent
cannabinoid exposure with differences in the neurobiology. Starting with CB1 receptors,
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Dalton & Zavitsanou exposed adolescent rats to a CB1-repcetor agonist at different doses
and frequencies of infusion (one time use, light use, chronic use). Results indicated a
dose-response decrease in CB1 receptor densities by dose and frequency of use relative to
control animals. Lower CB1 receptor densities were reported across the brain with
dramatic effects in the substantia nigra and CA1 subfield of the hippocampus (Dalton and
Zavitsanou, 2010). Those results were in line with a previous study that showed similar
effects on the amygdala, ventral tegmental area, and nucleus accumbens (Rubino et al.,
2008). Related lines of inquiry indicated that THC might be neurotoxic to both cortical
(Downer et al., 2001) and hippocampal neurons (Lawston et al., 2000; Quinn et al.,
2008b) as measured by differences in tissue characterizations and metabolic changes.
Together, these findings support the hypothesis that exposure to exogenous cannabinoids
during adolescence disrupts typical neurodevelopment and might be partially related to
phenotypic differences in those youths.
Animal studies have also reported on the functional neurobiological and
behavioral differences following exposure to cannabinoids in adolescence. Renard and
colleagues identified impaired long term potentiation in pretreated rats relative to controls
by probing network activity between the hippocampus (CA1/subiculum) and prefrontal
(prelimbic) cortex (Renard et al., 2016). Those findings elucidated previous studies that
showed deficits in domains dependent on hippocampal-PFC circuits including objectrecognition (O’Shea, 2004) and spatial learning (Cha et al., 2006).
Lastly, animal models have supported the link between adolescent use and mood
disorders in adulthood. Rubino and colleagues studied rats pretreated with THC during
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adolescence and identified more depressive-like behaviors in adulthood as indexed by a
forced swim test and a sucrose preference test (Rubino et al., 2008). Those findings are in
line with work by Bambico and colleagues who reproduced those two findings and also
reported evidence for elevated anxiety-like behaviors as indexed by a novelty-suppressed
feeding test in pretreated rats (Bambico et al., 2010). It is important to stress that all of
these studies suggested adolescent, but not adult, exposure to cannabinoids precipitated
structural, functional, and behavioral differences. These results underscore the need to
predict cannabis use in human samples to minimize the likelihood of adolescents
developing these brain and behavioral differences.

Genetic Associations with Cannabis Use
In a recent GWAS study using a very large sample (N=184,765), researchers
identified eight single nucleotide polymorphisms (SNPs) that explained 11% of the
variance of lifetime cannabis use. The top three SNPs were on a gene coding for
CADM2, a cell adhesion molecule that is expressed widely in the brain. Authors reported
this gene was previously affiliated with alcohol consumption and risk taking behaviors
(Pasman et al., 2018).
There were two GWAS for cannabis use dependence (DSM-IV). The first study
identified three SNPs having an association with cannabis use dependence. One SNP was
found on an antisense transcription region (RP11-206M11.7, rs143244591) whose
function was unknown. The other SNPs were found on a gene coding for a protein that
regulates extracellular calcium concentrations (SLC35G1, rs146091982), and a gene
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coding for a protein that regulates neuronal inflammation (CSMD1, rs77378271; Sherva
et al., 2016). In the earlier GWAS study, none of their SNPs passed significance levels
appropriate for GWAS studies (p < 1.0 x 10-8; Agrawal et al., 2011). However, authors
suggested a candidate-gene approach using neurotransmitter receptor genes (e.g.,
cannabinoid, opioid, dopamine), and relevant enzymes (e.g., fatty-acid amide hydrolase,
FAAH) might better uncover associations with cannabis use (Agrawal and Lynskey,
2009). Therefore, a GWAS approach might not yield the most clear or robust findings
despite their potential for identifying novel biological predictors of cannabis use.

Structural Brain Correlates of Adolescent Drug Use
Recently, Orr and colleagues compared a sample of very light cannabis users at
age 14 to a closely matched sample of controls and reported greater gray matter volumes
(GMV) across many subcortical regions like the amygdala, hippocampus, and striatum
with extent into the surrounding cortical regions (Orr et al., 2019). However, there is
mixed evidence in the literature. Ashtari and colleagues identified bilateral hippocampal
volume reductions in adolescent cannabis users compared to controls when scanned after
1 month of monitored abstinence. Self-reported levels of use were also inversely
correlated with the right hippocampus, suggesting a dose response in volume reduction
(Ashtari et al., 2011). Similarly, Yücel and colleagues reported GMV reductions in the
bilateral amygdala in adolescent users compared to controls (Yucel et al., 2008). In a
study of young adults, GMV was greater in the anterior cerebellum of heavy cannabis
users compared to controls. However, a negative correlation between dependency scores
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and right amygdala volumes, and negative correlation between weekly cannabis use and
bilateral hippocampal GMV was identified (Cousijn et al., 2012).
Generally, those studies provided convering evidence on medial temporal lobe
structures. All authors interpreted their finding in the context of the CB1 densities in
those regions and concluded cannabis use in adolescence might be toxic to those tissues.
Furthermore, those studies were inline with the animal models that reported neurotoxic
effects of exogenous cannabinoids on the hippocampus mentioned above.

Structural Brain Predictors of Cannabis Use
As the above studies were cross-sectional, they were unable to infer a causal
relationship between cannabis use and structural differences. Next, the few prospective
studies will be surveyed. Starting with a study by Cheetham and colleagues, researchers
studied an adolescent sample pre- and post-cannabis use. Findings indicated less GMV in
the orbital frontal cortex (OFC) at age 12 predicted cannabis use by age 16 (Cheetham et
al., 2012a). These findings are in line with work by Volkow & Fowler who reported
hypoactivity in the OFC using fMRI and positron emission tomography (PET)
characterized individuals with drug dependence (Volkow and Fowler, 2000). These two
studies suggest a propensity for drug use is partially predicted by differences in structure
and function of the OFC, a region putatively involved in relevant functions like reinforcer
evaluation (Noonan et al., 2012) and behavioral regulation (Bryden and Roesch, 2015).
Jacobus and colleagues investigated cortical thickness before (age 13) and after
(age 19) initiating alcohol-only, alcohol+cannabis, vs. drug-naïve controls. Less cortical
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thickness across many prefrontal regions, including the left precentral and superior
frontal gyri, predicted the future alcohol+cannabis group relative to alcohol-only, and less
thickness in right middle frontal gyrus predicted the alcohol+cannabis group relative to
controls (Jacobus et al., 2016). This study also contained repeated measures on some
neurocognitive and mental health screeners. Results indicated lower performance on
working memory tasks, and, higher externalizing scores at baseline predicted the
alcohol+cannabis initiating group relative to the others. These results suggested a
preexisting working memory deficit is continued (if not exacerbated) through prolonged
cannabis exposure in adolescence. These findings also indicate that a combination of
behavioral and neuroimaging measures yields a predictive profile of cannabis use in
adolescence.
In light of these two studies, findings generally indicated lower gray matter
volumes in prefrontal regions preceded cannabis use in adolescence. The interpretations
regarding these effects are challenging, although they might signal precocious
development as normative adolescent neurodevelopment is characterized by volume
reductions. Exhibiting lower volumes relative to their peers at the same age might
indicate an accelerated neurodevelopment, which in turn, facilitates maladaptive
psychosocial development involving cannabis use.

Functional Brain Correlates of Adolescent Cannabis Use
Cannabis use in adolescence has been largely understudied using fMRI. Work by
Tapert and colleagues studied response inhibition in a group of adolescents with and
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without cannabis use histories after 1 month of monitored abstinence. Despite not
observing behavioral task differences, higher and more diffuse cortical activations during
successful inhibition trials were observed in many prefrontal regions including bilateral
superior and middle frontal gyri in the cannabis using group relative to controls (Tapert et
al., 2007a). These findings indicated cannabis use might have partially induced lasting
functional differences as indexed by the lack of functional efficiency relative to their nonusing peers.
Similar studies also indicated that adolescent cannabis users did not differ on
cognitive task performance measures relative to controls following one-month of
abstinence. Instead, they were characterized by more diffuse brain activations throughout
parietal regions on a spatial working memory task (Padula et al., 2007; Schweinsburg et
al., 2008). Similar studies reported diffuse prefrontal activations during working memory
(Jager et al., 2010), and attention tasks (Abdullaev et al., 2010). Lastly, one study
identified more diffuse activity during a verbal working memory task correlated with an
earlier age of cannabis initiation (Becker et al., 2010). The consistency of these effects all
supports the interpretation that adolescent cannabis users may have compromised healthy
functional development as characterized by diffuse patterns of functional activations.
However, these studies did not evaluate their samples prior to cannabis initiation, so
causal interpretations are speculative.

Studies on Affective Processing
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Cannabis use elicits positively and negatively valenced mood altering properties
for the user, yet few investigators have used fMRI to study emotional processing in these
samples. Green and colleagues reviewed studies on the self-reported subjective
experiences related to acute cannabis use. Relaxation was the most common experience
reported by 91% of cannabis users. Negatively valenced experiences were also reported
as 40% of users reported anxiety and 27% reported depression (Green et al., 2003).
Together with the animal and human findings related to the emotional correlates and
consequences of cannabis use, these effects motivate a need to study cannabis use from
an affective neuroscience perspective. Furthermore, there is a gap in the literature for
studies using fMRI to illuminate differences in affective processing in adolescents.
However, the adult literature offers some insights.
The amygdala is a key brain region involved in visual threat detection systems
(Fox et al., 2015; Pessoa and Adolphs, 2010) and is commonly implicated during fMRI
studies of social affective processing (Adolphs, 2010). Amygdala reactivity has only been
studied in light of cannabis use for adults. A pharmacological fMRI study by Phan and
colleagues reported that acute administration of THC was associated with lower
amygdala reactivity during angry face processing relative to placebo (Phan et al., 2008).
Outside of the acute period, Gruber and colleagues corroborated this affect by reporting
that adults with chronic cannabis use displayed lower amygdala reactivity to angry faces
following a minimum 12-hour cannabis abstinence relative to non-users (Gruber et al.,
2009).
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In adolescents, one study by Heitzeg and colleagues probed for differences using
an emotional word processing task. In that study, researchers compared adolescents with
heavy cannabis use histories to a sample of very light cannabis using controls. Results
indicated that heavy users demonstrated lower bilateral amygdala activations when
processing both positively and negatively valenced words (Heitzeg et al., 2015).
Together with the adult studies, these reports indicated that cannabis use is correlated
with differences in affective processing, with converging evidence on amygdala
reactivity. Lower amygdala reactivity generally followed acute and protracted use
histories. It will be important to assess if emotional processing differences preceded use,
as it is hypothesized that higher emotional reactivity partially influences individuals to
use cannabis for the relaxing (anxiolytic) effects.

Functional Brain Predictors of Drug Use
There is a lack of prospective studies that examined functional brain activations
prior to cannabis use in adolescence. After searching the literature, a single report by
Tervo-Clemmens and colleagues was identified (Tervo-Clemmens et al., 2018). In that
study, researchers scanned children at age 12 and 15 using a working memory paradigm.
Results indicated that higher frontoparietal activations and lower visual cortex activations
during high task load in a sample of cannabis-naïve children predicted cannabis use by
age 15. A dose-response effect was also found in the cuneus, such that lower activations
predicted heavier use. Additionally, lower spatial planning scores from a cognitive test
battery (CANTAB) also predicted use. These results add to the literature despite being
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limited by a small outcome group (n=22 future cannabis users), therefore, replication and
larger studies are needed.
Reasons for the shortage of prospective fMRI results are unclear, but might be
related to publication bias. And although speculative, the structural studies reported by
Jacobus and Cheetham likely came from a larger project with fMRI as neuroimaging
batteries usually contain both structural and functional assessments. The lack of
publications on fMRI data from these groups might suggest no functional differences
were identified. And again, as this is speculative, the functional predictors of cannabis
use are likely to be small effects, which necessitates a large sample. As a final thought, it
might be the case that a non-linear or machine learning approach might be better suited to
identify neurobiology predictors as Jacobus and Cheetham and colleagues used
traditional mass-univariate approaches. To date, machine learning approaches are in their
infancy, as few longitudinal machine learning studies have been reported. This sparse
literature will be reviewed at the end of the following section.

1.4 Predictive Modeling of Drug Use
Predictive Modeling Overview
As outlined by Whelan & Garavan, predictive modeling is a technically
challenging pursuit with many opportunities for methodological errors leading to inflated
interpretations (Whelan and Garavan, 2014). These issues are pertinent to the field of
psychiatric neuroimaging (or any field with feature-rich datasets) as the number of
independent variables (hundreds of regions of interest or thousands of voxels) predicting
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a phenotype exceeds the sample size. In this scenario, estimating a multiple regression
model yields perfect fit to the data. In general, model fit statistics increase as the number
of parameters increases, and/or the number of subjects decreases (Babyak, 2004). In these
scenarios, an uninformed researcher might become overoptimistic and interpret the
results of an overfit model (Whelan and Garavan, 2014).
The ultimate goal for prediction analyses is to yield a model that accurately
predicts novel observations. The gold standard for predicting novel observations is to test
a model on a completely independent external dataset. However, the researcher might not
have this option with a limited sample size. To overcome the lack of an external dataset,
and to address the challenges in estimating a model with an excessive number of
variables, we will consider two remedies that can be used in parallel— cross-validation
and regularization (or feature selection more generally).

Cross-Validation
Cross-validation is a procedure commonly used to partition the original dataset
into subsamples of observations (Wong, 2015). A model is then estimated on one
subsample of the dataset (“training data”), and then evaluated using the observations in
the subsample not used (“test data”) during model estimation. A common practice is to
initially set aside a percentage of the data as the validation set, say 10%, and estimate a
predictive model on the remaining 90%. Thus, the researcher is able to evaluate how well
their predictive model generalizes to the set aside 10%. Generalizability may be
quantified using typical model performance statistics, like R2 for linear models or the area
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under the curve of the receiver-operating characteristic (ROC AUC) from logistic
models, returned from evaluating the model on the test data. For these two statistics,
values closer to 1 reflect superior prediction.
ROC curves plot the trade off between sensitivity and 1-specificity at all
probability thresholds provided by the classifier (i.e., the logistic model) (Hanley and
McNeil, 1982). For ROC AUCs, values from 0.99 – 0.51 reflect diminishing returns, with
0.50 reflecting chance performance. These values reflect the probability of a randomly
chosen “case” being ranked higher than a control. To help with interpretation, work by
Rice and Harris has shown that the ROC AUC can be equated Cohen’s d and Pearson’s
point-biserial correlation, such that a medium effect size Cohen’s d=0.5, and r=0.243, is
equivalent to a ROC AUC=.639 (Rice and Harris, 2005).
One specific form of cross-validation is k-fold cross-validation, where k = number
of partitions (or, “folds) of the original dataset (Wong, 2015). Each fold contains a
similar amount of unique samples from the original dataset (i.e., when k = 10 and N=100,
each kth fold will have 10 observations). k-fold cross-validation then becomes an iterative
process whereby a single fold is set aside as the test sample (“test fold”), and a model is
estimated on the remaining k-1 folds. The model estimated on the k-1 folds is then
evaluated on the set aside test fold, thereby insuring the independence of the final test
sample. This process is repeated k times, resulting in k final models. In doing so, each
observation is tested exactly once, and used in model estimation k-1 times.

Regularization
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Regularization is statistical technique used during regression model estimation
that attempts to minimize the amount of overfit to the data. (Zou and Hastie, 2005)
Similarly to model estimation using ordinary least squares, regularized regression
techniques seek to minimize the error between the predicted and observed outcome while
also minimizing the magnitude of the regression coefficients. It is important that all
independent variables are standardized prior to regularization so that coefficient
penalization is consistent across independent variables. Here, two specific forms of
regularization will be considered, LASSO (Least Absolute Shrinkage and Selector
Operator; Tibshirani, 1996), and Ridge regression (Hoerl and Kennard, 1970).
LASSO regression rejects complex models in favor of parsimonious models by
minimizing the sum of the absolute values of the coefficients (Tibshirani, 1996). In doing
so, the LASSO estimator solves for the 𝓵𝟏 -norm of the design matrix. During LASSO
estimation, predictors that are weakly correlated with the outcome measure are assigned a
regression coefficient equal to zero, effectively removing them from the final model. The
predictors remaining in the model are therefore more important to the outcome measure
than the predictors set to zero. LASSO regression is one technique available to
researchers when the number of predictors is immense, as the estimation procedure
performs feature selection while fitting a model.
Ridge regression seeks to solve problems arising from multicolinearity among
predictor variables (Hoerl and Kennard, 1970). The Ridge estimator minimizes the sum
of the squared values of the regression coefficients during model fit. In doing so, the
Ridge estimator solves for the 𝓵𝟐 -norm of the design matrix. All predictors are included
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during ridge regression (unlike LASSO) but are assigned smaller coefficients to reduce
their fit. As such, correlated predictor variables are given similar regression coefficients
and allowed to coexist in the model. Therefore, Ridge regression might be especially
valuable in modeling inherently correlated predictor variables common to neuroimaging
and psychological research (e.g., neighboring or functionally co-activating brain data;
alcohol and tobacco use levels).
In scenarios with excessive independent variables, and modeling correlated
variables might be of theoretical interest, a hybrid approach balancing LASSO and Ridge
regression, termed “elastic-net” regularization (Zou and Hastie, 2005), can be used. In
elastic-net regularization, LASSO and Ridge are combined using a mixing parameter, α
that balances the contribution of the LASSO to Ridge estimation methods. In addition to
the α parameter, a second parameter, λ controls the magnitude of the shrinkage applied to
the coefficients.
During elastic-net model estimation, the α and the λ values can be tuned within a
cross-validation procedure in order to identify the optimal set of parameter values that
minimize the test error returned from evaluating model fit on an independent sample of
observations. These tuning parameters are always non-negative values, such that 0 ≤ α ≤
1 and 0 ≤ λ. It can be shown that when α approaches 1, the LASSO estimator is favored,
and when α approaches 0, the Ridge estimator is favored (Zou and Hastie, 2005).
Intermediate values of α provide an interpolation between the two estimation procedures.

Tree-based Estimators
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Most regression models are an extension of the general linear model and assume
independent variables (IVs) combine in some linear fashion to predict the dependent
variable (DV). However, this might not always be a safe assumption when modeling an
excessive number of IVs from disparate sources, as many of these features might exhibit
non-linear effects when predicting the DV. In parallel, attempting to include interaction
terms (or other non-linear terms) for an already excessive number of IVs would be
prohibitive. Regression models also attempt to model the average (singular) relationship
between the IVs and DV (See Lemon et al. 2003, for comparison of regression to treeestimation) (Lemon et al., 2003). However, it is hypothesized that the observations in a
sample reach the same outcome through different pathways. Different pathways are
especially viable when the outcome is a behavioral measure. Therefore, estimating
regression models may not be the optimal way to leverage a large dataset or to probe
individual differences.
To address these concerns, non-linear modeling procedures like decision trees
and random forests (Breiman, 2001) can serve as candidate models to predict cannabis
use initiation. These tree-based models are more easily understood and interpretable nonlinear models relative to support vector machines or neural networks. A decision tree
consists of series of logical if-then rules that effectively partition the feature space to
group observations together (Quinlan, 1986). The optimal set of rules divides the feature
space until the observations are adequately separated into their respective outcomes.
Trees can be estimated for both categorical or continuous outcomes by minimizing class
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impurity or squared error within each partition. In the case of predicting drug use, trees
can be constructed to partition all future cannabis users separately from their naïve peers.
An extension of the decision tree is a random forest (Breiman, 2001). During
model estimation, a single decision tree is estimated on a randomly selected set of
features. This procedure is then repeated many times until many trees built off randomly
selected features comprise a “forest”. Random forests are ideal for feature rich datasets as
it is equally likely for any feature to be randomly selected during the construction of a
tree in the forest. And due to the random selection of features, random forests effectively
account for multi-colinearity. And while all randomly selected features (usually restricted
to the square root of the total number of features) are considered during tree estimation,
only those that separate the classes when split are assigned an if-then rule.
The forest can then be used to predict new observations by taking the majority
vote across all trees. Looking across the trees in the forest, one can also determine the
features that best predicted the outcome measure when split. A summary decision tree
may then be estimated using only those features. Therefore, a predictive profile informed
by a tree-based estimator conveys a unique pathway towards the outcome measure,
whereas a profile informed from a regression provides a singular pathway for the average
individual.
One caveat to this method is the high risk of overfitting, as a decision tree can
quickly become complex enough to exactly classify each observation (Schaffer, 1993).
Therefore, techniques to resist overfitting must be applied when predicting out of sample
observations. These techniques include limiting the depth of the tree and requiring a
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minimum number of observations present in a terminal leaf node. In doing so, these rules
stop the decision tree from completely isolating each single observation.

Predictive Modeling of Binge-Drinking by Age 16
Whelan and colleagues implemented cross-validated regularized regressions to
classify adolescent binge-drinkers at age 14, and, predict binge-drinking by age 16 from
data collected age 14. In applying these methods to a wealth of neuroimaging,
psychometric, and candidate SNP data, findings indicated highly significant classification
(AUC=0.90) and prediction (AUC=0.75). Hence, these methods yielded models that
performed well in classifying and predicting independent samples.
When probing the models further, the most reliable features that both classified
and predicted adolescent binge drinking were more frequent sexual life experiences and
higher novelty seeking, disorderly, and extravagant personalities, and lower
conscientiousness personality traits. The brain features that classified age 14 binge
drinking included lower GMV of the vmPFC, and lower activations in the left putamen
and hippocampus during reward anticipation, and right hippocampus during reward
outcome. The brain features that predicted binge drinking were lower activations in preand post-central gyri during failed response inhibitions. In sum, the classification was
driven by lower activity in regions serving appetitive processing, while the prediction
was driven by lower activity in sensory motor areas during failed response inhibitions.
Finally, Squeglia and colleagues recently published a machine learning study
predicting the initiation of alcohol use in adolescence (Squeglia et al., 2017). In that
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report, researchers used random forests on data collected at age 12-14 to predict moderate
to heavy alcohol use by age 18, relative to a sample of consistently alcohol naïve peers.
Three separate models were generated using an increasing number of feature domains
(demographics only; demographics + neurocognitive; demographics + neurocognitive +
neuroimaging). The prediction accuracies increased with the inclusion of each domain, as
indexed by sensitivity (.60, .67, .74) and specificity (.64, .70, .73) to alcohol initiation.
The most important features driving prediction were largely from the neuroimaging
domain, including lower thickness of the left supramarginal gyrus, lower activation in the
right posterior cingulate and superior temporal gyrus during a working memory task.
Aside from the neuroimaging data, sex, socioeconomic status (SES), and
cognitive measures were also selected as predictors of adolescent alcohol use. The lack of
consistency with Whelan and colleagues are likely due to differences in measurement
(Whelan used voxel-wise data, Squeglia used ROIs). Nonetheless, these results indicated
the highest prediction was achieved with the combination of behavioral and
neuroimaging data. And in keeping with the prediction study by Whalen and colleagues,
significant and meaningful predictions can be made using a machine learning approach to
leverage multi-domain data to uncover profiles predicting drug use in adolescence.

1.5 Overview of the IMAGEN study
The IMAGEN study (Schumann et al., 2010) is large longitudinal study of
adolescent development conducted across eight different sites in Europe (Paris, Dublin,
London,

Nottingham,

Berlin,

Hamburg,
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Mannheim,

Dresden)

(www.imagen-

europe.com). Study procedures included a comprehensive neuroimaging (MRI) battery
and blood assays for genetic measurements of the adolescent. Both the adolescent and
their parent also completed many psychosocial questionnaires. The study was designed to
address many different scientific aims (Schumann et al., 2010) but broadly seeks to
understand the relationship between adolescent psychosocial and neurobiological
development, and how those data characterize and predict behavioral health issues.
The study employed a convenient community sampling method by targeting the
local school systems. Efforts were made to stratify enrollment to capture differences in
ethnic and socioeconomic backgrounds. Baseline enrollment started at age 14, and youths
were reassessed at ages 16 and 19. At the baseline visit, study protocols were explained
to the family, written informed consent was obtained from the parent, and the child
provided assent. Local ethics committees at all participating sites approved the study
protocols. There were N=2,224 participants enrolled in the baseline sample.
At the baseline visit, parents completed a set of self-report questionnaires related
to their personality, drug use levels, and family histories. They also completed a mental
health screener for which they reported on their child. The mental health questionnaire
used in IMAGEN was the Development and Well-Being Assessment (“DAWBA”) and
the affiliated brief screener, the Strengths and Difficulties Questionnaire (“SDQ”)
(Goodman, 1997; Goodman et al., 2000).
The adolescent also provided self-report on many of the same questionnaires.
Personality was measured via the NEO, TCI, and SURPS questionnaires (Cloninger,
1999; Costa Jr. and McCrae, 1995; Woicik et al., 2009). Drug use frequencies were
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measured on an ordinal scale using the European School Survey Project on Alcohol and
Other Drugs instrument (ESPAD) (Hibell et al., 1997). Frequencies and valence ratings
for various stressful life events was measured via the life events questionnaire (Newcomb
et al., 1981). Various cognitive measures were also recorded (Kirby et al., 1999;
MacLeod et al., 1986; Robbins et al., 1994) including their performance and verbal IQ
levels (Wechsler, 2003).
Blood assays were performed at baseline from which DNA was extracted.
Genotype information was collected at 582,892 markers using the Illumina
HumanHap610 and HumanHap660 Genotyping BeadChips (San Diego, CA). The 1000
Genomes project reference set of markers (www.internationalgenome.org) was used for
imputation after reducing the markers to ~13 million SNPs for European populations.
Adolescents without any MRI contra-indications received a neuroimaging scan.
For brain structure, a high-resolution whole-brain anatomical scan (MPRAGE), and a
diffusion-tensor imaging (DTI) scan for white-matter fiber tractography were collected.
For brain function, three fMRI tasks were administered. The stop signal task measured
motor response inhibition (Rubia et al., 2005). The monetary incentive delay task
measured reward anticipation and reward outcomes (Knutson et al., 2000). Lastly, a face
processing scan that involved passive viewing of angry and neutral faces was collected
(Grosbras, 2005). Standardization efforts were in place to ensure all sites used similar
acquisition techniques, and all data were submitted to identical preprocessing pipelines.
Adolescents were then followed up at age 16 and 19. The age 16 assessment
contained only a brief follow up using psychosocial questionnaires and was completed at
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home using an online portal (Psytools, Delosis, London, UK). The age 19 visit also
included a follow up using the psychosocial questionnaires, and another neuroimaging
scan that was identical to the baseline visit. See www.imagen-europe.com for all standard
operating procedures as well as a selection of papers that previously reported on
IMAGEN data.
1.6 Current Report
This dissertation contains a collection of studies that uncover the correlates and
predictors of cannabis use in adolescence by leveraging data from the IMAGEN study.
The first study (in Chapter 2) tested for cross-sectional differences in the neurobiology of
adolescents who reported any lifetime cannabis use at baseline (age 14). As informed by
the animal and human studies, the face processing task was selected for use as it was
hypothesized that adolescents using cannabis would exhibit hyperactivity to social threat
processing cues. This study also adds to the apparent gap in the literature relating
adolescent cannabis use to the functional neurobiology supporting affective functions.
After characterizing those differences, the longitudinal nature of the IMAGEN
dataset was interrogated to determine if the differences observed in Chapter 2 preceded
cannabis use in adolescence. Hence, Chapter 3 begins the prediction theme of this
dissertation by predicting cannabis use levels at age 19 using a sample of individuals who
were cannabis-naïve at age 14. As such, the baseline data was disentangled from the
consequences of cannabis exposure.
The remaining studies in Chapters 4 & 5 better characterize a predictive profile
related to cannabis use in adolescence by examining data from all three feature domains
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in the IMAGEN study. Cannabis naïve samples at baseline were identified and machine
learning was used to identify the predictors of cannabis initiation by age 16 and 19.
Prediction models were executed separately by sex in light of the sex-differences
discussed above. Post-hoc analyses tested if the predictors were specific to each sex or
generalized to the opposite sex. Finally, drug-specificity was assessed by evaluating the
identified predictors of cannabis use on an independent sample of binge drinkers. As
cannabis use and binge drinking were found to be highly co-occuring, drug-specificity
was evaluated again by executing similar machine learning analysis predicting future
cannabis use versus future binge drinking.
Results from theses analyses uncovered the predictive profiles of cannabis use in
adolescence. These profiles can be used to both stratify risk and inform intervention
strategies designed to mitigate use. For instance, the level of risk for cannabis use can be
determined by how closely an adolescent aligns with the predictive profiles uncovered
here. The psychosocial and neurobiological predictors uncovered here inform treatment
strategies. As the literature indicated cannabis use in adolescence is associated with
psychosocial, cognitive, and neurobiological differences, the knowledge gained from this
dissertation will be translated to help lower cannabis use in adolescence through
interventions designed to alter a risk phenotype.
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CHAPTER 2: CROSS-SECTIONAL FACE PROCESSING DIFFERENCES IN
ADOLESCENTS USING CANNABIS
This Chapter has been previously published in the following format:
Spechler, P. A., Orr, C. A., Chaarani, B., Kan, K.-J., Mackey, S., Morton, A., ... Garavan,
H & IMAGEN Consortium.. (2015). Cannabis use in early adolescence: Evidence of
amygdala hypersensitivity to signals of threat. Developmental Cognitive Neuroscience,
16, 63–70.
Abstract
Cannabis use in adolescence may be characterized by differences in the neural
basis of affective processing. In this study, we used an fMRI affective face processing
task to compare a large group (n = 70) of 14-year olds with a history of cannabis use to a
group (n = 70) of never-using controls matched on numerous characteristics including IQ,
SES, alcohol and cigarette use. The task contained short movies displaying angry and
neutral faces. Results indicated that cannabis users had greater reactivity in the bilateral
amygdalae to angry faces than neutral faces, an effect that was not observed in their
abstinent peers. In contrast, activity levels in the cannabis users in cortical areas including
the right temporal- parietal junction and bilateral dorsolateral prefrontal cortex did not
discriminate between the two face conditions, but did differ in controls. Results did not
change after excluding subjects with any psychiatric symptomology. Given the high
density of cannabinoid receptors in the amygdala, our findings suggest cannabis use in
early adolescence is associated with hypersensitivity to signals of threat. Hypersensitivity
to negative affect in adolescence may place the subject at-risk for mood disorders in
adulthood.
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Introduction
Adolescence is a significant period of psychosocial development, with increases
in novelty-seeking and risk-taking behaviors (Adriani et al., 1998; Romer et al., 2010;
Trimpop et al., 1998). Experimentation with drugs of abuse – especially alcohol, tobacco,
and cannabis, is typically initiated during this phase (Chen and Kandel, 1995). As
cannabis becomes more available and public opinion trends towards acceptance,
adolescents may have increased access to the substance.
Current rates of cannabis use among adolescents are high, with a quarter of all
10th graders, and over a third of all 12th graders in the US reporting trying cannabis at
least once (SAMHSA, 2014). Chronic use also appears to be growing; in 2008, 5.5% of
users aged 12 and up reported near daily use while in 2013 this rate had risen to 8.1%
(SAMHSA, 2014). These increasing rates of use are consequential in that about 10% of
those who try cannabis will become weekly users in adulthood (Hall and Pacula, 2003).
Furthermore, adolescent beliefs about the risks associated with cannabis appear to be
declining (Johnston et al., 2011).
Adolescence is also a period of marked neural development including gross
volume changes, myelination, synaptic pruning, and receptor proliferation (Spear, 2000).
These changes are especially large in the prefrontal cortex (PFC) (Gogtay et al., 2004;
Whitford et al., 2007), amygdala, hippocampus, and striatum, and are governed in part by
the endogenous cannabinoid system (Bossong and Niesink, 2010). Interestingly, the
primary cannabinoid receptor, CB1, is found in high concentrations in these cognitive
and affective regions of the brain (Glass et al., 1997; Herkenham et al., 1991; Katona et
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al., 2001), and appears to be fully expressed by adolescence (Belue et al., 1995; de
Fonseca et al., 1993; Morozov and Freund, 2003; Romero et al., 1997). Studies have
shown that exogenous cannabinoids can interfere with the endogenous system (Hoffman
et al., 2007; Mato et al., 2004). Given the natural maturation occurring in the brain during
adolescence, and the propensity towards cannabis use, the consumption of exogenous
cannabinoids during adolescence may disrupt typical neurodevelopment within the
cognitive and affective neural systems.
Mounting evidence supports the relationship between early cannabis use and
mood disorders (Wittchen et al., 2007), even with relatively low levels of use (Cheung et
al., 2010). Hence, it is crucial to investigate the consequences of cannabis use on
emotional development. Although numerous studies have associated cannabis use in
adolescence with an increased likelihood of schizophrenia and/or other affective
disorders (Arseneault et al., 2004; Degenhardt and Hall, 2006; Fergusson et al., 2006;
Hall, 2006; Linszen and van Amelsvoort, 2007; Manrique-Garcia et al., 2012) there is
relatively little research on the impact of cannabis use from a cognitive and affective
neuroscience perspective.
The amygdala has a high density of CB1 receptors, notably in the basal and lateral
nuclei (Katona et al., 2001). In adulthood, increased amygdala activity is associated with
major depressive disorder (Drevets, 2001; Sheline et al., 2001), and generalized social
phobia (Evans et al., 2008; Phan et al., 2006). In adolescence, the amygdala was found to
yield stronger responses to fearful faces than adults (Thomas et al., 2001), and greater
amygdala reactivity may account for adolescent vulnerability to mood disorders (Guyer
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et al., 2008a; Monk et al., 2008; Roberson-Nay et al., 2006). In consideration of the
amygdala’s role in the endocannabinoid system and affective processing, adolescent
vulnerability to mood disorders and propensity for cannabis use, it is important to assess
functional differences in this region in cannabis-using teenagers.
Using an animal model, Rubino and colleagues (2008), and Schramm-Sapyta and
colleagues (2007) examined the relationship between anxiety and THC exposure in
adolescent and adult rats. Findings indicate that adolescent rats exhibit elevated signs of
anxiety, depression, and anhedonia when treated with THC compared to placebo.
Translating these findings to humans may imply cannabis use in adolescence is related to
differences in the generation and regulation of affect.
To examine the impact of cannabis use on brain regions subserving emotional
processing, we conducted an fMRI study on 14-year old cannabis users vs. controls using
affective face stimuli. Angry and neutral faces provide a robust probe of activity within
the amygdala and PFC in adults (Morris et al., 1996; Pessoa et al., 2002; Whalen et al.,
1998), as well as children and adolescents (Baird et al., 1999; Thomas et al., 2001). The
differential activity of the amygdala to angry versus neutral faces is an excellent index of
emotional processing and may relate to psychopathology. However, in order to prevent
ceiling effects, we used a set of stimuli that was only mildly negatively valenced on the
basis that they may provide a sensitive test of enhanced amygdala reactivity (Grosbras
and Paus, 2006).
To date, few study have examined the relationship between cannabis and face
processing. Phan and colleagues (2008) recruited healthy adults in a dual-session, double55

blind, placebo-controlled study of THC intoxication and face processing using fMRI.
Findings indicate THC attenuates the amygdala response to fearful faces. Similarly,
Gruber and colleagues (2009) studied 15 chronic cannabis users vs. matched controls
under fMRI during a masked affective face processing task. Results suggest chronic
cannabis use is associated with decreased reactivity in the anterior cingulate and
amygdala. While both Phan and Gruber’s findings suggest anxiolytic effects in
intoxicated adults, these studies do not address whether the effects would replicate in
users not intoxicated during scanning, nor does it address whether the effects would
generalize to adolescents. Nonetheless, these studies provide evidence that cannabis use
is associated with differences in affective processing.
In this relatively large fMRI study (N=140), we investigated the impact of
previous cannabis use (n=70) compared to closely matched controls (n=70) in early
adolescence using a face processing task during fMRI. To date, there has been no
previous research directly studying history of cannabis use with face processing,
especially not from a developmental affective neuroscience perspective.

Methods
Participants
We identified a sample of cannabis-experimenting adolescents (n=70) and
matched controls (n=70) from the IMAGEN dataset, a large multi-site longitudinal study
of adolescent development (Schumann et al., 2010). The European School Survey Project
on Alcohol and Other Drugs (ESPAD) item for lifetime history of cannabis use was used
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to identify the cannabis-experimenting group. Subjects provided a self-report based on a
scale from 0 to 6, (1=1–2x; 3= 6–9x; 6=40+; see Table 2.1 for complete distribution, and
Table 2.2 for substance use age of onset distributions). Subjects who endorsed using
other illicit substances were excluded, and any subject exhibiting signs of intoxication
were excluded from scanning.
Given the relationship between amygdalar reactivity and psychopathology,
subjects completed the Development and Well-Being Assessment (DAWBA; Goodman
et al., 2000) to screen for psychopathology symptomology. DAWBA clinical rating
scores were obtained from trained DAWBA clinicians who generated clinical rating
scores by reviewing parent, teacher, and adolescent DAWBA responses. Final scores
consisted of one of three categories: no-diagnosis, unsure, and, sure diagnosis, on any
DSM-IV symptom class of psychopathology. From our sample, five of the controls and
nine of the cannabis-experimenting group did not complete the DAWBA. Nonetheless,
subjects were matched to the best of our ability on the DAWBA as indicated via chisquare analyses.
Controls were identified and matched on sex, handedness, age, verbal
comprehension and perceptual reasoning IQ, pubertal development, socioeconomic
status, and site. As cannabis use is highly correlated with alcohol and cigarette use (Hall
and Pacula, 2003), which often makes it difficult to attribute group differences to the
cannabis use per se, controls were also matched on lifetime alcohol and cigarette use.
Chi-square tests were performed on the DAWBA, sex, and handedness; t-tests were
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performed on the remaining continuous measures (see Table 2.3 for subject information
and p-values).

Task
Participants passively viewed a collection of video clips that contained either a
person’s face or a control picture (concentric circles). The task was designed and
originally implemented by Grosbras and Paus (2006) and required participants to
passively view a series of short (2–5s) black-and-white video clips showing a face that
started from a neutral expression and progressively turned angry, or, progressively turned
to a second neutral expression. The control pictures contained expanding and contracting
concentric circles of various contrasts, roughly matching the contrast and motion
characteristics of the faces. These control images were designed and originally
implemented by Beauchamp and colleagues (2003) and were included to account for
neural activity associated with viewing non-biological motion. All stimuli were presented
as 18 s blocks, with 4–7 video clips per block during a face block. Each run was
comprised of 5 blocks of neutral faces and 5 blocks of angry faces.

Imaging parameters
All MRI data were acquired using 3T MRI scanners made by several
manufacturers (Siemens, Philips, General Electric, Bruker) in the eight IMAGEN
assessment sites (London, Nottingham, Dublin, Mannheim, Dresden, Berlin, Hamburg,
and Paris). Important scanning parameters were identical across sites (i.e., field of view,
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flip angle and matrix; see Schumann et al., 2010) and followed an extensive program of
cross-site standardization. Although our groups were matched on site, each participant’s
site was modeled as a nuisance covariate in the statistical analyses. In the present task,
160 volumes per subject were obtained, each comprising 40 slices. The slices were
aligned to the connecting line between the anterior and posterior commissure (2.4 mm
thickness, 1 mm gap, TR=2.20s, TE=30ms).

Imaging analysis
The pre-processing of the EPI data was done within SPM8 (Statistical Parametric
Mapping, http://www.fil.ion.ucl.ac.uk/spm/). Time series data were first corrected for
slice-timing, then corrected for movement (spatial realignment), non-linearly warped into
MNI space (using a custom EPI template), and Gaussian-smoothed at 5mm-FWHM.
Activation maps were computed with SPM8, and regressed using a general linear model
(GLM) with AR noise model (SPM default) against a design-matrix modeling each event
of the stimulus presentation. Contrast images were obtained for the main effect of angry
faces and neutral faces, as well as the differential activation for angry vs. neutral faces.

Preliminary analysis
A preliminary voxel-wise analysis directly comparing the cannabis-experimenting
group to the control group was conducted using the AFNI toolbox (Cox, 1996). We
subjected the data to a between-group t-test on the contrast image of angry minus neutral
face processing. We detected greater differential activation to angry faces in the
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cannabis-experimenting group in small clusters spanning potentially interesting cortical
and subcortical areas (dorsolateral prefrontal cortex (dlPFC), temporal parietal junction,
fusiform, and right extended amygdala into the striatum). However, at a whole-brain
uncorrected p < .005, the clusters were small and consequently prompted a functionally
defined region-of-interest analysis.

Voxel-wise analysis
The central goal of the voxel-wise analysis was to find unbiased clusters of brain
activation that discriminated between angry and neutral faces. All cannabisexperimenting and control subjects were combined and treated as one group in a t-test vs.
zero using the angry vs. neutral contrast. Scanning site was used as a nuisance covariate
to account for the variance associated with multisite data collection.

ROI selection
ROIs were defined based on the results from the above voxel- wise analysis. The
alpha-level for cluster detection was determined by running Monte Carlo simulations
using AFNI’s 3dClustSim. The smoothness of the data was estimated using 3dFWHMx
(details at http://afni.nimh.nih.gov/pub/dist/doc/program help/). Based on a voxel-wise
uncorrected alpha of p=.005, a minimum cluster extent was determined to be 112
contiguous voxels, so as to arrive at a corrected ROI-level alpha of p = .01. From these
criteria, we identified seven regions that were significantly more active for angry faces
relative to neutral faces.
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Based on prior knowledge of the importance of the amygdala in affective face
processing, left and right anatomically defined amygdala ROIs were also included in the
analysis. Amygdala ROIs were obtained using the Eickhoff–Zilles macro label atlas in
MNI space distributed within AFNI (Eickhoff et al., 2005). The voxels in the amygdala
ROIs were then resampled to match the grid dimensions of the functional data.

ROI Analysis
The seven functionally defined clusters, plus the left and right amygdala ROIs,
were used to extract the mean BOLD signal from the angry face and neutral face
contrasts for all subjects. The mean signal for each ROI were then subjected to a 2-by-2
(group × face type) analyses of variance using SPSS v. 22 (IBM Corp. Armonk, NY). All
p-values reported were corrected for multiple comparisons using a modified Bonferroni
procedure (Keppel and Wickens, 2004). For display purposes, the mean signal for face
type by group was plotted using MATLAB v. R2014a (The MathWorks, Inc., Natick,
MA). Lastly, we tested for any correlation between the mean signal per face type within
all the ROIs with the level of cannabis use, and age of onset of cannabis, alcohol, and
cigarette use.

Results
Subjects
As shown in Table 2.3, the two groups did not differ in sex, handedness, age, verbal or
perceptual IQ, pubertal development, socioeconomic status, total (any) DSM-IV
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diagnoses, lifetime alcohol or cigarette use. Further, the cannabis-experimenting group’s
mean verbal and perceptual IQ did not significantly differ from the means of the entire
IMAGEN sample (N = 1849) at p < .05.

Voxel-wise analysis results
Seven clusters were identified centered on the right and left middle temporal
gyrus, right and left inferior frontal gyrus, bilateral anterior cingulate, left cerebellum,
and right lingual gyrus (see Table 2.4).

ROI ANOVA Results
As expected given how they were identified, all seven functionally defined ROIs,
plus the amygdalae, exhibited a significant main effect of face type (F9,130=30.03,
p<.001). None showed a main effect of group but, instead, five of the nine had significant
interactions between face type and group. These five were the left amygdala (F1,138=8.54,
p<.001); right amygdala (F1,138=8.54, p=.004); right middle temporal gyrus with extent
into temporal parietal junction (F1,138=5.28, p=.006); left inferior frontal gyrus with
extent into dlPFC (F1,138=4.87, p=.008); and right inferior frontal frontal gyrus with
extent into dlPFC (F1,138=5.71, p=.006) (see Figs. 2.1–3 and Table 2.4).
Post hoc tests revealed that within the cannabis-experimenting group, there were
significant differences in the bilateral amygdalae with greater activation for the angry
faces (right amygdala t69=4.02, p< .001; left amygdala t69=3.15, p=.002) but no effect of
face type on activity in the cortical ROIs. Controls showed a different pattern; there were
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significant face type differences in all the cortical regions with greater activation for
neutral faces, but no effect of face type on the BOLD signal in the amygdalae (right
middle temporal gyrus t69=−7.20, p<.001; left inferior frontal gyrus t69=−5.13, p<.001;
right inferior frontal gyrus t69=−5.68, p<.001: see Table 2.5 for all post-hoc t-test results).

ROI Correlations with Other Drugs
To examine dosage–response effects, we investigated Pearson’s correlation on
frequency of cannabis use with the mean signal per face type within each region. Dosage
effects within bilateral amygdalae and dlPFC were non-significant at p<.05. Interestingly,
we detected a significant correlation within the right TPJ cluster with frequency of
cannabis use. Both the mean signal related to angry faces (r=−.25, p<.05), and neutral
faces (r=−.26, p<.05), was correlated with frequency of cannabis use, such that, more
frequent cannabis use is associated with less processing by the right TPJ during
presentation of both face types.
We also investigated Pearson’s correlation on age of onset of cannabis, alcohol,
and cigarette use with the mean signal per face type within each ROI. However, we failed
to detect any significant correlations at p<.05 between age of onset for any drugs of abuse
with any of the ROIs.

Psychopathology Symptomology
The DAWBA clinical rating scores revealed 14 cannabis- experimenters and 10
control subjects (X21,122=1.19, p>.05) were identified as having a “sure” DSM-IV
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symptom class diagnoses. Chi-square analyses revealed the only symptom class that
significantly differed between the two groups was conduct disorder: X21,122=5.55, p<.05.
This finding is consistent with previous studies reporting an association between conduct
disorder and cannabis use initiation during adolescence (Castellanos-Ryan and Conrod,
2011; Hopfer et al., 2013).

Influence of Psychopathology
To examine if the conduct disorder finding was related to our results, we first
excluded the five subjects with a conduct disorder diagnosis and re-ran the ANOVA and
post hoc t-tests. Both the ANOVA and post hoc t-tests results remained the same as the
initial analysis with all subjects included. We then tested to see if conduct disorder in the
cannabis-experimenting group was correlated with the BOLD signal in any of the ROIs,
but failed to detect any significant correlation at p < .05.
Lastly, to test if any psychopathology influenced the dataset, we excluded all 14
cannabis-experimenting and 10 control subjects with a strong probability of a DSM-IV
category diagnosis from the ANOVA and post hoc t-tests, and reran the analyses. When
correcting for multiple comparisons, the left and right amygdala and right TPJ maintained
significance on the ANOVA face type × group interaction. Nonetheless, the same five
regions that initially survived correction for multiple comparisons for the full sample
analysis still passed significance at an uncorrected p-value of <.05. Additionally, the post
hoc t-test results remained the same. Consequently, with minor exceptions regarding
correction for multiple comparisons, results remained largely the same even when
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analyzed on sub-groupings devoid of any mental health symptomology. Hence, these
findings suggest that mental health symptomology was not contributing to the full sample
group differences.

Discussion
In this study, we examined the functional neurobiology of angry and neutral face
processing in a group of cannabis-experimenting adolescents vs. matched controls using
fMRI. We found group- by-face type interaction effects in bilateral amygdala and three
clusters of activation that span the right TPJ and bilateral dlPFC. Decomposing these
results by face type, we found the cannabis-experimenting group exhibited increased
activity to angry faces in the amygdala. Conversely, the control group exhibited increased
activity to neutral faces in the cortical regions. Therefore, cannabis use during early
adolescence is associated with hypersensitivity to negative affect in the amygdala. While
we stress that this study does not permit us to conclude cannabis-experimentation caused
the observed functional neurobiological differences, we are confident these differences
are associated with the cannabis use status of the participants due to our relatively large
sample size (N = 140), carefully matched control group (who did not differ on sex,
pubertal development, IQ, site, psychopathology, or alcohol and cigarette use), and a
conservative criteria to meet statistical significance.
With regard to the cortical findings, the right TPJ and bilateral dlPFC showed
greater activation to neutral faces than angry faces in the control group. The right TPJ has
been implicated in theory of mind, social processing, and face processing (Allison et al.,
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2000; Saxe and Kanwisher, 2003; Saxe and Powell, 2006). Furthermore, the right
superior temporal gyrus encodes biologically relevant motion (Grossman et al., 2000;
Puce and Perrett, 2003; Saygin, 2007). Therefore this cluster may represent a signal of
social salience related to the moving face stimuli. In contrast to controls, post hoc t-test
results show the cannabis-experimenting group fails to process angry faces differently
from neutral faces within the right TPJ (see Fig. 2.2). As this region was also the only
region to exhibit significant dosage effects, a higher degree of cannabis experimentation
may contribute to a departure from healthy social processing. Interestingly, as none of the
regions exhibited a significant correlation with age of onset for any drugs of abuse, we
are unable to make claims regarding face processing and cannabis use in relation to age
of onset with other drugs.
Considering that the cortical clusters spanned the temporal, parietal, and bilateral
frontal lobes, we suggest that the neutral faces demanded more cognitive resources. The
neutral faces had greater ambiguity and variability in their content, such as nose
twitching, mouth movements, and eye-blinks. Furthermore, all stimuli video clips started
from neutral and transitioned to angry or neutral faces. The stimuli that transitioned to
angry faces were more explicit during the shift to threat, whereas the transition to another
neutral face may have required more cognitive strategies to decode. Hence, the neutral
faces may have demanded a greater degree of attention and interpretation by these
cognitive systems.
With regard to the amygdala findings, it is unclear whether amygdala
hypersensitivity preceded cannabis use or was a consequence of use since this was a
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cross-sectional study. If amygdala hypersensitivity preceded use, which might seem most
plausible given the low levels of reported use, then it’s possible that these individuals
may have been inclined to self-medicate for the drug’s acute anxiolytic effects (Phan et
al., 2008). Consistent with this interpretation, recent evidence has identified altered angry
face processing in the ventromedial PFC (vmPFC) to predict future binge drinking
(Whelan et al., 2014) and the vmPFC is part of a brain circuit that attenuates amygdala
activity (Banks et al., 2007; Urry et al., 2006). If, however, the amygdala hypersensitivity
is a consequence of cannabis use, then it is likely that this is due to exogenous stimulation
of the endocannabinoid system. If confirmed, these findings would raise concerns
regarding the risks associated with cannabis consumption and emotional health in
adolescent users. Animal studies suggest exogenous cannabinoids inhibit GABAergic
neurotransmission in the amygdala (Katona et al., 2001). Interestingly, this effect is
magnified when the animal is given THC and placed in a threatening environment (Patel
et al., 2004). Together these findings suggest that cannabinoids may compromise the
major neuronal inhibitory mechanism within the amygdala and lower the threshold for
activation, especially during signals of threat. Consistent with this interpretation, the
angry faces used in the task were not exceptionally potent signals of threat yet the
cannabis-experimenting group showed a heightened reactivity to them, an effect that is
not observed in healthy controls viewing the same stimuli (Grosbras and Paus, 2006).
The amygdala’s role in affective processing serves an important role in
evolutionary biology as it directs attention towards aversive stimuli. However, mounting
evidence suggests that overrecruitment of the amygdala is associated with various mood
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disorders. Greater signal change in the amygdala, specifically during affective face
processing, is exhibited by children with anxiety (Thomas et al., 2001), and adults with
major depressive disorder (Drevets, 2001; Fu et al., 2008; Sheline et al., 2001) and
generalized social phobia (Evans et al., 2008; Phan et al., 2006). Thus, cannabis use in
adolescence may contribute to the etiology of mood disorders in adulthood. Moreover,
relatively light use by an early age may contribute to an early marker of maladaptive
affective processing. Nonetheless, major longitudinal studies are needed to illuminate
these hypotheses as the current study is unable to infer causality.
The results reported here are inconsistent with those of Phan and colleagues
(2008) and Gruber and colleagues (2009) who both found attenuated amygdala reactivity
to threat signals in adults following acute THC administration, and chronic nonintoxicated users, respectively. In contrast, we report trait-related increased amygdala
reactivity to threat signals in adolescence. Hence, we report divergent effects in
adolescents compared to adults. As previous research demonstrates divergent findings
between adolescents and adults during affective face processing (Guyer et al., 2008a,b),
we do not hypothesize adolescent data to mirror the adult data. Indeed, our results support
the notion that adolescence is period of sensitive affective development that can be
perturbed even with very low levels of cannabis experimentation.
The current results are consistent with the animal models of cannabinoid exposure
during adolescence (Rubino et al., 2008; Schramm-Sapyta et al., 2007) and suggest that
more human research is needed on the long-term effects of cannabis use in adolescence.
In consideration of the animal studies and the link between early cannabis use and mood
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disorders later in life, acute THC consumption effects in the adolescent brain may be
different or, indeed, the long-lasting effects of repeated exposure may be different beyond
the acute intoxication phase. As adolescents tend to be more reactive to emotional
stimuli, especially face processing in the amygdala, the observed differences in
adolescent cannabisusers may suggest evidence of maladaptive cognitive and affective
systems related to psychosocial development.
Lastly, a notable feature of the present results is that our sample of cannabis users
reported relatively low levels of use, but nonetheless exhibited significant differences in
processing threat signals. Furthermore, due to the closely matched control group, we
excluded a range of possible confounding factors, including mental health comorbidities,
which may have accounted for the observed differences. As excluding subjects with
mental health comorbidities failed to change the pattern of our results, the findings
suggests that very low use of cannabis during early adolescence may compromise healthy
emotional reactivity.
An alternative explanation regarding the observed differences in affective face
processing may be attributed to unmeasured pre- existing differences in emotional
functioning, which might have contributed to the adolescents’ experimentation with
cannabis. Indeed, we have previously shown that activation in response to these angry
faces in the left PFC predicted binge drinking two years later, which would suggest
altered emotional reactivity may precede use (Whelan et al., 2014). However, in the
present analyses the measured psychiatric symptomology results failed to show elevated
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levels of any of the affective disorders, therefore, it is unclear which preexisting
differences, if any, might have been present in the cannabis-experimenting group.
Future studies will be performed on the follow-up (age 16 and 18) data of this
project to identify predictive factors contributing to the cannabis use phenotype profile.
As this was a cross-sectional study from the baseline IMAGEN dataset, we stress that we
are unable to claim cannabis use caused amygdala hypersensitivity to negative affect. To
investigate this question, longitudinal data analysis will inform whether hypersensitivity
to threat signals precedes use or is a consequence of use, and assessments of
psychopathology will clarify if early cannabis use and differences in face processing
contribute to the generation of clinically relevant disorders.
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Tables
Table 2.1: Frequency of cannabis use
Frequency

n

1-2 times
3-5 times
6-9 times
10-19 times
20-39 times
40+ times
Any use in month prior to scan

49
7
7
2
3
2
7

Table 2.2: Age of first use by substance
Measure

Group

Age of first cigarette (M, SD)
Age of first wine (M, SD)
Age of first beer (M, SD)
Age of first wine cooler (M, SD)
Age of first spirit (M, SD)
Age of first cannabis use (M, SD)

p

Cannabis (n=70)

Controls (n=70)

12.73, 1.07
12.20 , 1.25
12.46 , 0.98
12.90 , 1.25
13.25 , 0.87
13.57, 0.94

12.64 , 1.00
12.11, 1.17
12.44 , 1.04
12.97, 0.98
13.21, 0.84
-

.640
.723
.906
.708
.858
.000

Table 2.3: Demographic information and statistics by group
Group
Measure

Cannabis
(n=70)

Controls
(n=70)

p

Males/Females (n)
Left / Right Handedness (n)
Age (M,SD)
Perceptual Reasoning IQ (M,SD)
Verbal Comprehension IQ (M,SD)
Puberty Development Scale (M,SD)
Socioeconomic Status (M,SD)
Lifetime Alcohol Use (M,SD)
Lifetime Cigarette Use (M,SD)
Lifetime Cannabis Use (M,SD)*

50/20
6/64
14.765, 0.40
104.219, 16.876
110.74, 16.84
3.60, 0.60
18.45, 4.42
3.71, 1.63
3.106, 2.215
1.70, 1.30

41/29
5/65
14.61, 0.655
105.72, 13.879
110.43, 13.329
3.8, 0.63
18.24, 4.70
3.56, 1.32
2.54, 2.215
0, 0

.111
.753
.607
.555
.905
.585
.751
.530
.158
.000

* Based on a self-report scale from 0-6. (1=1-2 times; 2=3-5 times; 3=6-9 times; 4=10-19
times; 5=20-39 times; 6=40+ times)
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Table 2.4: Anatomically and functionally defined ROIs with group by condition
interaction statistics.
Peak Voxel Location

Center of Cluster
Mass
size
Coordinate
(MNI)
x , y, z
k

Group x
Condition
Interaction
F

p

Left amygdala

120

8.54

.000

Right amygdala

139

5.56

.004

Right middle temporal gyrus, cluster
extends into temporal parietal junction
(TPJ)

-54, 47, 6

1333

5.28

.006

Left inferior frontal gyrus, cluster
extends into dorsolateral prefrontal
cortex (dlPFC)
Right inferior frontal gyrus, cluster
extends into dorsolateral prefrontal
cortex(dlPFC)

54, -14, 28

417

4.87

.008

-49, -14, 33

356

5.71

.004

53, 51, 9

1181

2.19

.115

Left cerebellum

12, 78, -39

477

2.36

.096

Right lingual gyrus

-13, 79, -8

317

1.53

.219

0, -45, 7

830

3.72

.026

Left middle temporal gyrus, cluster extends
into temporal-parietal junction (TPJ)

Bilateral anterior cingulate, cluster extends
into ventromedial prefrontal cortex

Rows in bold survived a modified Bonferroni correction for multiple comparisons.
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Table 2.5: Post-hoc t-test comparison for within-group differences.
Region of Interest

Angry faces vs. Neutral faces
Cannabis

Controls

Left amygdala

t(69) = 4.02, p < .001

t(69) = -0.32, p = .750

Right amygdala

t(69) = 3.15, p = .002

t(69) = -0.73, p = .470

Right middle temporal gyrus,
cluster extends into
temporal parietal junction (TPJ)
Left inferior frontal gyrus,
cluster extends into
dorsolateral prefrontal cortex (dlPFC)
Right inferior frontal gyrus,
cluster extends into
dorsolateral prefrontal cortex (dlPFC)

t(69) = -1.21, p = .231

t(69) = -7.20, p < .001

t(69) = -0.60, p = .551

t(69) = -5.13, p < .001

t(69) = -0.56, p = .576

t(69) = -5.68, p < .001

Cells in bold are significant at p < .05, corrected.
Figures
Figure 2.1: Mean activation for face type by group plotted for right and left amygdala.

Asterisks indicate post-hoc t-test differences significant at p<.05, corrected. Error bars
represent the standard error of the mean.

79

Figure 2.2: Mean activation for face type by group plotted for the cluster spanning the
right temporal parietal junction.

Blue bars represent angry faces, red bars represent neutral faces. Asterisks indicate posthoc t-test differences significant at p<.05, corrected. Error bars represent the standard
error of the mean.

Figure 2.3: Mean activation for face type by group plotted for the cluster spanning the
right and left dorsolateral prefrontal cortex.

Blue bars represent angry faces, red bars represent neutral faces. Asterisks indicate posthoc t-test differences significant at p<.05, corrected. Error bars represent the standard
error of the mean. Cutout: y = 4, z = 48.
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CHAPTER 3: AMYGDALA REACTIVITY BEFORE AND AFTER CANNABIS
USE IN ADOLESCENCE
3.1. Before: Amygdala Reactivity Predicts Cannabis Use By Age 19
Introduction
Cross-sectional analyses from Chapter 2 (Spechler et al., 2015) identified
significant group by face-type interactions across several cortical and subcortical regions
when comparing a group of adolescents reporting cannabis use by age 14 relative to a
group of matched controls. Of particular interest, heightened bilateral amygdala reactivity
to angry faces were observed in individuals who reported any lifetime cannabis use at
baseline. This initial investigation characterizing the functional neurobiology of
adolescent cannabis use was unable to determine if the amygdala effect was predictive, or
a consequence, of cannabis use. Fortunately, the longitudinal nature of the IMAGEN
study can be interrogated to approach this question by analyzing the face processing data
in a sample of teens who were cannabis naïve at baseline and then report use later in
adolescence.
As reported in Chapter 2, there was no correlation between either the left or right
amygdala activations with cannabis use age of onset. Additionally, no correlation was
found using the baseline level of cannabis use. It is therefore possible that heightened
amygdala reactivity was a pre-existing difference in cannabis users, rather than a
consequence arising from use. Given this lack of association with age of use onset and
use levels, the hypothesis guiding the subsequent analyses is that heightened amygdala
reactivity to angry faces at age 14 will predict the level of cannabis use by age 19.
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Previous studies indicated that heightened amygdala activations, specifically to
emotionally evocative faces, may be characteristic of emotional dysregulation in
adolescence (van den Bulk et al., 2014; Monk et al., 2008; Thomas et al., 2013). And
while chronic cannabis use (Gruber et al., 2009) and acute administration of THC (Phan
et al., 2008) have been implicated in the attenuation of amygdala activations to evocative
faces, there is mounting evidence that cannabis use may negatively impact adolescent
development (as discussed in Chapter 1). Adolescents with pre-existing heightened
amygdala reactivity may be vulnerable to initiate and maintain cannabis use as a means to
down-regulate their amygdala activity and achieve anxiolytic effects. In doing so, these
adolescents also risk experiencing some consequences of their use. Further research is
therefore required to confirm dysregulated amygdala processing as a risk factor for
cannabis use. If substantiated, these findings may implicate amygdala reactivity as a
prognostic biomarker in the identification of vulnerable adolescents. These findings
would also inform safe treatment methods by directly targeting this biomarker via biofeedback mechanisms (Zotev et al., 2011), pharmaceuticals (Arce et al., 2008; Paulus et
al., 2005), or indirectly via cognitive behavioral therapy (McClure et al., 2007).
For the analyses in the current section, bilateral amygdala reactivity to angry faces
measured at baseline (age 14) served as the independent variables in a linear regression
model predicting the level of cannabis use by the age 19 assessment of the IMAGEN
study. Critically, all participants were selected for being cannabis-naïve at baseline. Other
variables potentially influencing amygdala reactivity and/or related to future cannabis use
were modeled as nuisance covariates, including baseline cigarette, alcohol, and anxiety
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levels. Therefore, any significant effects related to the amygdala were identified over and
above the influence of these measures.

Methods
Participants
Participants from the IMAGEN study were selected based on their reported drug
use levels at all time points from the ESPAD survey (Hibell et al., 1997). Starting with
the full baseline sample (N=2,224), there were n=2,045 individuals who reported no
lifetime cannabis use by age 14. From these n=2,045, there were 571 who reported
cannabis use by age 19. Only those with reliable reporting patterns (age 16 level <= age
19 level) were selected. No exclusions were made for other drug use levels at any time
point, although tests for drug specificity were completed (detailed later).
From those 571, there were 40 who did not supply a face processing scan, and an
additional 6 excluded for excessive head motion. Therefore, 525 participants were
included in the subsequent analyses (see Table 3.1.1 for sample characteristics). Across
these 525, their lifetime cannabis use by age 19 data was plotted. These levels followed a
U-shape distribution with relatively high levels at the opposite tails, with lower
intermediate use levels (See Figure 3.1.1 and Table 3.1.2).
There were no controls in the primary linear regression analyses (described
below) in order to test if amygdala reactivity would exhibit a dose-response relationship
in predicting the level of future use in an analysis restricted to users. As a secondary
analysis, a control sample was identified to determine if the future cannabis users differed
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as a whole from a sample of participants who were cannabis-naïve at all time points.
Hence, from the full sample of participants with ESPAD data at baseline (N=2,224), there
were n=648 identified as being cannabis-naïve at all time points. From those 648, there
were 46 who did not supply a face processing scan, and an extra 8 who were excluded
due to excessive head motion. Therefore, 594 participants were included in the cannabisnaïve sample.

fMRI Data
The face processing fMRI data were analyzed using standard preprocessing
methods as described in Chapter 2. During image realignment, head motion estimates
were obtained for each of the three translation and rotation directions. From these motion
estimates, framewise displacement (Power et al., 2012) was calculated. The mean
framewise displacement across the entire run (mean FD) constituted a single summary
statistic for head motion and was used as a nuisance covariate in the regression analyses
(described below). Participants exceeding a mean FD >0.5mm were excluded for quality
assurance purposes.
Whole-brain task activation maps were estimated using the GLM, and contrast
images were obtained for angry faces vs. control images, and neutral faces vs. control
images. In keeping with the methods of Chapter 2, bilateral amygdala regions of interests
(ROIs) using the “Eickhoff–Zilles” macro label atlas (Eickhoff et al., 2005) were used to
extract the mean values from each whole-brain contrast image.

84

Nuisance Covariates
A set of nuisance covariates was included to adjust for potentially confounding
factors influencing both amygdala reactivity and cannabis use levels. These covariates
included age at baseline scan, pubertal development scale (Carskadon and Acebo, 1993),
sex, handedness, performance and verbal IQ, mean FD, and site of scanning acquisition.
Lifetime cigarette and alcohol use from the baseline ESPAD survey were also modeled as
covariates. Finally, given the relationship between amygdala activation and anxiety, the
baseline DAWBA band score (Goodman et al., 2000) for generalized anxiety disorder
(DSM-IV) was included as the final covariate. The band score is an ordinal measure
estimated by a computer algorithm using the pattern of responses from the DAWBA
instrument and reflects the probability of receiving a DSM-IV diagnosis. See Table 3.1.3
for the probability bands for each level of this measure for each group. Bivariate
correlations between anxiety and the amygdala activation, and, anxiety and the outcome
measure were also reported to address the self-medication hypothesis.

Regression Models
Linear regression analyses were constructed to predict cannabis use by age 19
from a set of measures collected at age 14 including left and right amygdala reactivity to
angry faces. The regression models were also estimated in a stepwise fashion in three
blocks, starting with all the nuisance covariates, followed by the left amygdala, and
finishing with the right amygdala. This order was implemented to obtain an adjusted R2
signifying the percent variance explained following the inclusion of each amygdala as a
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predictor after first modeling the nuisance covariates. Similar regression models were
estimated using bilateral amygdala activations to neutral faces. Although angry faces was
the primary contrast of interest given the finding from Chapter 2 indicating angry faces
elicits the most robust activations. All statistical analyses were conducted using SPSS
v.24 (Armonk, NY: IBM Corp).

Results
Primary Regression Analyses (Future Cannabis Users Only)
525 participants were included in a multiple linear regression model predicting
their level of cannabis use by age 19 with a set of independent variables measured at
baseline. Results indicated that the full model containing all variables at age 14
significantly predicted cannabis use by age 19 (F19,504 = 3.48, p<.001), explaining roughly
8% of the variance in future cannabis use. Within this full model adjusted for all nuisance
covariates, the right amygdala reactivity to angry faces significantly predicted the level of
cannabis use by age 19 (Right amygdala: β=1.11, p<.05). The positive beta value
indicates that an increase in right amygdalar activation to angry faces at age 14 predicts
an increase in the level of future cannabis use. Moreover, sex (β=-.50, p<.05) and
baseline cigarette use (β=.23, p<.05) also emerged as significant predictors within the full
model. When estimating a stepwise regression model, it was found that after including all
other predictors, the inclusion of the right amygdala activation to angry faces explained
an extra 1% of the variance (∆R2=.01, p < .05) in future cannabis use.

86

The left amygdala activation to angry faces was not a significant predictor when
adding it into the stepwise regression either before or after the inclusion of the right
amygdala, nor was it a significant predictor when considering a simple regression model
excluding all other predictors. Moreover, when executing identical analytic procedures
using the bilateral amygdala activations to neutral faces, no significant effects were
observed. Therefore, when considering angry and neutral face processing in the left and
right amygdala, only the activation to angry faces in the right amygdala emerged as a
significant predictor of cannabis use later in adolescence.

Associations With Anxiety Levels
Interestingly, baseline anxiety did not emerge as a significant predictor within the
multiple regression model. Baseline anxiety was included as a covariate because anxiety
has been previously reported to predict both cannabis use (Agosti et al., 2002; Buckner et
al., 2008), and heigthened amygdala activations (Monk et al., 2008). To address these
potential relationships in the current dataset, Pearson’s bivariate correlations between
baseline anxiety, follow-up cannabis use, and the baseline amygdala activations were
estimated. Results indicated that, again, no relationship was found between baseline
anxiety and future cannabis use, or, baseline anxiety and any of the amygdala activations
(left or right; angry or neutral) (all ps > .05). Spearman’s rho correlation was also
estimated given the ordinal nature of the measure, but null results were reproduced.
Hence, baseline anxiety had no influence on future cannabis use when considering the
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two measures in isolation, or in the presence of the other predictors. See the following
Section 3.2 for analyses testing for changes in anxiety levels from baseline to follow up.

Correlated Measures
Concerns with multicolinearity among the predictor variables can be addressed by
estimating the variance inflation factor (VIF), which signifies the extent to which a
regression coefficient’s standard error is inflated given the correlation with the other
independent variables. Generally, VIFs greater than or equal to 5 indicate serious
multicolinearity and compromises the interpretation of the results. Considering the
significant predictors, the VIF for sex (VIF=1.5), baseline cigarettes (VIF=1.3), and the
right (VIF=1.9) amygdala activation to angry faces, were well below values of concern.
And while the left amygdala was not a significant predictor, its VIF was also low
(VIF=1.9).
Sex was identified as a significant predictor of future cannabis use within the
multiple regression model. As between-group t-tests indicated that males exhibit higher
activations to angry faces than females (t=3.5, p<.05), and also use more cannabis (t=2.4,
p<.05), it could be argued that the amygdala effect is a proxy for sex. This argument is
countered by the low VIF on sex and the right amygdala coefficients. Those results
indicated stable coefficient estimates with low colinearity with each other despite their
modest correlation. Lastly, the low VIF for the left amygdala indicated that it is unlikely
that its failure to predict cannabis use was due to colinearity with the right amygdala.
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Secondary Regression Analyses (Inclusion of Cannabis-Naïve Participants)
As a final analysis to determine that the reported effects discriminates all future
users from controls, the linear regressions were repeated with the inclusion of the
cannabis-naïve sample. Here, the results were consistent with the primary analysis, and
also indicated a substantial improvement in the overall R2. Results indicated the full
model containing all variables at age 14 significantly predicted cannabis use by age 19
(F19,1097 = 4.34, p<.001), explaining roughly 15% of the variance in future cannabis use.
Consistent with the cannabis-only regression model, the right (but not left) amygdala
activation to angry faces significantly predicted the level of cannabis use by age 19
(Right amygdala: β=.74, p<.05). Lastly, when estimating a stepwise regression model,
the inclusion of the right amygdala activation to angry faces explained an extra .3% of the
variance (∆R2=.003, p < .05) in future cannabis use. The lower explained variance in this
secondary model is likely due to the addition of noise. See Figure 3.1.2 for the positive
linear relationship between the baseline right amygdala reactivity adjusted for all other
covariates in the model plotted against future cannabis use level. A dose-response
relationship was observed such that the lowest reactivity is exhibited by the controls, and
higher reactivity exhibited with increasing cannabis use levels at follow up (see Figure
3.1.2). And in line with the primary regression results, no significant effects were
observed using the bilateral amygdala activations to neutral faces.

Drug Specificity
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As the sample of future cannabis users were not excluded on the basis of their
other drug use levels at age 19 (follow up), a test of drug specificity is warranted. When
testing the follow up data, it was found that cannabis use level significantly correlated
with alcohol (r=.20, p<.001) and cigarette use (r=.40, p<.001) levels. Therefore, similar
linear regression analyses predicting the level of alcohol and cigarette use at follow up
were necessary to determine if baseline amygdala reactivity is a risk factor that
generalizes to predict other drug use.
To start, a linear regression model predicting follow up alcohol use was estimated
using the same baseline covariates and right and left amygdala reactivity to angry faces.
The full model significantly predicted follow up alcohol use (F19,504=2.83, p<.001), with
verbal IQ (β=.01, p<.05) and baseline alcohol (β=.08, p<.05) identified as significant
predictors of follow up use. Rerunning the model without baseline alcohol was still
significant (F19,504=2.44, p<.001). Neither the left or right amygdala emerged as
significant predictors in these models.
Results were consistent using a similar model to predict follow up cigarette use
(F19,504=5.2, p<.001), with baseline age (β=-.65, p<.05) and cigarettes (β=.48, p<.05)
identified as significantly predicting follow up use. Rerunning without baseline cigarettes
was still significant (F19,504=2.83, p<.001). Likewise, neither the left nor right amygdala
reactivity to angry faces emerged as significant predictors in these models. These
analyses suggest the right amygdala reactivity to angry faces specifically predicted
cannabis use at follow up.
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Discussion
This Section 3.1 builds on the cross-sectional findings of Chapter 2 by indicating
the right amygdala reactivity to angry faces likely precedes cannabis use in adolescence.
This effect is supported by the dose-response relationship predicting the level of use five
years later, and also by the finding that the lowest baseline amygdala activations were
exhibited by the cannabis-naïve sample. This study is supported by the longitudinal
design, where all participants were selected on the basis of being naïve to cannabis at the
baseline scan. And while it would be incautious to assert the amygdala activations caused
later cannabis use, these findings suggested that amygdala activations to angry faces
might be considered a specific risk factor for cannabis use in adolescence.
The finding that the right, but not left, amygdala activation was significantly
predictive is consistent with the literature. In a meta-analysis of neuroimaging studies on
the amygdala, data suggests that the right amygdala is specific to rapid detection of
threatening stimuli as right-sided activations are commonly reported in studies using
temporally masked presentation (e.g., when a threatening stimulus presentation is brief
and immediately followed, or “masked”, by an alternate stimulus) (Costafreda et al.,
2007). While the task paradigm used in the IMAGEN study is by no means a masked
presentation, each stimulus involves a short presentation (2-5 seconds) of faces starting
from a neutral expression shifting to either a neutral or angry expression (Grosbras,
2005). It is plausible that a brain system sensitive to detecting threatening stimuli may
also be engaged by this shift. This interpretation is supported by two studies that

91

demonstrated rapid right-sided amygdala activations to angry faces using temporally
precise magnetoencephalography (Dumas et al., 2013; Hung et al., 2010).
Interestingly, sex and baseline cigarette use also emerged as significant predictors
of cannabis use five years later. With regard to sex, this finding is in line with
epidemiological studies of adolescent drug use indicating that males use both cigarettes
and cannabis at higher rates than females (Johnston et al., 2018). For baseline cigarette
use, this finding is also consistent with the literature implicating cigarette use as a robust
predictor of cannabis use (Agrawal et al., 2012).
In considering the significant reactivity of the right amygdala, the positive linear
relationship uncovered from the regression analysis indicated more amygdala activation
predicts more cannabis use. Hence, individuals with the most exaggerated amygdala
activations to signals of threat might be vulnerable to use more frequently. The results of
these analyses point to a self-medication interpretation. Phan and colleagues (2008)
previously demonstrated that acute administration of THC attenuates amygdala reactivity
to angry faces. Therefore, the motivation to consume and maintain cannabis use in these
individuals is hypothesized to be driven, in part, through negative reinforcement
properties achieved by the interaction between THC and amygdala function. However,
the lack of a correlation between baseline anxiety level and amygdala reactivity fails to
support this framework. Other measures of life stress or psychiatric symptomatology
might be useful to better explain the reasons for baseline hyperactivity in this sample.
It will also be important to determine how amygdala reactivity might change
following cannabis use before discounting the self-medication hypothesis. In keeping
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with this framework, amygdala reactivity is expected to decrease over time with
protracted use. A similar pattern in anxiety levels is also hypothesized to follow cannabis
use. See the subsequent Section 3.2 for analyses testing these hypotheses.
The implication of the current Section 3.1 is that heightened amygdala reactivity
to angry faces may be considered a biomarker predictive of cannabis use in adolescence.
Mitigating risk associated with adolescent use might be achieved by targeting this
biomarker. Research conducted by Paulus and colleagues, and Arce and colleagues,
provided converging evidence on the attenuation of amygdala reactivity via common
psychiatric medications. In these studies, researchers demonstrated that acute
administration of the anxiolytic lorazepam (Paulus et al., 2005) and three weeks use of
the antidepressant escitalopram (Arce et al., 2008), significantly reduced amygdala
reactivity to angry faces. In tandem with the Phan report on THC, cannabinoids,
lorazepam, and escitalopram, may all be effective in normalizing dysregulated affect by
targeting the same biomarker (despite their differing pharmacological properties). While
rigorous studies are needed, it is hypothesized that lorazepam or escitalopram might have
secondary effects of minimizing cannabis use in vulnerable adolescents by attenuating
their amygdala reactivity, thus disrupting their risk phenotype.
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Tables
Table 3.1.1: Demographic Information for Each Group
Future
Cannabis Use
Sample
(n=525)

CannabisNaïve
Sample
(n=594)

p

Age in years (M, SD)
PDS (M,SD)

14.39, .39
2.88, .57

14.44, .41
2.95, .56

.06
.04

Sex (M, F)

Measure

282, 243

226, 368

.00

Handedness (L, R)
Performance IQ (M,SD)

46, 479
109.27, 13.33

65, 529
110.48, 14.02

.23
.14

Verbal IQ (M,SD)

113.49, 13.05

112.23, 13.55

.11

All tabulated measures collected at the baseline assessment (age 14). Future cannabis use
participants (n=525) were selected for being cannabis-naïve at age 14 and then report
cannabis use by age 19. Cannabis-naïve participants (n=594) were selected for being
cannabis–naïve at all time points. PDS: Pubertal development scale (Carskadon and
Acebo, 1993). P-value from chi-square test for between-group differences.
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Table 3.1.2: Cigarette and Alcohol Use Levels for Each Group
Future Cannabis Use Sample (n=525)

Cannabis-Naïve Sample (n=594)
p

0

12x

35x

69x

1019x

2039x

40+

0

12x

35x

69x

1019x

2039x

40+

Baseline
Cigarettes
(n)

357

83

24

18

12

9

22

528

40

7

7

8

2

2

.01

Baseline
Alcohol
(n)

91

132

113

76

68

28

17

199

164

104

65

39

16

7

.01

Baseline cigarette and alcohol use from the ESPAD instrument (Hibell et al., 1997) and
reflects lifetime usage by age 14. P-value from chi-square test for between-group
differences.

Table 3.1.3: Anxiety Band Score for Each Group
Future Cannabis Use
Cannabis-Naïve
Sample (n=525)
Sample (n=594)
<.1% .5% 3% 15% 50% <.1% .5% 3% 15% 50%
Anxiety
Band
Score
(n)

380

123

0

18

3

424

126

0

35

8

p
.12

Anxiety Band Score from the DAWBA instrument (Goodman et al., 2000) and represents
the probability of receiving a generalized anxiety disorder diagnosis for individuals
contained in that band level. P-value from chi-square test for between-group differences.
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Figures

Count

Figure 3.1.1: Cannabis Use By Age 19 in Previously Cannabis-Naïve Participants

160
140
120
100
80
60
40
20
0

Cannabis Use By Age 19 in Previously CannabisNaive Participants
N=525

1-2x

3-5x

6-9x

10-19x

20-39x

40x+

Cannabis Use Level

Data from the ESPAD survey (Hibell et al., 1997) represents the level of lifetime
cannabis use by age 19. All N=525 participants were selected from the IMAGEN study
for reporting no cannabis use at the baseline assessment (age 14).
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Figure 3.1.2: Adjusted Right Amygdala Reactivity By Cannabis Use Level (N=1019)
Baseline Right Amygdala Reactivity By Future Cannabis Use Level

Adjusted Right Amygdala Reactivity

.23

.22

.21

.20

.19

.18
0
(Controls)

1-2x

3-5x

6-9x

10-19x

20-39x

40+

Cannabis Use Level at Age 19

Right amygdala reactivity at baseline adjusted for all other covariates in linear regression
model containing the controls. Plotted against cannabis use level at follow up (age 19).
The sample of controls was consistently cannabis-naïve at all time points (n=594). Error
bars reflect +/- 2 standard deviations at each use level.
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3.2. After: Amygdala Reactivity Following Cannabis Use
Introduction
Chapter 2 and the preceding Section 3.1 provided evidence that amygdala
reactivity to angry faces both correlated with concurrent use and predicted later use. The
remaining temporal characteristic is to determine if amygdala reactivity changed
following cannabis use. The longitudinal nature of the IMAGEN study can be leveraged
to study the extent to which cannabis use may influence amygdalar functional
development. In this Section 3.2, analyses were conducted on amygdala reactivity at age
14 and age 19. The individuals from Chapter 2 were studied since they were
hypothesized to yield the most robust changes in amygdala reactivity as they had the
most chronic cannabis use in the IMAGEN sample (initiating by age 14). This sample
was compared to a closely matched sample of individuals who were cannabis-naïve at all
time points.
The comparison sample was also used to illuminate typical amygdalar functional
development. Previous studies on amygdalar functional development provided evidence
that amygdala reactivity to angry faces increases across development. For instance, in the
first developmental study on face processing using fMRI, Thomas and colleagues
reported that angry face processing in the left amygdala increased from childhood to
adulthood (Thomas et al., 2001). These findings have since been reproduced in a larger
sample by Todd and colleagues (Todd et al., 2011), although evidence for a
developmental decrease has also been reported (Guyer et al., 2008). This Section 3.2 was
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therefore useful in examining both typically-developing, and cannabis-using, functional
development using large samples from the IMAGEN study.
In considering the relationship between cannabis and neurodevelopmental
processes, research on the endogenous cannabinoid system indicated the primary
cannabinoid receptor (CB1) proliferates across prefrontal, striatal, and medial temporal
lobe regions from early development through adolescence (Mato et al., 2003).
Researchers also consistently identified high CB1 densities in the amygdala, with
specificity for basal and lateral nuclei (Glass et al., 1997; Katona et al., 2001; Mailleux
and Vanderhaeghen, 1992). Given the localization of these receptors, the endogenous
cannabinoid system is putatively involved in regulating emotional and stress responses
(Marco and Viveros, 2009). Any perturbations of this system by exogenous cannabinoids
used during adolescence may precipitate changes to the functional neurobiology and
emotional well being of the individual. Therefore, patterns of both amygdala reactivity
and anxiety levels from baseline to follow up were examined within the context of
cannabis use in adolescence.

Methods
Participants
The individuals from Chapter 2 who reported cannabis use at the baseline
assessment (n=70) were revaluated at the age 19 (follow up) assessment. From the
starting 70, there were 25 who were lost due to attrition. From the remaining 45, there
were 7 subjects excluded for inconsistent reporting in their drug use levels (e.g., age19 <
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age 16). Therefore, n=38 subjects were included in the final sample. A comparison of
these 38 to the 25 who dropped out indicated the two samples did not differ on various
demographic measures (See Table 3.2.1 for comparison). Cannabis use patterns at
baseline and follow up were tabulated for the retained 38 participants. Generally, the 38
participants exhibited an escalation in their cannabis use levels over time (Table 3.2.2).
Next, from the n=594 consistently cannabis-naïve participants identified in
Section 3.1 on the basis of having acceptable face processing data at baseline, there were
546 who supplied a face processing scan at follow up. From the 546, there were three
participants excluded due to excessive head motion. A comparison sample of n=38
individuals was then selected from this pool of 543 participants who were cannabis-naïve
at all time points. The comparison sample was selected to be perfectly matched on sex
and site, and best matched on handedness, IQ, baseline PDS, baseline and follow up
anxiety levels, baseline and follow up age, baseline and follow up head motion (FD), and
baseline alcohol use. Unfortunately, it was not possible to best match on baseline
cigarette or follow up cigarette and alcohol use. The full sample of n=543 participants
was also used in select analyses to characterize neurotypical patterns of amygdala
reactivity and anxiety levels over time. See Table 3.2.3 for sample characteristics for the
cannabis group, matched comparison group, and full sample of controls.

Baseline and Follow Up Amygdala Reactivity
Standardization efforts were implemented to ensure the follow up neuroimaging
session was identical to the baseline scan. Moreover, the fMRI data for each time point
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was processed using an identical analytic pipeline. Whole-brain contrast images were
estimated for the angry vs. control images, and neutral vs. control images. In similar
fashion to Chapter 2 and Section 3.1, the same left and right amygdala ROI was used to
extract the mean values for angry faces and neutral faces for all subjects.
The data were then submitted to a 2 x 2 (group [cannabis, controls] by time
[baseline, follow up]) repeated measures analysis of covariance (ANCOVA) with a test
for the interaction between the two factors, for the left and right amygdala. To adjust for
variation in baseline and follow up cigarette and alcohol use, a mean centering approach
was used. For both measures, the mean of the two time points was computed, and used to
center the baseline and follow up measure (Winer et al., 1991). These three measures for
alcohol, and three measures for cigarettes, were included as covariates in the model.
Follow up analyses on these models were conducted using paired-samples t-tests within
the cannabis group and control groups, whereby baseline amygdala reactivity was
compared to follow up. Finally, to examine changes in anxiety levels, similar repeated
measures ANCOVA models were estimated using the DAWBA band scores for
generalized anxiety disorder.

Results
Comparison of Retained vs. Lost Cannabis Users
Chi-square and t-tests were used to determine if the 25 cannabis using participants
who dropped out of the study prior to the age 19 assessment were different from the 38
retained individuals. These two groups were largely similar on their demographic
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characteristics, except for verbal and performance IQs which were significantly lower in
the lost sample (p<.05). However, IQ was not correlated with baseline amygdala
reactivity, and the two groups did not differ on their baseline drug use levels, anxiety
levels, or amygdala reactivity (Table 3.2.1). Therefore, the retained sample is largely
representative of the full sample of n=70 studied in Chapter 2.

ANCOVA Findings
A repeated measures ANCOVA model indicated there was no significant
interaction effect for the left (F1,70=0.33, p=.57), or right amygdala (F1,70=1.9, p=.17), and
no significant main effect of group, time (ps >.05). Given these null results, a similar
ANCOVA model was estimated using the full sample of cannabis-naïve participants
(n=543). This model was also adjusted for sex and age as significant between-group
differences were observed (Table 3.2.3). Again, null results for the interaction for the left
(F1,576=.17, p=.68), and right amygdala (F1,576=3.02, p=.07), and main effects were
reproduced (all p>.05). As the interaction trended to significance for the right amygdala,
the adjusted means for both amygdalae were plotted for the cannabis users and matched
controls for exploratory purposes (Figures 3.2.1-2). Finally, given the lack of an
association uncovered by modeling the two groups together, exploratory analyses were
conducted to analyze amygdala reactivity within each group separately.

Paired-samples Tests
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Paired-samples t-tests were conducted comparing baseline to follow up reactivity
to angry faces for the left and right amygdala for each group. To start, the full sample of
cannabis-naïve participants (n=543) were analyzed to determine a neurotypical pattern of
functional development. While there was no significant change for the left amygdala
(t=1.2, p> .05), there was a significant increase in follow up activations observed in the
right amygdala (t=2.9, p<.005). When analyzing the matched sample of controls (n=38),
this effect was reproduced as the right amygdala exhibited a robust increase at follow up
(t=3.7, p<.005), while the left amygdala approached a significant increase (t=1.8, p<.08).
In considering the cannabis users (n=38), there was no significant change from baseline
to follow up for either the left (t=-.30, p>.05) or right amygdala (t=-.53, p>.05).
For reference, there was no significant change when analyzing neutral face
processing at either the left or right amygdala, within any group. Therefore, it is
specifically the right amygdala activations to angry faces that showed an increase in
reactivity in typically developing adolescents only.

Adjusted Means for Baseline and Follow Up by Group
The adjusted means for the right and left amygdala along with their standard
errors were plotted at baseline and follow up for each group for (See Figures 3.2.1 and
3.2.2). These graphs visually depicted an interaction with group and time despite the null
results from the ANCOVA models. As reflected by the paired-samples t-tests, the
matched control group exhibited a clear increase in reactivity from baseline to follow up
in the right amygdala (Figure 3.2.1), and to a lesser extent in the left amygdala (Figure
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3.2.2). For the cannabis users, an opposite pattern emerged, such that a marginal decrease
in reactivity from baseline to follow up was reflected in the right and left amygdala
although statistically non-significant.

Anxiety Levels at Baseline and Follow Up
As previous research has supported relationships between amygdala reactivity and
anxiety levels, the DAWBA band scores for generalized anxiety at baseline and follow up
were analyzed in a similar fashion. A 2 (Group: cannabis, controls) by 2 (Time: baseline,
follow up) repeated measures ANOVA model estimated group changes in anxiety levels
over time. Results indicated there was no significant interaction (F1,72=.08, p=.79),
however, a highly significant main effect of time (F1,72=24.5, p<.001) was identified,
with anxiety levels increasing from baseline to follow up (See Table 3.2.2). There was no
main effect of group. These results were consistent using the full sample of controls
(n=543). Consistent with the patterns reported in Section 3.1, no significant bivariate
correlation between anxiety level and left or right amygdala was detected at follow up.

Discussion
The statistical analyses from this section suggests that amygdala reactivity does
not significantly change following heavy cannabis use in adolescence. However, the
control groups exhibited a significant increase in activation from baseline to follow up.
This effect informs a typically developing pattern of functional development related to
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angry face processing in the amygdala, and is consistent with the smaller developmental
studies reported by Thomas and colleagues (2001) and Todd and colleagues (2011) .
The null results for the cannabis group indicated these individuals failed to exhibit
change over time. One possible interpretation is that cannabis use is associated with
precocious development. The significantly higher levels of amygdala reactivity at age 14
reported in Chapter 2 and Section 3.1 might suggest these individuals developed faster
than their non-using peers. This interpretation is supported by the neurotypical effect that
indicated higher amygdala activations at age 19. The lack of a significant change at age
19 in the cannabis users would indicate a ceiling effect of the amygdala if these
individuals were already at an advanced stage of amygdala reactivity at age 14.
A group by time interaction effect was visually depicted in Figures 3.2.1-2 but
should be interpreted cautiously given the null ANCOVA results. Statistical significance
may have emerged if 25 adolescents from the baseline sample were not lost to attrition.
And while it is impossible to assume the lost participants would exhibit a similar pattern
of amygdala reactivity at follow up as the retained sample, the finding that these 25 were
no different from the retained sample might support this hypothesis (Table 3.2.1).
In terms of the anxiety level, the main effect of time demonstrated an increase in
anxiety levels from age 14 to 19, while the lack of a main effect of group indicated both
groups increased at the same rate. Throughout this Chapter, it was hypothesized that
repeated exposure to an anxiolytic like THC would decrease their anxiety levels over
time. And while the amygdala reactivity did not significantly change in cannabis users,
the negative linear trend depicted in Figures 3.2.1-2, which contrasts with the increase in
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cannabis naïve control, might have been interpreted as a decrease in anxiety. Yet, the null
results from the anxiety analyses failed to support this interpretation, as anxiety level was
not related to cannabis exposure nor was there a significant interaction with group.
It is important to note that the anxiety measure used here reflected the probability
of receiving a generalized anxiety disorder (DSM-IV) diagnosis. Therefore, this measure
is sensitive to more clinically relevant anxiety. While the cannabis users might not have
clinical levels of anxiety per se, they might experience more reinforcing properties under
acute exposure relative to individuals without hyperactive amygdalae. Unfortunately no
data exists regarding their motivations or intentions for cannabis use. Therefore, these
analyses were only able to determine if cannabis use predicted a change in anxiety
disorder diagnoses, and unable to probe nuances related to their motivation or subjective
experiences during cannabis use.
Finally, the IMAGEN study is a rich dataset containing other measurements that
might reflect the nuances influencing cannabis use and therefore better characterize their
predictive profile. The following Chapters will consider measures from the brain,
behavioral, and genetic domains to uncover a comprehensive predictive profile of
cannabis use in adolescence.
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Tables
Table 3.2.1: Retained Sample (n=38) vs. Lost Sample (n=25) of Cannabis Users

Measure
Age (M, SD)
Sex (M, F)
Handedness (L, R)
PDS (M,SD)
Anxiety (M,SD)
Verbal IQ (M, SD)
Performance IQ (M,SD)
Cannabis (M, SD)
Cigarettes (M, SD)
Alcohol (M, SD)
R. Amygdala Reactivity to
Angry Faces (M, SD)
L. Amygdala Reactivity to
Angry Faces (M, SD)

Retained
Sample
(n=38)

Lost Sample
(n=89)

14.6, .42
25, 13
2, 36
2.9, .47
0.58, 1.0
115.4, 17.2
111.3, 15.3

14.7, .38
19, 6
4, 21
3.0, .49
0.32, .84
106.5, 16.0
97.7, 15.1

.29
.39
.16
.59
.08
.04
.01

1.4, 1.1
2.5, 1.9
3.9, 1.6

2.0, 1.5
3.5, 2.2
3.6, 1.7

.32
.22
.29

.24, .27

.26, .38

.80

.25, .29

.32, .24

.26

p

Comparison of the retained cannabis users who provided follow up (age 19) data versus
the participants who dropped out of the IMAGEN study. All tabulated measures
collected at baseline (age 14). P-values from chi-square and t-tests for between-group
differences. Significant differences detected for IQ only (p<.05).
Table 3.2.2: Baseline and Follow Up Cannabis Use Level
Time
Point

Age 19

Age 14

Use Level
1-2x
3-5x
6-9x
10-19x
20-39x
40+
SUM

1-2x
1
0
0
0
0
0
1

3-5x
5
0
0
0
0
0
5

6-9x
1
0
0
0
0
0
1

10-19x
2
0
0
0
0
0
2

20-39x
4
0
0
0
0
0
4

40+
17
4
2
0
1
1
25

Cross-tabulation of cannabis use levels at baseline (age 14) and follow up (age 19) in the
cannabis using sample (n=38). Overall, the majority of the sample increased their
cannabis use level over time.
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Table 3.2.3: Characteristic Information for Groups in Follow Up Analyses
A.)
Cannabis
Users
(n=38)

B.)
Matched
Controls
(n=89)

C.)
Full Sample
of Controls
(n=543)

A vs. B
p

A vs. C
p

BSL Age (M, SD)
FU Age (M, SD)
Sex (M, F)

14.6, .42
19.4, .96
25, 13

14.5, .37
19.3, .65
25, 13

14.4
18.9, .67
210, 336

.39
.54
1.0

.02
.01
.01

Handedness (L, R)

2, 36

4, 34

.40

.26

2.9, .47

2.8, .50

.41

.95

BSL Anxiety (M,SD)

0.58, 1.0

0.32, .84

.30

.40

FU Anxiety (M,SD)

1.34, .97

1.16, .60

.49

.20

115.4,
17.2
111.3,
15.3

110.1,
10.6
108.8,
11.8

.11

.18

110.5, 13.8

.42

.74

2.5, 1.9
5.8, .81
3.9, 1.6
5.8, .55

1.0, 1.5
1.5, 2.0
2.9, 1.5
4.8, 1.5

0.22, .78
1.2, 1.9
1.4, 1.4,
4.4, 1.7

.01
.01
.25
.01

.01
.01
.01
.01

Measure

PDS (M,SD)

Verbal IQ (M, SD)
Performance IQ (M,SD)

BSL Cigarettes (M, SD)
FU Cigarettes (M, SD)
BSL Alcohol (M, SD)
FU Alcohol (M, SD)

61, 485
2.9, .56
0.45, .89
1.32, .74
112.3,13.2

All measures were collected at baseline except where noted as follow up (Age 19, “FU”).
Drug use measured on an ordinal scale from 0-6 (See table 3.2.1 for levels) using the
ESPAD instrument. A.) Sample of cannabis users from Chapter 2 who provided suitable
imaging data at the follow up assessment. B.) Sample of matched controls who were
cannabis-naïve at all time points. C.) Full sample of controls who were cannabis-naïve at
all time points. P-values from chi-square and t-tests for between-group differences.
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Figures
Figure 3.2.1: Right Amygdala Reactivity to Angry Faces by Time (N=76)
Right Amygdala Reactivity to Angry Faces by Time
Groups

Matched Controls
Cannabis Users

0.40

Mean

0.30

0.20

0.10

0.00

Baseline (Age 14)

Follow Up (Age 19)

Plotted adjusted means for angry face processing in the right amygdala for the cannabis
users (n=38; Green lines) and matched control (n=38; Blue lines) samples at baseline and
follow up. Error bars represent +/- 1 standard error of the mean. Note, no significant
differences were identified using repeated measures ANCOVA, nor using a pairedsamples t-test within the cannabis users (ps>.05). Only a paired-samples t-test within the
controls exhibited a significant increase from baseline to follow up (p<.05).
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Figure 3.2.2: Left Amygdala Reactivity to Angry Faces by Time (N=76)
Left Amygdala Reactivity to Angry Faces by Time
Groups

Matched Controls
Cannabis Users
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Baseline (Age 14)

Follow Up (Age 19)

Plotted adjusted means for angry face processing in the left amygdala for the cannabis
users (n=38; Green lines) and matched control (n=38; Blue lines) samples at baseline and
follow up. Error bars represent +/- 1 standard error of the mean. Note, no significant
differences were identified using repeated measures ANCOVA, nor using a pairedsamples t-test within either group (ps>.05).
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CHAPTER 4: USING MACHINE LEARNING TO PREDICT THE INITIATION
OF CANNABIS USE IN ADOLESCENCE FROM NEUROIMAGING, GENETIC,
AND PSYCHOSOCIAL DATA
4.1. Predicting the Initiation of Cannabis Use By Age 16
This Chapter has been previously published in the following format:
Spechler, P.A., Allgaier, N., Chaarani, B., Whelan, R., Orr, C., Albaugh, M., D’Alberto,
N., Higgins, S.T., Hudson, K.E., Mackey, S., Potter, A., ... Althoff, R.R., Garavan, H. &
the IMAGEN consortium.. (2018). The Initiation of Cannabis Use in Adolescence is
Predicted by Sex‐Specific Psychosocial and Neurobiological Features. European
Journal of Neuroscience.
Abstract
Cannabis

use

initiated

during

adolescence

might

precipitate

negative

consequences in adulthood. Thus, predicting adolescent cannabis use prior to any
exposure will inform the aetiology of substance abuse by disentangling predictors from
consequences of use. In this prediction study, data were drawn from the IMAGEN
sample, a longitudinal study of adolescence. All selected participants (n = 1,581) were
cannabis‐naïve at age 14. Those reporting any cannabis use (out of six ordinal use levels)
by age 16 were included in the outcome group (N = 365, males n = 207). Cannabis‐naïve
participants at age 14 and 16 were included in the comparison group (N = 1,216,
males n = 538). Psychosocial, brain and genetic features were measured at age 14 prior to
any exposure. Cross‐validated regularized logistic regressions for each use level by sex
were used to perform feature selection and obtain prediction error statistics on
independent observations. Predictors were probed for sex‐ and drug‐specificity using
post‐hoc logistic regressions. Models reliably predicted use as indicated by satisfactory
prediction error statistics, and contained psychosocial features common to both sexes.
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However, males and females exhibited distinct brain predictors that failed to predict use
in the opposite sex or predict binge drinking in independent samples of same‐sex
participants. Collapsed across sex, genetic variation on catecholamine and opioid
receptors marginally predicted use. Using machine learning techniques applied to a large
multimodal dataset, we identified a risk profile containing psychosocial and sex‐specific
brain prognostic markers, which were likely to precede and influence cannabis initiation.

Introduction
Cannabis use in adolescence is associated with a range of adversity in adulthood
including cannabis dependence (DSM-IV)(Hall and Degenhardt, 2009; Moss et al.,
2014b), polydrug use (Secades-Villa et al., 2015), cognitive deficits (Meier et al., 2012;
Schuster et al., 2016), compromised physical (Kalant, 2004) and mental health
(Degenhardt et al., 2013; Kedzior and Laeber, 2014; Malone et al., 2010), and diminished
life attainment goals (e.g., socioeconomic factors; (Fergusson and Boden, 2008). These
findings are supported by animal models linking adolescent cannabis exposure with
detrimental outcomes in adulthood (O’Shea, 2004; Quinn et al., 2008a). However, in
humans, it is difficult to assert a causal role for cannabis in subsequent outcomes as any
negative outcomes arising from use could be related to a number of factors confounded
with the choice to initiate use (Jackson et al., 2016).
Results from the 2013 National Survey on Drug Use and Health indicated that
nearly 25% of 10th graders reported ever trying cannabis (NSDUH, 2014). From 2005 to
2010 rates of cannabis-related emergency room visits increased 54% in males and 42% in
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females aged 15-17 years (NSDUH, 2014). Moreover, beliefs concerning the risk of use
are declining (Johnston et al., 2011) despite the increase in drug potency relative to
previous decades (ElSohly et al., 2016). These trends are a source of concern as in vitro
models indicate that delta-9-tetrahydrocannabinol (THC), a psychoactive compound in
cannabis, could be more toxic in adolescent than in adult tissue (Pope et al., 2003; Quinn
et al., 2008a; Renard et al., 2016; Rubino et al., 2015; Schneider, 2008), and human
studies suggest early, compared to adult, initiation of cannabis is associated with worse
outcomes (Brook et al., 2011; Coffey and Patton, 2016).
Global studies suggest cannabis use is typically initiated prior to age 18
(Degenhardt et al., 2008). Thus, adolescence might be a developmental period during
which initiation can be best predicted. Investigations of the risk factors associated with
cannabis initiation commonly report features like temperament (Creemers et al., 2010),
delinquent behaviors (Bree and Pickworth, 2005), alcohol and tobacco use (von Sydow et
al., 2002), and parental (Day et al., 2006) and peer influences (Ellickson et al., 2004),
while rarely considering any neurobiological or genetic contributions. Incorporating these
domains may uncover biobehavioral processes that are specific to the initiation of
cannabis use. Therefore, we sought to uncover a comprehensive risk profile of adolescent
cannabis use by predicting the initiation of use via a large multimodal biobheavioral
dataset.
Prior studies have stressed the importance of attending to sex differences in
substance abuse research. Indeed, males and females differ in their biological response to
cannabis, such that females produce more psychoactive THC metabolites (Narimatsu et
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al., 1991) and exhibit elevated gene expression levels of both CB1 & CB2 cannabinoid
receptors (Onaivi et al., 1999) relative to males. Behaviorally, female cannabis users
endorse more positive subjective ratings associated with abuse liability to smoked
cannabis (vs. placebo; (Cooper and Haney, 2014). Moreover, converging evidence using
animal (Fattore et al., 2007) and human studies (Hernandez-Avila et al., 2004; Schepis et
al., 2011) indicates the transition from cannabis use initiation to regular use is accelerated
in females. Hence, the identification of a predictive profile may identify sex-specific
etiological mechanisms while also informing sex-specific interventions to attenuate the
risk of ever becoming a user.
While prediction analyses can illuminate the nature of drug initiation, these
studies are rare as they necessitate large, longitudinal samples, especially when featurerich domains are considered (Whelan and Garavan, 2014). Large samples are also needed
for cross-validation schemes to ensure predictive models are tested on independent
samples. Hence, we modeled our analytic approach on a related study using the
IMAGEN dataset in which Whelan and colleagues developed predictive models which
identified multi-domain features at age 14 that predicted binge drinking at age 16
(Whelan et al., 2014a). Given this work, we hypothesized cannabis use could be
predicted in a similar fashion using multi-domain data from the IMAGEN sample. We
extend the methods of Whelan and colleagues by identifying multi-domain risk profiles
for each sex while considering a range of subsequent cannabis use levels. In doing so, we
identify predictive features that are both common and unique between the sexes, and
between future cannabis use and binge drinking. While we anticipate replicating many
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psychosocial predictors and uncovering a sparse set of brain and genetic predictors, these
exploratory analyses are data driven. In an era where large multisite neuroimaging
projects and big datasets are becoming more prevalent, we leverage machine learning
techniques to uncover a sparse set of predictors of cannabis use from a large multidomain set of variables that generalize to predict use in independent samples.

Methods and Materials
Full details of the multisite IMAGEN study (Schumann et al., 2010) are available
in the online Standard Operating Procedures (https://imagen-europe.com/). Imaging
acquisition parameters and quality assurance procedures were standardized across site to
ensure comparable data (see Schumann et al., 2010 for standardization of procedures
across sites). The IMAGEN study conformed to the ethical standards outlined by
Declaration of Helsinki and was approved by ethics committees at each site including
King’s College, London; Central Institute of Mental Health, Mannheim; Charite,
Universitatsmedizin Berlin; University Medical Center Hamburg- Eppendorf; University
of Nottingham; Trinity College Dublin; Institut National de la Sante et de la Recherche
Medicale, Orsay. After description of the IMAGEN study to the participants and their
parents, written informed consent was obtained. Individuals who provided assent were
studied at age 14 & 16.

Participants
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Inclusion was determined by a self-report drug use questionnaire (using the
“ESPAD”, described below). Participants from the baseline sample (age 14) who
provided ESPAD data and were cannabis-naïve were eligible for inclusion (n=2,018). At
age 16, n=1,581 participants (78% of the cannabis-naïve sample) provided usable data
(see Table 4.1.1 for evaluation of participants unavailable for follow-up) and were thus
included in the analysis. Participants reporting any level of cannabis use by age 16 were
assigned to the outcome groups (n=365). Participants who remained cannabis-naïve at
age 14 and 16 were assigned to the comparison group (n=1,216).
The European School Survey Project on Alcohol and Drugs (ESPAD; Hibell et
al., 1997) was administered at age 14 and 16 using Psytools (London, UK). Lifetime
usage was measured on an ordinal scale: 0, 1=1-2x, 2=3-5x, 3=6-9x, 4=10-19x, 5=2039x, 6=40x+. See Table 4.1.2 for sample demographics and drug use levels.
Data
Participants were extensively characterized at age 14 using psychosocial (of
parent and child), neuroimaging, and genetic assessments (see supplemental materials).
Psychosocial data were largely self-reported, and included demographics, summary
scores for personality dimensions (Cloninger, 1999; Costa Jr. and McCrae, 1995; Woicik
et al., 2009), frequency of candidate life events (Newcomb et al., 1981), cognitive
(Robbins et al., 1994) and intelligence (Wechsler, 2003) assessments, and drug use levels
of the parent and child (additional features described in supplemental materials). Genetic
data included 108 candidate single nucleotide polymorphisms (SNPs) on genes coding
for neurotransmitter receptors (cannabinoid, opioid and catecholamines), related enzymes
119

(FAAH), eight SNPs previously associated with cannabis dependence (Hartman et al.,
2009; Hopfer et al., 2006; Hurd et al., 2014), and one genetic risk-score based on the
summation of those eight risk-alleles (Cornelis, 2009). Brain data included three fMRI
tasks designed to engage cognitive processes associated with substance abuse (reward
processing, motor response inhibition, and social affective (face) processing; see
supplemental materials for task specifics) and one structural MRI scan. Whole-brain
fMRI contrast maps (generated using a standard GLM) and gray matter volume maps
(GMV; generated using voxel-based morphometry) were each parcellated into 278
regions of interest (ROIs) (Shen et al., 2013). All data (except the cannabis use outcome)
were collected at age 14 and used to predict cannabis use by age 16, and all predictors (n
variables=2,413; see Table 4.1.3 for summary of predictor variables) from each domain
were considered during predictive model estimation.

Statistical Analyses
The overall analytic procedure was designed to accomplish three goals: (1)
perform feature selection to identify the predictors of light to heavy use in males and
females separately; the selected features then informed post-hoc analyses to (2) probe the
identified predictors for sex- and drug-specificity, and (3) assess the relative contribution
of each data domain to the prediction of cannabis use initiation.

Feature Selection
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Six prediction analyses were conducted for each sex in order to predict each level
of use via the ESPAD scale (use levels of 1 and above (Males n=207; Females n=158),
levels 2 and above (Males n=172; Females n=120), and so on up to level 6). Predictive
models were estimated using elastic-net regularization (Zou and Hastie, 2005) with
logistic regression to perform feature selection (from n variables=2,413) and reduce
model overfit. The elastic-net minimizes both the sum of the squared and absolute values
of the regression coefficients, effectively setting some coefficients to zero, thereby
performing feature selection during model estimation. Elastic-net parameters (see
supplemental information) were tuned on independent samples (via nested k-fold crossvalidation), and then final models were tested on an independent internal validation set.
These analyses were implemented using the “glmnet” function in MATLAB (v. R2014a,
Natick, MA).
k(10)-fold cross-validation was used during model estimation to evaluate
predictive models on independent observations. Partitioning a completely external
validation set would have reduced an already small group of interest. Therefore, internal
validation using k-fold cross-validation was used as a proxy for external validation.
During k-fold cross-validation, the full sample of data is partitioned into subsamples of
data, where k equals the number of partitions (or “folds”) of the original starting sample.
k-fold cross-validation then becomes an iterative process whereby a single fold is set
aside as the test sample (“test fold”), and a “training model” is estimated on the
observations in the remaining k-1 folds (“training folds”). The training model is then used
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to predict the observations in the set aside test fold, thereby ensuring the independence of
the test fold sample. This procedure returns k final models.
Each of the six sex-specific prediction analyses were run 100 times to account for
the subtle differences in results incurred due to the random assignment of participants to
folds. Results were thresholded to identify only the predictors that were present in at least
six final models (from k=10) across all 100 runs within a use level analysis. Predictors
passing this threshold were selected for use in post-hoc analyses. See Figure 4.1.1 for a
schematic of the analytic method.
The area under the curve (AUC) of the receiver-operating characteristic (ROC)
was calculated based on the model’s ability to predict cannabis use in the independent
samples segregated during cross-validation. Broadly, here the ROC AUC represents the
probability that a randomly selected individual from the outcome group will be predicted
as a future user (Fawcett, 2006). Null-hypothesis significance testing on the AUC was
conducted using a Mann-Whitney U-test (Mason and Graham, 2002) (significance set
using a Bonferroni corrected p<.008 (p<.05/6 models)) to test the hypothesis that models
predicted independent samples better than chance.
Features selected from each use level analysis were then used in post-hoc analyses
described below. Correlations between each identified feature and cannabis use were also
analyzed using Pearson’s point-biserial correlation to predict any level of future use in a
binary fashion.

Specificity Analyses
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Sex-specificity was assessed by including the selected features of male cannabis
use as the independent variables of a logistic regression model estimated on the female
sample (and vice versa). Drug-specificity was assessed by including the selected features
of male cannabis use as the independent variables of a logistic regression model
estimated on an independent sample of binge drinking males (and likewise for females).
The binge drinking sample contained new individuals (n=400) who were naïve to binge
drinking at age 14 (with a maximum of 2 lifetime drinks), but endorsed binge drinking
episodes (i.e., being drunk from alcoholic beverages) by age 16 (see Table 4.1.4 for binge
drinking sample demographics).

Domain Contribution Analyses
The selected features for each sex were also modeled in a hierarchical fashion to
measure the relative change in model fit after the inclusion of each domain-specific set of
predictors. Model fit for all post-hoc regressions were determined using a chi-square
goodness of fit statistic and the delta Akaike information criterion of model selection
(ΔAIC; Akaike, 1974).

Results
Feature selection analyses predicting each use level returned a range of ROC
AUC values (Males: AUC=0.65–0.74, p=1.4x10-8–5.3x10-10; Females: AUC=0.74–0.82,
p =1.8x10-16–5.5x10-13), indicating high accuracy in predicting independent samples for
each use level (Figure 4.1.2). Best performance was achieved predicting ≥20 uses for
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males (AUC=.74, p=5.3x10-10) and ≥10 uses for females (AUC=. 82, p=5.5x10-13). For
context, in a study using only psychosocial features to predict the initiation of cannabis
use, authors reported a final predictive logistic regression model returning a ROC
AUC=.78 (von Sydow et al., 2002). Additionally, Whelan and colleagues reported a
cross-validated ROC AUC=.75 in their study of brain, psychosocial, and genetic
predictors of binge drinking (Whelan et al., 2014a). Hence, the AUCs reported here are in
line with previous research, while the AUCs from the female models reflect an even
higher degree of cross-validated prediction than what has been previously reported.

Selected Psychosocial Predictors
Six psychosocial predictors were found to be common to both sexes, including
greater lifetime alcohol and cigarette use, parental lifetime cannabis use, novelty-seeking
personality and the disorderliness personality subscale (Cloninger, 1999), and lessnegative feelings towards deviant behaviors (Newcomb et al., 1981). Post-hoc
regressions indicated these predictors returned strong model fit for the full sample (males
and females) for all levels of cannabis use

(χ26,N=1539=184.02, p=4.7x10-37;

ΔAIC=175.02), and also predicted binge drinking (χ25,N=379=29.58, p=1.8x10-5;
ΔAIC=19.58) in an independent sample. See Figure 4.1.4 for a summary of all identified
predictors and their point-biserial correlation with use initiation.
Male-specific predictors included greater parental novelty-seeking (Cloninger,
1999) and sensation seeking personality. While these parental personality traits measure
similar constructs, partial correlations indicated parent sensation seeking predicted use
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(r739=.10, p=.005) after accounting for parent novelty seeking personality (r740=.10,
p=.007). Furthermore, although personality traits are heritable, partial correlations also
indicated child novelty-seeking personality predicted use (r739=.14, p=2.1 x10-4) after
accounting for parent novelty-seeking personality, r740=.10, p=.007).
Female-specific predictors included greater extravagant personality
subscale (Cloninger, 1999) in both the parent and daughter. The extravagant subscale
assesses overspending behaviors and diminished planning, and conveys a tendency to
approach reward cues. Similar to males, greater extravagance of both the parent and
daughter made separate contributions to the prediction (post-hoc partial correlation
between the outcome measure and child extravagance r823=.12, p=3.6 x10-4, after
accounting for parent extravagance r824=.16, p=6.0 x10-6). Additionally, greater
impulsive personality subscale (Cloninger, 1999), frequent sexual experiences, and
higher verbal IQ, predicted female use.

Selected Brain Predictors
For males, six functional and two structural brain features predicted cannabis use.
For females, fifteen functional and two structural brain features predicted use with no
overlap with the predictors for males. Post-hoc point-biserial correlations indicated that
five regions for males, and sixteen regions for females, significantly predicted any level
of use across each sample. See Figures 4.1.3-4 for visualization of all brain features and
direction of effects.
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Sex- and Drug-specificity
Post-hoc regressions confirmed that male-specific brain predictors of use returned
strong model fits when estimated on the male sample (χ28,N=745=24.3, p=.002;
ΔAIC=8.3), as did the female-specific brain predictors estimated on the female sample
(χ217,N=836=101.7, p=4.3x10-14 ΔAIC=67.7). The male-specific brain predictors failed to
predict use in females (χ28,N=836=9.9, p=.272; model with predictors ΔAIC=6.1 relative to
the base rate model) and failed to predict binge drinking in males (χ28,N=180=8.3, p=.405;
model with predictors ΔAIC=7.6 relative to the base rate model). Likewise, the femalespecific brain predictors failed to predict use in males (χ217,N=745=18.8, p=.341; model
with predictors ΔAIC=15.2 relative to the base rate model), and failed to predict binge
drinking in females (χ217,N=220=16.6, p=.482; model with predictors ΔAIC=17.4 relative
to the base rate model). See Table 4.1.5 for all sex- and drug-specific post-hoc regression
summaries.
Genetic Predictors Sex-specific feature selection analyses did not identify any
SNPs, therefore, as a post-hoc exploratory analysis, we collapsed across sex and reran the
analyses with only the genetic predictors (plus nuisance covariates). This analysis
returned an ROC AUC range = 0.54–0.61; p=.01–1.4x10-6 (See Figure 4.1.5). We note
that given the relatively small p-values, these models do not pass a Bonferoni correction,
and as the highest use level analysis (use level 6) yielded a non-significant prediction
(AUC=.53, p=.23), only results from the uncorrected significant models (use level 1-5)
were probed further. Moreover, the genetic multidimensional scaling factors plus
demographic covariates inflated model performance. With that in consideration, two
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SNPs on genes coding for the β2-adrenergic receptor, one SNP on a gene coding for the
α1b-adrenergic receptor, two SNPs on genes coding for the DRD1 receptor, and five SNPs
on genes coding for the µ1-opioid receptor, predicted cannabis use. Post-hoc analyses
suggested three SNPs were significantly related to cannabis use for the male sample (β2adrenergic: rs1042711, rs1801704; and DRD1: rs1174661), whereas none of the SNPs
were significant for the female sample (see Table 4.1.6 and Figure 4.1.6 for SNP
statistics, including their correlation with the outcome measure across the entire sample).
When including these ten SNPs in a post-hoc hierarchical logistic regression
predicting cannabis use, the model exhibited strong fit to the full sample after first
modeling the nuisance covariates (Δχ29,N=1581=25.7, p=.002; ΔAIC=7.7). However, these
SNPs returned poor model fits to the full sample of binge drinkers after first modeling the
nuisance covariates (Δχ29,N=312=9.03, p=.435; ΔAIC=9 relative to the model with
nuisance covariates only).

Domain Contribution Effects
The psychosocial predictors were entered first and significantly improved model
fit relative to the base rate model for the male sample (χ28,N=742=94.5, p=5.5x10-17;
ΔAIC=78.53) and the female sample (χ211,N=826=134.1, p=2.5x10-23; ΔAIC=112.13).
Next, the brain predictors were added and significantly improved model fit for the male
sample (Δχ28,N=742=17.3, p=.027; ΔAIC=1.3) and the female sample (Δχ217,N=826=101.1,
p=5.8x10-14; ΔAIC=67.1). Finally, the ten SNPs were added and significantly improved
model fit for the male sample (Δχ210,N=742 =24.2, p=.007; ΔAIC=6.2) but not the female
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sample (Δχ29,N=826=6.5, p=.689; psychosocial and brain model ΔAIC=11.5). These
findings held irrespective of the order in which each domain was entered. Thus, while
psychosocial data alone can be used to significantly predict use, models containing both
psychosocial and sex-specific brain features return superior fits, highlighting the utility of
capturing individual neurobiological differences in predicting adolescent cannabis use.

Discussion
Psychosocial Findings
The six shared psychosocial predictors replicate previous findings establishing
alcohol and tobacco as predictors of cannabis use (Hall and Pacula, 2003; Siegel et al.,
2014), as are novelty-seeking and disorderliness personality traits (Hale et al., 2003; Sher
and Trull, 1994), and parental transmission of drug use (Brook et al., 2001; Kandel et al.,
1978; Kosty et al., 2015). As these features also predicted binge drinking, they may be
considered general risk factors for adolescent drug use. In considering the parental
influence, parents with behaviorally disinhibited personality traits, coupled with a history
of cannabis use, were found to increase risk for use in their children, mirroring previously
published studies (Day et al., 2006; Kerr et al., 2015). Moreover, less-negative feelings
towards deviant behaviors may signal a predisposition towards conduct disorder, which
previous literature has linked to cannabis use (Crowley et al., 1998). Risk of use was also
identified for females exhibiting higher verbal IQ, which has been implicated in cannabis
experimentation (Fried et al., 2002). Additionally, higher impulsivity, extravagance, and
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sexual experiences are consistent with the novelty-seeking phenotype of individuals most
likely to initiate substance use.

Brain Findings
For males, the brain predictors were largely related to cerebellar activation
differences during response inhibition. Animal models suggest the lateral cerebellum is
involved in motor preparation and inhibition via projections to cortical motor and
inhibitory regions through the thalamus (Middleton and Strick, 2001). Additionally, the
cerebellar regions identified have also been implicated in a network underlying motor
inhibitory control (Stevens et al., 2007). Thus, hypoactivity in all three cerebellar regions
may suggest a compromised motor inhibitory control system constitutes a
neurobiological vulnerability that influences the initiation of cannabis consuming
behaviors. Moreover, larger GMV in the right medial prefrontal cortex (PFC) might
indicate a neurodevelopmental delayed maturation in regions supporting executive
functioning. This finding is supported by studies reporting an adolescent male-specific
increase in PFC volume with alcohol use disorder (Medina et al., 2008) and conduct use
disorder (Brito et al., 2009).
In females, a structural-functional finding in the right pre-supplemental motor
area (pre-SMA) predicted cannabis use. As myelination proliferates during adolescence,
especially in motor areas requiring expedited signal propagation (Paus, 1999), higher
GMV and activity during failed inhibitions observed in the right pre-SMA suggests a
functional consequence of delayed cortical maturation. This structural finding is notable
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for the female sample as cortical maturation (thinning) occurs earlier in females
compared to their male peers (Giedd, 2004).
Additionally, lower activity compared to non-users in the right inferior frontal
gyrus (IFG) during failed inhibitions was predictive of cannabis use in females. As the
right IFG is a key region implicated in the stop task (Garavan et al., 1999), lower activity
is notable as hypoactivity here is also associated with cigarette use (Spechler et al., 2016).
As our test for drug-specificity was restricted to binge drinking, some brain predictors
might generalize to other drugs of abuse not tested here. In the orbitofrontal cortex
(OFC), females also displayed lower bilateral activations during successful inhibitions,
and lower right-sided GMV. The volumetric finding is concordant with Cheetham and
colleagues who reported lower OFC GMV at age 12 predicts use at age 16, with only the
right OFC remaining significant after accounting for poly-drug use (Cheetham et al.,
2012b), thus underscoring the right OFC specificity to cannabis initiation. Furthermore,
as other studies have correlated OFC hypoactivity with adolescent substance use (Whelan
et al., 2012), the anterior prefrontal cortex might be especially valuable for inquiry
relating female-specific neurobiological pathways with substance abuse.
For females, more predictors related to face processing were identified.
Specifically, lower processing of neutral faces in the right superior frontal and lingual
gyri. Previous studies suggest neutral faces can be misperceived as threatening, especially
in individuals with social anxiety disorder (Cooney et al., 2006; Yoon and Zinbarg,
2008). Given the higher prevalence of social anxiety in females (Schneier, 1992) and the
correlation between social anxiety and prevalence of cannabis use in females (Buckner et
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al., 2006, 2007) these results suggest a female-specific pathway towards cannabis use.
Additionally, higher female-specific activation to angry faces in the ventromedial
prefrontal cortex is notable given this region’s involvement in emotion regulation (Urry
et al., 2006).

Genetic Findings
The number of predictive µ1-opioid receptor SNPs highlights the importance of
the opioid system in substance abuse. Opioid and cannabinoid systems co-localize in the
striatum (Rodriguez et al., 2001) and exhibit reciprocal signaling (Robledo et al., 2008).
However, the biobehavioral effects orchestrated by these systems remain unclear in
humans. Animal models suggests the µ1-opioid receptor is specifically involved in
reinforcement as µ1-opioid receptor knockout mice failed to exhibit THC-induced
conditioned place preference compared to δ1-knockout and wild-type mice (Ghozland et
al., 2002). Hence, our findings that cannabis users had a greater number of risk alleles for
both DRD1 SNPs and three µ1-receptor SNPs suggest alterations in their neurobiological
processing of rewards. As these findings were uncovered from exploratory models that
were not as robust to predict use as the multi-domain models, larger GWAS studies or
candidate SNP analyses are needed to reinforce these results.

Conclusions
In this large longitudinal study, we offer evidence that psychosocial and sexspecific neurobiological predictors of cannabis use preceded, and likely influenced,
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teenage cannabis consuming behaviors. Hence, these analyses identified individual
differences at age 14 that predict later cannabis use, and thus have potential for guiding
proactive interventions. Despite having thousands of multi-domain variables per
individual, prediction with high generalizability was achieved with a sparse set of sexspecific brain and psychosocial features, and six shared psychosocial features. And while
the psychosocial data alone was found to predict both cannabis and binge drinking, the
addition of the brain features improved cannabis prediction and augmented the sexspecificity of the findings.
The superior prediction of the female sample suggests they exhibit a more distinct
predictive profile at age 14, despite having lower levels of subsequent use. These findings
are clinically meaningful given the female-specific vulnerability towards accelerated
dependency. Moreover, the fMRI findings highlight the sex-specific psychological
processes potentially driving the initiation of cannabis use in adolescence. Thus, our
findings underscore the importance of attending to sex-differences in addiction research,
and fulfills the recent NIH policy for investigators to examine sex-differences in
biobheavioral research (Clayton and Collins, 2014).
Limitations of this study include the absence of measures of peer influences. The
addition of these variables, as well as interactions between features, might yield a higher
AUC, as the reported AUCs indicate a departure from perfect prediction. Future analyses
to identify how psychosocial, brain, and genetic feature interact to influence the
likelihood of cannabis use are needed. Additionally, the convenient community sampling
of predominantly white Europeans may impact generalizability to other populations.
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Finally, despite predicting high levels of use (e.g., ≥40 uses by age 16), it is
unknown if these individuals will meet DSM-V diagnostic criteria for cannabis use
disorder later in life. However, by design of the analysis, all participants were early
initiators of cannabis, with the heavy users always present in the prediction models.
Therefore, these predictors may signify risk for higher use. Still, the heavy users only
encompassed a small proportion of the sample, therefore even larger studies are needed.
And while our predictive models generalized to independent observations via internal
cross-validation, a completely set aside external validation set was not possible due to the
limited sample sizes. As such, the gold standard remains a completely independent
external validation set. Studies assessing the degree by which cross-validated prediction
metrics may differ by cross-validation scheme are also needed (although Whelan et al.,
2014 reports similar AUCs for internal and external validation). Taken together, our
findings supply new hypotheses to be tested using additional time points from the
ongoing IMAGEN and larger ABCD (www.ABCDstudy.org) studies.
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Tables
Table 4.1.1: Comparison of Age 16 Dropouts vs. Retained Sample

Measure
Age (M,SD)
Sex (Male, Female)
Handedness (L,R)
PDS (M,SD)
Perceptual IQ (M,SD)
Verbal IQ (M,SD)
SES (M,SD)

Groups
Age 16 Dropouts
Retained Sample
(n=437)
(n=1581)
14.6, 0.41
14.5, 0.42
229, 208
745, 836
37, 400
169, 1412
3.6, 0.7
3.5, 0.8
104.5, 13.24
108.11, 13.8
106.8, 14.8
111.2, 13.5
17.01, 4.5

18.00, 3.8

p
.002
.051
.174
.573
.000
.000
.000

Participants who completed the baseline ESPAD assessment and reported no lifetime cannabis
use but then were unavailable for follow up assessment two years later were assigned to the
dropout sample. Compared to the retained sample, the dropout sample had significantly higher
age, and lower IQs and SES.
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Table 4.1.2: Participant Demographics
Groups
Male
Measure
Age
(M,SD)
Handedness
(L,R)
PDS
(M,SD)
Perceptual IQ
(M,SD)
Verbal IQ
(M,SD)
SES
(M,SD)

Females

Cannabis Use
by Age 16
(n=207)

Comparison
Group
(n=538)

Cannabis Use
by Age 16
(n=158)

Comparison
Group
(n=678)

14.50, 0.47

14.52, 0.39

.54

14.51, 0.53

14.54, 0.42

.33

25, 182

66, 472

.94

18, 140

60, 618

.32

2.65, 0.49

2.54, 0.55

.01

3.22, 0.39

3.17, 0.44

.13

108.11, 13.55

108.18, 14.56

.95

109.40, 13.49

107.77, 13.23

.17

114.19, 13.267

112.07, 13.14

.05

112.93, 12.29

109.22, 13.80

.002

18.52, 3.97

17.88, 3.82

.05

18.26, 3.94

17.88, 3.68

.26

p

Cannabis Use
Levels

1

2

3

4

5

6

1

2

3

4

5

6

(N)

62

35

26

24

23

37

56

39

19

20

9

15

p

PDS: Puberty Development Scale (Carskadon & Acebo, 1993); SES: Socioeconomic
status. Cannabis use levels from the ESPAD and measured on an ordinal scale (1=1–2x,
2=3–5x, 3=6-9x, 4=10-19x, 5=20-39x, 6=40+) All data (with the exception of cannabis
use) were obtained at age 14. All demographics measures were also included as
predictors in feature selection analyses.
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Table 4.1.3: Summary of data used as independent variables in predictive modeling.
Domain

Measures

•
•
Psychosocial •
•
•
•
Genetic
•

Demographics
Cognitive assessments
Personality assessment
Life-events questionnaires
Baseline cigarette & alcohol use
Parent personality and drug use
A-priori SNPs
• Cannabinoid Receptor
• Catecholamine Receptors
• Opioid Receptors
Structural • Total GMV
Neuroimaging • Gray-Matter Volume ROIs
• Reward Processing Task
Functional
• (2 Contrasts)
Neuroimaging • Stop Signal Task
• (2 Contrasts)
• Face Processing Task
• (3 Contrasts)
Total predictors per subject

Data points
• 80 measures

• 108 SNPs

• 1 total GMV
• 278 GMV ROIs
• 1946 ROIs
• 278 per contrast

2413

A related analysis including psychopathology measures was conducted but did not improve
predictive performance. Site was also modeled in the analysis and yielded Paris (data not shown)
as a significant predictor due to the higher prevalence of cannabis use at age 16 for both sexes.
Table 4.1.4: Binge Drinking Sample Demographics.

Measure
Age (M,SD)
Sex (Male, Female)
Handedness (L,R)
PDS (M,SD)
Perceptual IQ (M,SD)
Verbal IQ (M,SD)
SES (M,SD)

Groups
Binge Drinkers by age 16 Comparison Group
(n=208)
(n=192)
14.5, 0.41
14.5, 0.39
103, 105
77, 115
21, 171
20, 188
2.8, 0.6
2.9, 0.6
106.2, 13.5
105.8, 14.3
109.5, 13.1
108.5, 14.5
18.1, 3.7

17.8, 3.8

p
.71
.06
.67
.61
.78
.51
.79

All participants at baseline reported no lifetime binge drinking episodes and a maximum of 2
lifetime alcoholic drinks. Participants who then went on to report any level of binge drinking by
age 16 were included in the binge drinking at age 16 sample, compared to participants who
endorsed a maximum of 2 lifetime drinks.
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Table 4.1.5: Post-hoc Regression Model Summaries.
Cannabis
Predictive
Features

Test Sample
SexSpecificity

Shared
Psychosocial
Features
Male
Brain
Features
Female
Brain
Features
Shared
Genetic
Features

Model Fit

χ 2, p

DrugSpecificity
Binge Drinking

Females:
Cannabis Use
Males:
Binge Drinking
Males:
Cannabis Use

29.6, p<.01

19.6 (base rate model –model with
predictors)

9.9, p >.05

6.1 (model with predictors –base rate
model)
7.6 (model with predictors –base rate
model)

8.3, p >.05
18.8, p >.05

Females:
Binge Drinking
Binge Drinking

ΔAIC*

16.6, p >.05
9.03, p >.05

15.2 (model with predictors –base
rate model)
17.4 (model with predictors –base
rate model)
9 (model with predictors –nuisance
model)

Features identified from each cannabis predictive modeling scenario were used to probe sex- and
drug-specific effects. Male & Female shared psychosocial predictors of cannabis use also
predicted binge drinking by age 16. Male brain predictors and female brain predictors failed to
model cannabis use in the opposite sex, or, binge drinking in the same sex. *ΔAIC always in
reference to the better fitting model. ΔAIC= AICmodel_i – AICmin and reflects the relative increase
in information gained from the AICmin (better) model. Values >=2 favor the AICmin model.
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Table 4.1.6: Statistics and Frequencies for Cannabis Predictive SNPs.
Locus

Gene

HW P
value

MAF

Major:
Minor
Alleles

Imputation
Quality
2
(R )

Association
with age 16
Cannabis Use
r

p

Genotype
(% Hminor : HT : Hmajor)
Comparison
Group
16:55:30

Minor Allele
Effect On
Cannabis Use

rs1042711

ADRB2

.86

.122

T:C

.97

.06

.02

Cannabis Use
by age 16
12:54:34

rs1801704

ADRB2

.86

.122

T:C

.97

.06

.02

12:54:34

16:55:30

Protection

rs6888306

ADRA1b

.92

.099

C:T

.89

.03

.25

3:33:64

4:32:64

Protection

rs686

DRD1

.85

.135

A:G

.85

-.03

.23

12:51:37

12:44:44

Risk

rs11746641

DRD1

.84

.060

T:G

.64

-.05

.05

4:25:71

2:22:76

Risk

rs2281617

OPRM1

.88

.098

G:T

.86

.01

.72

2:23:76

1:23:76

Risk

rs563649

OPRM1

.91

.158

G:A

.89

.03

.27

0:14:86

1:13:86

Protection

rs10485057

OPRM1

.89

.094

A:G

.87

.02

.41

1:13:86

1:14:85

Protection

rs1074287

OPRM1

.90

.256

A:G

.99

-.04

.15

9:34:57

8:29:63

Risk

rs511420

OPRM1

.87

.097

T:C

.99

-.04

.09

2:18:80

1:17:83

Risk

Protection

Measures of Hardy-Weinberg Equilibrium (HW), Minor Allele Frequency (MAF). Association
with cannabis use by age 16 calculated using Spearman’s rank correlation between SNP and the
outcome measure collapsed across sex. Hminor: Homozygote minor (high-risk genotype), HT:
heterozygote (intermediate-risk genotype), Hmajor: Homozygote major (low-risk genotype).
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Table 4.1.7: Frequency of Selected Male Features

Domain

Feature
Lifetime Cigarette Use
Parental Cannabis Use

Psychosocial

Feelings of Deviance
Lifetime Alcohol Use
Sensation Seeking Personality (Parent)
Disorderly Personality
Novelty Seeking Personality

Structural MRI

Novelty Seeking Personality (Parent)
L. Mid-Cingulate Cortex
R. Medial Prefrontal Cortex
Stop Success: R.Midbrain-Thalamus

Functional
MRI

Stop Success: L. Inferior Temporal Gyrus
Stop Success: L. Post-Lateral Hemisphere
Stop Success: L. Anterior Cerebellum
Stop Success: L. Paravermis
Neutral Faces: R.Midbrain-Thalamus

Analysis Levels
≥6x ≥10x ≥20x

≥1x

≥3x

≥40x

100
100
100
100
100

100
100
100
100
100

100
100
100
90
33

100
98
100
0
0

100
100
0
0
0

100
100
5
0
0

100
40
28
24
0
100
84
0
0
0
0

96
100
88
0
0
12
9
0
0
1
0

97
100
100
0
0
0
2
100
0
97
0

100
100
20
0
0
0
15
100
0
0
0

100
69
0
0
0
0
100
100
0
100
0

100
0
0
100
100
0
100
100
100
98
100

Count of the number of runs (out of 100) that a predictor was selected in at least 6 of 10
final models.
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Table 4.1.8: Frequency of Selected Female Features
Analysis Levels
Domain

Feature

≥1x

≥3x

≥6x

≥10x

≥20x

≥40x

Lifetime Cigarette Use

100
100
100
100
100

100
100
100
100
100

100
100
100
100
87

100
100
100
100
97

100
100
42
0
0

100
50
0
0
0

100
100
100
100
97
33
100
0
100
100
100
100
100
100
100
87
0
100
100
100
100
100

89
46
17
0
44
89
35
0
0
0
0
0
0
0
4
62
0
100
0
0
0
0

23
100
0
0
100
86
95
70
0
0
0
0
0
0
0
100
0
53
0
0
0
0

100
100
0
0
100
100
0
100
0
0
0
0
0
0
0
100
100
0
1
0
0
0

0
100
0
0
0
1
0
60
0
0
0
0
0
0
0
100
9
0
0
0
0
0

0
81
0
0
0
0
0
58
0
0
0
0
0
0
0
4
34
0
5
0
0
0

Lifetime Alcohol Use
Novelty Seeking Personality

Psychosocial

Parental Cannabis Use
Extravagant Personality (Parent)
Feelings of Deviance
Disorderly Personality
Verbal IQ
Impulsive Personality
Frequency of Sexual Life Events

Structural
MRI

Extravagant Personality
R.Pre-Supplementary Motor Area
R.Middle Frontal Gyrus
Stop Success: L. Orbital Frontal Cortex
Stop Success: R. Orbital Frontal Cortex
Stop Success: R.Middle Temporal Gyrus
Stop Success: R.Middle Temporal Gyrus

Functional
MRI

Stop Failure: L.Midbrain
Stop Failure: R.Post-Central Gyrus
Stop Failure: R.Inferior Frontal Gyrus
Stop Failure: R.Pre-Supplementary Motor Area
Stop Failure: L.Lateral Paravermis
Stop Failure: L.Pre-Post Central Gyrus
Angry Faces: R.Anterior Cerebellum
Angry Faces: L.Ventromedial Prefrontal Cortex
Neutral Faces: R. Superior Frontal Gyrus
Reward Anticipation: L.Middle Frontal Gyrus

Count of the number of runs (out of 100) that a predictor was selected in at least 6 of 10
final models.
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Table 4.1.9: Analysis of Head Motion
Sex
Males

Females

Task
Faces
MID
Stop Signal
Faces
MID
Stop Signal

Mean Framewise Displacement:
Age 16 Users vs. Comparison Group
t720= -0.73, p > .05
t684= -0.85, p > .05
t669= -1.69, p > .05
t806= -2.09, p =.04
t772= -0.22, p > .05
t765= -1.00, p > .05

Framewise displacement was calculated from the six-directional head motion parameters
estimated during image realignment. 2-sample t-tests on the participants endorsing any cannabis
at age 16 vs. their non-using peers failed to detect significant differences in head motion (mean
FD) for any of the tasks for either sex, with the exception of the faces task for females. The
modest motion effect detected for the faces task in females is driven by outliers in the comparison
sample. Exclusion of these participants does not affect predictive model performance.
Furthermore, the faces task predictors were lower activity (with one exception) in the cannabis
use sample therefore, any motion effects are likely non-influential.
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Figures
Figure 4.1.1: Schematic of Analytic Method
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First, data are divided into k(10) outer-folds. k-1 outer-folds are then divided into k(10)
nested subfolds. Elastic-net regularized logistic regression applied to k-1 subfolds, during
which the α, λ parameters are tuned by finding the optimal pair returning the highest
AUC when it’s model is tested on the kth subfold. The iterative process is completed for
the k(10) subfolds, generating 10 final nested models. The 10 nested models are ranked
by their AUC returned when tested on each respective test-fold. The highest-ranking
model is then tested on the outer fold, and used to generate the reported test AUC. This
process is repeated k-times, and the entire procedure executed 100 times.

150

Figure 4.1.2: Mean Receiver-operating characteristic (ROC) AUC For Each Use Level by
Sex

ROC AUC
For Each Increasing Use Level by Sex

mean AUC

1

Females
Males

0.9
0.8

0.78

0.74

0.7
0.6

0.81

0.77
0.75

0.71
0.65

0.82

0.73

0.74
0.66

0.65

0.5
≥1x

≥3x

≥6x

≥10x

≥20x

≥40+

Minimum Cannabis Use Level at Age 16
Mean ROC AUC indicates the performance of the predictive models on independent
samples across 100 runs for each use level by sex.
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Figure 4.1.3: Sex Specific Brain Predictors of Adolescent Cannabis Use

Females

Males
A

B

Stop Success =
GMV =

Cannabis > Controls

Stop Failure =
Angry Faces =
Reward Anticipation =
Stop Failure & GMV =

D

C

Stop Success =
GMV =
Neutral Faces & Stop Success=

Cannabis < Controls

Angry Faces =
Stop Success =
GMV =
Neutral Faces =
Stop Failure =

Panels A&B: Brain regions where age 16 cannabis users displayed higher average grouplevel activation or gray matter volume relative to their non-using peers.
Panel A: Male Specific Predictive ROIs. Stop Success refers to successful inhibition
trials minus implicit baseline during the stop signal task; ROI (red) in left inferior
temporal gyrus. GMV ROI (yellow) in right medial prefrontal cortex.
Panel B: Female Specific Predictive ROIs. Stop Failure refers to failed inhibition trials
minus implicit baseline during the stop signal task; ROIs (pink) in left lateral paravermis,
left midbrain, left pre- & post-central gyrus, right post-central gyrus. Angry Faces refers
to passive viewing of angry faces minus control images; ROI (orange) in left
ventromedial prefrontal cortex. Reward Anticipation refers to the processing of monetary
reward cues; ROI (dark green) in left middle frontal gyrus. Stop Failure & GMV
overlapping ROI (purple) in right pre-supplementary motor area.
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Panels C&D: Brain regions where age 16 cannabis users displayed lower average grouplevel activation or gray matter volume relative to their non-using peers.
Panel C: Male Specific ROIs. Stop Success ROIs (dark blue) in left cerebellum include
the anterior cerebellum, paravermis, and posterior-lateral portion of the left hemisphere.
GMV ROI (bright green) in left middle cingulate. Neutral Faces (passive viewing of
neutral faces minus control images) & GMV overlapping ROI (teal) in right midbrain
with extent into thalamus.
Panel D: Female Specific ROIs. Angry Faces ROI (light blue) in right cerebellar tonsil.
Stop Success ROIs (dark blue) in bilateral orbitofrontal cortex and two contiguous
regions in the right middle temporal gyrus. GMV ROI (bright green) in right middle
frontal gyrus. Neutral Faces ROIs (maroon) in right superior frontal gyrus and lingual
gyrus. Stop Failure ROI (dark yellow) in right inferior frontal gyrus.
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Figure 4.1.4: Correlations Between Identified Predictors and Outcome Measure by Sex.

Pearson’s point-biserial correlation (r) between predictor and outcome. Error bars
represent 95% confidence intervals generated from 5000 bootstrap samples.
Circles=Drug use (ESPAD). Triangles=personality (from TCI & SURPS). Squares=Life
Event (from LEQ). Pentagon=Verbal IQ. Diamonds = Neuroimaging data.
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Figure 4.1.5: Receiver-operating characteristic (ROC) mean AUC for Gene-specific
analysis
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ROC AUC indicates the performance of the predictive models on independent samples.
This plot visualizes the mean AUC across 100 runs for each use level collapsed across
sex.
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Table 4.1.6: Correlations Between Identified SNPs and Outcome Measure by Sex.
-0.2

Males
0

0.2

GENE

-0.2

Females
0

0.2

0
r

0.2

ADRB2
rs1042711
rs1801704
ADRA1b
rs6888306
DRD1
rs686
rs11746641
OPRM1
rs563649
rs10485057
rs1074287
rs511420
rs2281617
-0.2

0
r

0.2

-0.2

Pearson’s point-biserial correlation (r) between SNP and outcome. Error bars represent
95% confidence intervals generated from 5000 bootstrap samples.
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4.2: Predicting The Initiation Of Cannabis Use By Age 19: Exploratory Analyses
Introduction
As discussed in Chapter 1, early age of onset for cannabis use predicts worse
functional outcomes later in life (Lisdahl et al., 2013). Therefore, predicting initiation by
age 16 was likely the most impactful cannabis prediction analysis that can be conducted
using the IMAGEN dataset. Those analyses provided evidence that cannabis use by age
16 is reliably predicted using multi-domain data collected at age 14 prior to exposure.
Results from those analyses identified sex- and drug-specific psychosocial and
neurobiological predictors that might inform etiological mechanisms and provide targets
for interventions related to cannabis use by age 16.
As the IMAGEN study also contained assessments at age 19, a natural extension
of this line of inquiry is to also predict cannabis initiation by age 19. If the age 16
predictors identified from Chapter 4.1 (future cannabis users vs. all non-users) were
reproduced, then that would underscore their predictive validity. A reproduction might
also be used to characterize those features as trait-like predictors, meaning, those features
are predictive of cannabis use regardless of the age of initiation. Alternatively, if the
predictors were not reproduced, that might highlight their specificity to early initiation.
These analyses were conducted for exploratory purposes to test if any level of
cannabis use by age 19 can be predicted using multi-domain data collected at age 14,
regardless of the future use level. Hence, the technique in Chapter 4.1 that involved
predicting each increasing use level was not used here. That technique dramatically
added complexity to an already complicated analysis, but was justified in light of the
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importance to identify the predictors of early initiation. Moreover, the majority of the
predictors from Chapter 4.1 were identified from the most lenient cannabis use threshold
(ESPAD 1>=1; Tables 4.1.7-8). Therefore, these exploratory analyses reported here were
most likely to identify the greatest number of predictors to compare to the predictors from
Chapter 4.1. Lastly, setting a low threshold to include all future cannabis users also
provided the most statistical power.

Methods
Participants
Participants from the IMAGEN study were selected based on their reported drug
use levels at all time points from the ESPAD survey (Hibell et al., 1997). From the full
baseline sample (N=2,224), there were n=648 (Females n=398) identified as being
cannabis-naïve at all time points and were therefore used in the comparison groups. Next,
there were n=313 (Females n=145) who were cannabis-naïve at age 14 and 16 and then
reported any cannabis use by age 19. In keeping with the theme of sex-specificity, the
samples were separated by sex. See Table 4.2.1 for demographic information for each
group including their cannabis use levels by age 19.

Data Analysis
Similar data analytic procedures from the preceding section were used here. In
brief, k(10)-fold cross-validated logistic regression with elastic-net regularization was
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used to predict cannabis initiation by age 19 separately for each sex. All predictors were
drawn from the age 14 assessment only.
As these analyses were exploratory in nature, the increasing use level technique
was not used here. Therefore, the analysis was designed to predict any amount of
cannabis use (ESPAD >=1) by age 19 vs. controls. The predictors selected from these
analyses were identified using the same threshold as Chapter 4.1 (i.e., present in at least
six final models (from k=10) across all 100 runs). Finally, sex-specificity was assessed in
a similar fashion by including the selected predictors in a post-hoc logistic regression
model estimated on the opposite sex.

Results
Prediction Accuracies
Prediction model accuracies indicated a significant prediction of age 19 cannabis
use in females (mean ROC AUC=.63, p=1.8x10-6), but not males (mean ROC AUC=.52,
p>.05).

Feature Selection
When probing the results from the female-specific analysis, only two predictors
passed feature selection threshold and they were higher baseline alcohol use and novelty
seeking personality (Cloninger, 1999). The results from the male-specific analysis were
not probed given the null prediction accuracies.
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Sex-specificity
In keeping with the methods of Chapter 4.1, the two psychosocial predictors
(alcohol and novelty seeking personality) from the female specific analysis were used to
estimate a post-hoc logistic regression model on the male sample. Findings indicated that
these two psychosocial predictors returned strong model fits when tested on the full male
sample (χ22,N=418=13.5, p=.001; ΔAIC=9.4). As there were only two predictors, the
regression coefficients were probed in an exploratory fashion. Findings indicated only
novelty seeking personality emerged as a significant predictor of cannabis use by age 19
for males (Adj.OR 1.03 [95% CI: 1.01-1.05], p<.05).

Discussion
These results indicated that age 19 cannabis use can be predicted for females but
not males using machine learning applied to a large set of multi-domain data collected at
age 14. The predictive profile identified from the female-specific analysis contained two
psychosocial predictors: higher baseline alcohol use and novelty seeking personality.
Tests for sex-specificity indicated that novelty seeking personality generalized to predict
cannabis use by age 19 in males.
Here, males were not predicted using machine learning, but were predicted using
the single novelty seeking personality predictor. This may have been due to the loss of
statistical power incurred when the sample was split during cross-validation prior to
model estimation. As the post-hoc model was estimated on the full sample of males, the
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modest odds ratio and confidence interval might reflect this subtle effect was observed
due to the increase in statistical power.
Baseline alcohol predicted cannabis use by age 19 for females, but not males.
This finding is consistent for females relative to the results in Chapter 4.1 and suggests
higher baseline alcohol use is a trait-like characteristic that predicts cannabis use
throughout adolescence and into adulthood.
In these analyses, novelty seeking personality predicted females using machine
learning, and predicted males in a post-hoc fashion. Novelty seeking personality was also
identified as a predictor common across the sexes in Chapter 4.1. This converging
evidence indicated that novelty seeking personality is also trait-like, and confers risk for
cannabis use regardless of sex or age of initiation.
Translating these findings into treatment is challenging, however, personalitytargeted intervention programs may be useful (Conrod, 2016). These interventions are
grounded in cognitive-behavioral therapies, and are tailored to the individual following
measurement on the substance use risk profile scale (SURPS) personality instrument
(Woicik et al., 2009). Although SURPS data was collected in IMAGEN and used in all
the machine learning analyses here, only the Temperament and Character-Inventory
(TCI) (Cloninger, 1999) measurement of novelty seeking personality was identified as
predictive. The SURPS measurement that is broadly in line with novelty seeking
personality is the sensation seeking personality trait, which measures sensitivity to
rewards (Woicik et al., 2009).
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Personality-targeted intervention programs have been effective in adolescent
samples. Mahu and colleagues tested this intervention technique at high schools with
students who were designated high risk for cannabis use (Mahu et al., 2015). Following a
brief personality-targeted intervention in 9th grade (ages 13-14), adolescents were
followed up every six months for two years. Authors reported that children from schools
receiving the intervention exhibited a reduction in cannabis use frequency 12 and 18
months later compared to control schools. Of note, authors also reported that individuals
receiving a targeted intervention for an elevated sensation seeking personality
demonstrated a delay in the onset of cannabis use (Mahu et al., 2015). Therefore,
targeting novelty seeking personality traits in a similar fashion as the Mahu report might
be effective in altering the risk phenotype for both males and females. A delay in the
onset of use might generalize to the samples characterized using the TCI novelty seeking
personality trait following a similar personality-targeted intervention.
These analyses used only the predictors measured at age 14. The IMAGEN study
also assessed participants at age 16. Future analyses could incorporate the age 16 data,
and could, for example, also incorporate changes in relevant measures from age 14 to 16.
For example, the life events questionnaire at age 16 (Newcomb et al., 1981) is expected
to reflect the stressful life experiences that are more proximal in time to cannabis use at
age 19. Moreover, the difference in those measures would reflect severity of change and
is hypothesized to better predict cannabis use. Likewise, baseline cigarette use was a
strong predictor in Chapter 4.1, but not reproduced here. It would be interesting to test if
an increase in cigarette use at age 16 predicts cannabis use by age 19 as the literature
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commonly reports a correlation between those two drugs (Agrawal et al., 2012). Finally,
the brain data were absent from these results. Future analyses could also incorporate the
age 14 brain data with the age 16 psychosocial data to perform mediation analyses
linking the brain to behavior two and five years later. For example, a path from one the
baseline predictors of cannabis use uncovered in Chapter 4.1, might predict performance
on a cognitive measure at age 16, which in turn, might predict cannabis use at age 19.
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Tables
Table 4.2.1: Participant Demographic Information by Sex
Groups
Males (N=418)
Measure
Age
(M,SD)
Handedness
(L,R)
PDS
(M,SD)
Perceptual IQ
(M,SD)
Verbal IQ
(M,SD)
SES
(M,SD)

Females (N=543)

Cannabis Use
by Age 19
(n=168)

Comparison
Group
(n=250)

Cannabis Use
by Age 19
(n=145)

Comparison
Group
(n=398)

14.5, 0.36

14.5, 0.42

.30

14.5, 0.4

14.6, 0.4

.11

15, 153

29, 221

.38

10, 135

39, 359

.30

2.6, 0.5

2.5, 0.56

.33

3.1, 0.5

3.2, 0.4

.16

106.6, 13.3

111.0, 15.1

.01

108.5, 13.2

109.3, 13.0

.52

112.3, 12.9

113.4, 13.1

.40

110.5, 12.7

110.4, 13.9

.97

18.0, 4.0

18.2, 3.7

.54

18.7, 3.4

18.0, 3.6

.03

p

Cannabis Use
Levels

1

2

3

4

5

6

1

2

3

4

5

6

(N)

62

32

21

20

12

21

64

34

16

9

9

13

p

PDS=Puberty Development Scale (Carskadon and Acebo, 1993). SES=Socioeconomic Status.
Cannabis Use Levels from the ESPAD and measured on an ordinal scale (1=1-2x, 2=3-5x, 3=69x, 4=10-19x, 5=20-39x, 6=40x+). All measures (with the exception of cannabis use) were
obtained at age 14. All demographics measures were also included as predictors in feature
selection analyses. The comparison group was cannabis-naïve at all time points.
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CHAPTER 5: DIFFERENTIAL PREDICTION OF FUTURE CANNABIS
USE VS. FUTURE BINGE DRINKING
Introduction
It is important to consider drug specificity in analyses identifying risk factors and
predictors of a single substance as it is uncommon for individuals to only use one drug of
abuse. For instance, data from a nationally representative sample of adolescents indicated
that cannabis is commonly used in tandem with alcohol and tobacco and only 1% of
individuals who use cannabis do so exclusively (Patrick et al., 2018). When considering
cannabis and alcohol use together, Terry-McElrath and colleagues report that 13% of
teens use the two drugs concurrently (defined as separate use occasions within the past 30
days), whereas 21% of teens use the two drugs simultaneously for overlapping
intoxication (Terry-McElrath et al., 2014).
Alcohol is the most commonly used drug during adolescence (Johnston et al.,
2018), however many teens with binge drinking episodes might not necessarily have
experiences using cannabis. Instead, for the adolescents who use cannabis, it may be
considered common for these teens to engage in excessive alcohol consumption.
Therefore, when predicting future cannabis use in adolescence it is important to consider
the extent to which teens also go on to binge drink. Evidence of concurrent drug use
could undermine the strength of the study conclusions, as it is unclear if the prediction
accuracy or predictors themselves are indicative of cannabis use per se or a likelihood to
consume drugs, specifically alcohol, more generally.
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Guided by this framework, the study in Chapter 4 contains an important caveat
that the future cannabis users also reported some binge drinking by age 16. The
examination of drug specificity in that Chapter involved testing the sex-specific
predictors on an independent sample of future binge drinkers only. Therefore, a stricter
test of drug specificity targeting a typical pattern of cannabis use is required.
To this end, a differential prediction analysis between the future cannabis use
sample (which also contained some binge drinking) and future binge drinking without
future cannabis use will be performed. These analyses are therefore much more rigorous
than Chapter 4. In considering these very similar behavioral phenotypes, it is
hypothesized that the prediction accuracy in these analyses will not be as large as those
reported in Chapter 4.
Few investigations have used neuroimaging to explicitly predict or compare teens
with concurrent cannabis use and binge drinking (“cannabis+binge drinking”) to teens
with binge drinking only. While the study by Whelan and colleagues used very similar
methods to classify and predict binge drinking, the authors compared binge drinking
teens to a sample with very light alcohol use (maximum two lifetime alcohol uses, no
binge drinking), and did not comment on the amount of co-occurring cannabis use in
their samples (Whelan et al., 2014b). Three cross-sectional structural neuroimaging
studies compared teens with cannabis+binge drinking experiences to teens with only
binge drinking experiences. Medina and colleagues found that binge drinkers exhibited
smaller left hippocampal volumes, and larger right-to-left hippocampal asymmetry
relative to the cannabis+binge drinking groups (Medina et al., 2007b). Jacobus and
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colleagues used diffusion tensor imaging and found the binge drinking only group had
lower fractional anisotropy (a measure of white mater integrity) relative to teens with
cannabis+binge drinking, in four major white matter tracts across the brain (Jacobus et
al., 2009). Finally, Schweinsburg and colleagues used a working memory fMRI task and
reported the cannabis+binge drinking group exhibited lower activations than the binge
drinking only group in bilateral prefrontal and right temporal and occipital regions
(Schweinsburg et al., 2005).
Together, these findings underscore the use of neuroimaging in delineating group
differences between cannabis+binge drinking and binge drinking only adolescents. In
both structural studies, authors posited that cannabis might have provided some
neuroprotective properties relative to alcohol. In the fMRI study, authors suggested that
the cannabis+binge drinking group might have compromised their attentional processing
abilities. And while all authors were unable to assert causality, they were less inclined to
interpret their findings as being predictive of use. Therefore, the analyses here are
tailored to address a gap in the literature by identifying a generalizable predictive profile
characterizing a typical pattern of cannabis use in adolescence.
Critically, the analysis in this Chapter will, by design, compare two groups who
are matched on their levels of future binge drinking. The distinctive characteristic of one
group will therefore be their future cannabis use. Any predictors that separate these two
groups are hypothesized to be specific to the combination of future cannabis use and
binge drinking. Moreover, as the results from Chapter 4 demonstrated that the shared
psychosocial predictors of future cannabis use generalized to predict future binge
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drinking, it is hypothesized that the psychosocial predictors will no longer discriminate
the two groups, and instead, the discriminating predictors will be from the neuroimaging
and/or genetic domains.

Methods
Participants & Data
All data were drawn from the IMAGEN study. Binge drinking levels reported by
age 16 were tabulated for both the male and female samples of future cannabis use
studied in Chapter 4 (now referred to as “cannabis+binge drinking”), as well as the binge
drinking levels for the future binge drinking only group (See Figure 5.1). Participants
from the starting samples of cannabis+binge drinking and future binge drinking groups
were then randomly sampled without replacement to identify a reduced sample of two
groups perfectly matched on future binge dinking levels. For example, in the male
starting sample, there were 32 participants in the cannabis+binge drinking group, and 50
in the binge drinking only group, who reported a binge drinking level of 1-2x by age 16
(see Table 5.1 or Figure 5.1). Therefore, 32 participants from the binge drinking only
group use level 1-2x were randomly selected for inclusion to match the size of the future
cannabis+binge drinking group. Similar logic was executed for each use level for each
sex. This procedure resulted in n=148 females (74 per group), and n=178 males (89 per
group) who were matched on the level of future binge drinking. See Tables 5.2 and 5.3
for baseline demographic information and drug levels by age 16 for the samples used in
the differential prediction analyses.
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The same set of multi-domain predictors (2,412 total predictors) collected at
baseline (age 14) was used in the differential prediction analyses, except for baseline
alcohol use. The exclusion of baseline alcohol use was necessary so that data from the
participants in the binge drinking only group were minimally confounded with
consequences of early alcohol use. Thus, the future binge drinkers were restricted to have
used alcohol a maximum of 1-2x in the life by age 14.

Analysis
Similar logistic regressions with elastic-net regularization (Zou and Hastie, 2005)
as explained in Chapter 4 were applied separately for each sex. The main difference is
that given the reduced sample sizes, a smaller k-fold cross-validation scheme was
implemented (k=5). All other procedures applied, including the nested k(5)-fold crossvalidation scheme to tune the alpha and lambda parameters for the elastic-net. Likewise
from Chapter 4, these procedures were looped 100 times to account for the randomness
of participants being assigned to the k-folds.
As preliminary analyses using regularized logistic regressions returned very
sparse results for the male sample, the prediction analyses were conducted again using a
random forest model (Breiman, 2001). This model was chosen based on the hypothesis
that non-linear relationships between the predictors might better differentiate between
two very similar behavioral phenotypes. When estimating the random forest models, a
similar 5-fold cross validation scheme was implemented, including a nested 5-fold cross
validation scheme for random forest parameter tuning. These tuning parameters included
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the number of decision trees (100 to 500 trees), and the number of samples required for a
“leaf” node (defined as the minimum number of samples to be contained within a
partition of the decision tree). Generally, more decision trees the better, however, an
excessive number of decision trees risks fitting many trees using poor predictors. The
minimum samples per leaf may be considered a method to resist overfitting. By requiring
a larger number of samples in a leaf, the decision tree is restricted from becoming overly
complex and fitting to the noise and nuances of small samples. As above, the entire
analytic scheme was run 100 times to account for the random assignment of participants
to folds.
After running the logistic regression and random forest analyses separately for
each sex, the predictors were evaluated for sex-specificity using post-hoc analyses.
Predictors identified from the logistic regression analyses for one sex were used in a posthoc regression model to predict the opposite sex. For the results of the random forests, in
keeping with tree-based estimators, the predictors for one sex were used to estimate a
single decision tree to predict the opposite sex. Prediction model accuracy was evaluated
for all scenarios using the area under the receiver-operating characteristic curve (ROC
AUC). Null-hypothesis significance testing on the ROC AUC was conducted using a
Mann–Whitney U-test (Mason and Graham, 2002).

Results
Drug Use Levels
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The exact levels of future binge drinking in the cannabis+binge drinking group
and the future binge drinking only group was plotted for each sex (see Figure 5.1). The
distribution of binge drinking within the cannabis+binge groups was nearly uniform
across the use levels for males and females, whereas the future binge drinking only
groups were more skewed to lighter binge drinking. These data suggest that while it is
likely for future cannabis users to also binge drink, the patterns of use are not consistent
across the two drugs. Therefore, identifying subsamples of individuals matched on binge
drinking (described below) removes the confound of predicting co-occurring use, and
substantiates future cannabis use as the defining outcome measure.
Prior to the pseudo-random selection process to match groups on future binge
drinking levels, it was found that 89% of females, and 91% of males in the future
cannabis using groups from Chapter 4 also indicated some level of future binge dinking.
Therefore, 11% and 9% of participants for each sex who had not initiated any binge
drinking were initially excluded from the sample. Of the remaining samples, participants
were randomly sampled without replacement from the larger group within each binge
drinking level (described above). This procedure yielded n=178 males (89 per group; see
Table 5.2) and n=148 females (74 per group; see Table 5.3) who were then passed
forward to the differential prediction analysis (See Figure 5.2 for graphs of matched
samples use levels). For each sex, chi-square and t-test analyses on various baseline
demographic measures indicated the two groups did not differ on age, handedness,
pubertal development, SES or IQs (with the exception of lower performance IQ in the
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male cannabis+binge drinking group, see Table 5.3). Nonetheless, all demographics were
also included as candidate predictors in the analysis.

Predictive Models Performance
When evaluating the logistic regression differential prediction analyses on
independent samples, results indicated significant predictions in the female sample: mean
ROC AUC=.6567 (p<5.92x10-6), and the male sample: mean ROC AUC=.6140
(p<4.6x10-4). When evaluating the random forest prediction analyses on independent
samples, results were nearly identical for females: mean ROC AUC=.6593 (p<4.23x10-6)
and consistent for males: mean ROC AUC=.6286 (p<9.25x10-5), relative to the AUCs
from the logistic regression analyses. Hence, the prediction accuracy was consistent
across the two machine learning algorithms.

Permutation Tests
The AUCs reported above may be considered modest relative to those reported in
Chapter 4. To further investigate the prediction accuracies for these analyses, a nonparametric test on the significance of the ROC AUCs was performed. Here, the
prediction analyses were run an additional 100 times while randomly shuffling the group
labels. These analyses empirically derive a distribution of ROC AUCs over the null
hypothesis. The ROC AUCs from the true label analysis are then compared to this null
distribution. Given the very similar AUCs across the two machine learning algorithms,
the permutation analyses were conducted using the random forest algorithm.
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These permutation analyses returned a mean ROC AUC=.50 for both males and
females, indicating the models failed to predict the two randomly labeled groups better
than chance. For both males and females, the true label AUC results for both the logistic
and random forest models were greater than 95 of the 100 ROC AUC derived from the
random label permutation analysis (p<.05). Taken together, these results provide strong
supporting evidence that for each sex, the two groups were distinct and the performance
of the prediction analyses were significantly above chance levels.

Features Selected
As the differential prediction models were fitted within a 5-fold cross validation
framework (thus supplying 5 final models), and looped 100 times, a threshold was
necessary to perform feature selection. Therefore, in keeping with the threshold from
Chapter 4, a feature must have been present in at least half of the final models (here, a
minimum 3 of 5) across all 100 runs. With this threshold in place, the logistic regression
analyses identified four features for females, and one feature for males. After
interrogating the random forest analyses, five features for females, and three features for
males were identified.
Starting with the four female features from the logistic regression analyses, higher
baseline cigarette use and less negative feelings towards deviant behaviors in the future
cannabis+binge drinkers were the two psychosocial predictors identified. From the brain
domain, higher activations in the left superior cerebellum during reward anticipations was
identified in the cannabis+binge drinking group (Figure 5.3). The final predictor was
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rs521674, a SNP on a gene coding for the alpha-2A adrenergic receptor, with a higher
number of risk alleles present in the future binge drinking only group. See Table 5.4 for
summary of SNP rs521674 allele frequencies by group.
Moving to the five female features identified from the random forest analyses,
only higher baseline cigarette use was reproduced from the logistic results. The other four
predictors were brain predictors from the stop signal task. During stop success, lower
activations in the right inferior temporal and paracentral lobule, and left middle frontal
gyrus, were identified in the cannabis+binge drinking group. Finally, during stop failures,
lower activation in the left inferior frontal gyrus was identified in the cannabis+binge
drinking group. See Figure 5.3 for all female brain predictor results.
Considering the male results, only higher baseline cigarette use in the future
cannabis+binge drinking group was identified from the logistic regression analyses. For
the random forest analyses, higher baseline cigarette use was also observed, and less
negative feelings towards deviant behaviors in the cannabis+binge drinking group was
identified. Finally, higher gray matter volume in the right inferior temporal lobe was
identified in the cannabis+binge drinking group (Figure 5.4). Interestingly, this was the
same ROI that exhibited lower activations during stop success trials for future female
cannabis+binge users.

Sex-Specificity
Like Chapter 4, the differential prediction analyses returned a unique set of brain
predictors for each sex. Sex-specificity was tested in a similar manner as Chapter 4, such
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that a post-hoc logistic regression model using the female-specific brain predictors was
estimated on the entire female sample, and then tested on the entire male sample. This
was done only for females because the male analysis identified only one shared predictor
(baseline cigarette use) using a logistic regression model.
To begin, estimating a post-hoc logistic regression model using only the
cerebellar ROI during reward processing returned a ROC AUC=.65 (p<8.2x10-4) when
tested on the entire female sample, and a ROC AUC=.48 (p>.05) when tested on the
entire male sample. Thus, cerebellar activations to rewards may be considered a femalespecific differential predictor of future cannabis+binge drinking. For reference,
estimating a post-hoc logistic regression model using all the female-specific predictors
(feelings of deviance, SNP rs521674, and the cerebellar ROI) returned a ROC AUC=.80
(p<1.5x10-10) when tested on the entire female sample. When tested on males, that model
returned a ROC AUC=.61 (p<.05). This modest prediction is likely driven by the feelings
toward deviant behaviors predictor, which was identified for males using the random
forest model, and approached selection threshold for the male logistic model (64 of 100
runs). See Table 5.5 for the number of runs each predictor was selected by the alternate
analytic model.
Turning to the predictors uncovered from the random forest analyses, sexspecificity was assessed in a similar way using a decision tree. Here, a post-hoc decision
tree using the four female-specific brain predictors from the stop signal task was
estimated on the females. This decision tree returned a ROC AUC=.83 (p<2.1x10-12)
when tested on the full female sample, and failed to predict better than chance when
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tested on the full male sample, ROC AUC=.53 (p>.05). Taken together with the result of
the cerebellar ROI from the logistic regression analysis, all brain predictors for females,
regardless of the model from which they were identified, exhibit clear sex-specificity in
differentially predicting future cannabis use vs. binge drinking.
For the male results, only the random forest identified a brain predictor. A single
post-hoc decision tree was estimated on the male sample using the GMV ROI. This
decision tree returned a ROC AUC=.74 (p<1.6x10-8) when tested on the full male
sample, and failed to predict better than chance when tested on the full female sample,
ROC AUC=.49 (p>.05). Hence, the random forest identified brain predictor exhibited
sex-specificity for males. For reference, estimating a single post-hoc decision tree using
the two male-specific predictors (feelings towards deviant behaviors and the GMV ROI)
returned a ROC AUC=.76 for males (p<1.5x10-9). This decision tree predicted marginally
better than chance when tested on the full female sample, ROC AUC=.57 (p<.05), and
was likely driven by the feelings towards deviant behaviors predictor.

Comparison of Predictors Identified from Random Forests vs. Logistic Regression
With the exception of baseline cigarette use, the predictors identified from the
random forest were different than the predictors identified from the logistic regression. A
likely interpretation of these discrepant findings is that the random forest is capable of
modeling predictors exhibiting both linear and non-linear relationships. To assess this
possibility, the predictors identified form the random forest analyses were used to
estimate a post-hoc logistic regression model and a decision tree for each sex. It was
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hypothesized that the AUCs for the logistic regression models would be lower than the
decision trees, thus supporting the argument that the tree-based estimators achieve their
results by capturing non-linearities among the features.
The four female-specific brain predictors identified from the random forest
analysis were first used in a post-hoc logistic regression model on the full female sample.
This model returned a ROC AUC=.71 (p<5.2x10-6). Using these predictors in a post-hoc
decision tree returned a ROC AUC=.83 (p<2.1x10-12). Similarly for males, the one malespecific brain predictor identified from the random forest model was used to estimate a
post-hoc logistic regression model on the full male sample. This model returned a ROC
AUC=.70 (p<2.4x10-6). Using this predictor to estimate a post-hoc decision tree returned
a ROC AUC= .76 (p<1.5x10-9).
In all cases, using predictors identified from the random forest analyses returned
inferior prediction in a logistic regression model relative to the decision tree model.
Interestingly, the post-hoc logistic regression models were still highly significant when
predicting each sample, although to a lesser extent than the decision tress. These results
indicate that tree-based estimators are more flexible in modeling relationships. And while
the predictors uncovered from the random forests exhibit some degree of non-linearity (as
the post-hoc decision tree returned superior performance), they also exhibit linear
relationships as the logistic regression also return highly significant prediction. Post-hoc
analyses using predictors identified from the logistic regression analyses to estimate
decision trees were not conducted. This is because decision trees are robust in capturing
linear relationships and will inevitably perform as well as a logistic regression.
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Influence of Baseline Cigarette Use
Given the finding that baseline cigarette use was the most robust predictor, the
logistic regression and random forest analyses were executed again with this variable
excluded. Any fluctuation in the ROC AUC would indicate the extent to which the
prediction accuracy is dependent on baseline cigarette use. Additionally, the dominant
relationship between baseline cigarette use and the outcome measure might interfere with
the likelihood of other predictors being selected within the context of the regularization
procedure. As regularization favors sparse models, the predictors that were less correlated
with the outcome measure were unlikely to coexist in a model containing baseline
cigarettes. This problem is less of an issue with random forests, but similar logic applies
if baseline cigarettes was part of the randomly selected set of predictors. Therefore,
rerunning the analyses without cigarettes might permit discovery of novel predictors.
For females, the logistic regression analyses returned a mean ROC AUC=.6196
(p<.01), whereas the random forest analyses returned a mean ROC AUC=.6077 (p<.05).
Relative to the original analyses with baseline cigarette use included, the logistic
regression model was slightly more resilient (∆AUC= -.0371) than the random forest
(∆AUC= -.0516). These results indicate that baseline cigarette use is important, but not
critical, to differentially predict future cannabis+binge drinking in females. Probing the
logistic regression analyses further, all three predictors identified from the original
analyses (feelings of deviance, SNP rs521674, and the cerebellar ROI during reward
outcome) passed threshold for feature selection, along with 12 new predictors across all
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domains. Probing the random forest analyses, only two of the four stop task ROIs were
reproduced (right inferior temporal and left middle frontal gyrus during stop success)
from the original analyses. One additional ROI during stop success (right cerebellum)
and neutral face processing (left visual cortex) were identified from the random forest. In
both scenarios, the models attempted to compensate for the loss of the best predictor
through other predictors, as indexed by the many new predictors selected by the logistic
regression analysis, and the lack of a consistency in the predictors identified by the
random forests.
For the male sample, a different finding emerged. The logistic regression analyses
returned a mean ROC ACU=.49, and the random forest returned a mean ROC AUC=.54
(p>.05). Therefore, the exclusion of baseline cigarettes eliminated the ability of either
model to significantly predict between the two groups. For exploratory purposes, the
predictors selected from these non-significant models were probed to determine if there
was any consistency with the original analyses despite their non-significant prediction.
Interestingly, both the right temporal GMV ROI and feelings towards deviant behaviors
predictors were identified as the top predictors across both of the non-significant
analyses, along with frequency of sexual life events. These results indicated that GMV
ROI and feelings towards deviant behaviors predictors explained a very small portion of
the variance, and must be modeled with baseline cigarette use to predict between the
groups. Frequency of sexual life events was identified presumably as a proxy for baseline
cigarette use as these two predictors were correlated in males (r=.29, p<.001).
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Discussion
The analyses reported here better model the predictive profile of teenagers who
use cannabis in adolescence. As it is rare for an adolescent to use cannabis exclusively,
these prediction analyses target a typical pattern of adolescent cannabis use by
differentially predicting cannabis and binge drinking versus binge drinking only. This
chapter was also distinguished by its exploratory use of two competing machine learning
algorithms. As elastic-net regularized logistic regression was used successfully in
Chapter 4 to develop predictive profiles containing brain and behavioral data, the use of
regularized regression in this chapter returned very sparse profiles. While these sparse
results here may seem in conflict with Chapter 4, those results were an amalgamation of
six analyses predicting each increasing use level. Implementing a similar technique for
the differential predictions outlined here would not be feasible due to the very low sample
sizes within each use level.
Starting with the cross-validated prediction accuracies, the random forest analyses
returned surprisingly similar ROC AUCs relative to the logistic regression analyses,
indicating one model is not necessarily superior to the other. This is beneficial in that
both results may be considered a form of internal replication, and reaffirms the significant
differential prediction between the two groups. And while both analyses returned a very
sparse set of shared and unique predictors within each sex, the difference between the
predictors identified is likely due to the flexibility of the random forest model.
Higher baseline cigarette use predicted future cannabis+binge drinking across all
models and sexes. This predictor was also identified in Chapter 4 as being predictive of
181

cannabis use vs. controls for both sexes. These consistent results across samples, models,
and sexes provided strong evidence that cannabis use in adolescence is likely to follow
from early cigarette use. The similarities in route of administration for the two drugs may
influence transition from one to the other as experiences smoking a cigarette may
facilitate smoking cannabis.
Epidemiological data indicated a downward trend in cigarette use in teens
(Johnston et al., 2018), and researchers are just starting to study how these trends might
impact cannabis use. Miech and colleagues assert that despite the observed decrease in
cannabis risk perception, a hypothesized increase in cannabis use has not been observed
due to the decrease in cigarette use levels (Miech et al., 2017). This interpretation
suggests lowering cigarette use would be protective against cannabis use. Therefore,
policies and programs designed to discourage cigarette use in youths are already showing
efficacy in helping to delay cannabis use. However, considering the change in landscape
regarding e-cigarette use, it will be important to monitor how e-cigarettes might influence
cannabis use in adolescence.
The other identified psychosocial predictor was less negative feelings towards
deviant behaviors taken from the life events questionnaire (Newcomb et al., 1981). This
measure asks the teen to assign a valence score to the idea of engaging in deviant
behaviors (e.g., stealing something valuable). Given the nature of this measure, the
finding reported here is likely signaling a propensity for poor conduct. This interpretation
is consistent with Pedersen and colleagues who demonstrated that subclinical conduct
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disorder predicted cannabis initiation in adolescence for both sexes, with a stronger
association reported for females (Pedersen et al., 2001).
Interestingly, the feelings towards deviant behaviors predictor were identified for
both sexes but using different models (Females: logistic regression; Males: random
forests). For males, this predictor was selected less often during the logistic regression
model (64 of 100 runs) but nearly passed threshold for females with the random forest
model (95 of 100; Table 5.5). Post-hoc analyses supported these trends, and indicated the
inclusion of this predictor in a decision tree modestly improved prediction for males
(∆AUC=.02), whereas the inclusion of this predictor (and rs521674) in a logistic
regression model dramatically improved prediction for females (∆AUC=.15).
Given the superiority of the post-hoc logistic model predicting cannabis use in
females relative to the decision tree predicting cannabis use in males, the relationships
between the feelings toward deviant behavior predictor and the other variables may be
characterized as linear for females, and non-linear for males. This result underscores the
use of the random forest model, as one might have assumed feelings toward deviant
behaviors to be female-specific if only a linear model was used. As Chapter 4 only used a
logistic regression model for both the prediction analyses and post-hoc tests, it is possible
that some of the sex-specific predictors for one sex might generalize to the opposite sex if
non-linear model was used. This finding highlights the need for prediction analyses to
consider both types of relationships when modeling human behavior.
As baseline cigarette use and less negative feelings toward deviant behaviors were
also identified in Chapter 4 and generalized to predict binge drinking, it is unusual that
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they would also emerge as differential predictors here. Indeed, this effect counters the
initial hypothesis that the differential predictors will be from the brain and genetic
domain. Given this effect, it is likely the case that there is a linear relationship with these
two psychosocial predictors and the three samples (controls, binge drinking only, and
cannabis+binge drinking). In other words, the controls have the lowest levels on these
two measures, followed by the future binge drinking only, with the cannabis+binge
drinking groups exhibiting the highest levels. This pattern would explain why these two
measures are consistently identified as a predictor of cannabis use relative to the two
comparison samples.
In support of the initial hypothesis, a unique finding for females was SNP
rs521674 identified from the logistic model. For this SNP, more risk alleles were present
in the future binge drinking only group (Table 5.5). This finding is in line with a study by
Clarke and colleagues who reported a correlation between this SNP and a family history
of alcoholism in a sample of individuals with alcohol use disorder (Clarke et al., 2012).
And while the exact predictive mechanism is difficult to ascertain, it is likely that these
future binge drinking only adolescents initiated alcohol abuse for different reasons, one
of which being this genetic variation.
From the female brain results, the logistic analyses identified that the future
cannabis+binge drinking group exhibited higher activations in the superior cerebellum
during reward outcome (Figure 5.3). This predictor was also selected by the random
forest model, albeit at a slightly lower threshold (91 out of 100 runs; Table 5.5). This
finding is consistent with a previous neuroimaging study on adolescent binge drinking by
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Cservenka, Jones, & Nagel (2015). In that study, lower activations during reward
outcome in the left superior cerebellum correlated with binge drinking levels later in
adolescence. Moreover, the peak voxel location reported in that study is contained in the
ROI identified here. Therefore, this study adds converging evidence on blunted reward
processing in the cerebellum as predictive of adolescent binge drinking. And while the
cerebellum is classically implicated during motor functioning, recent work has identified
cortical-cerebellar circuits involved during cognitive and affective processing (Strick et
al., 2009), and have incorporated the cerebellum into brain-based models of addiction
(Moulton et al., 2014).
In the random forest analyses, all the brain predictors identified for females were
from the stop signal task. When referencing the brain predictors from Chapter 4, 10 out
of the 17 female brain predictors were from the stop task so this task may be especially
useful in developing brain-based predictive profiles. The effects observed here were all
lower activations in the future cannabis+binge group. This pattern is broadly consistent
with Schweinsburg and colleagues who reported lower activations in prefrontal regions
for cannabis+binge drinking adolescents (Schweinsburg et al., 2005).
The lower activations reported here might indicate that these individuals failed to
recruit sufficient processing resources to execute inhibitory control behaviors. Lower
activations in the left middle frontal gyrus and left inferior frontal gyrus were implicated
during stop success and stop failures (respectively). This finding may suggest that in
these individuals, the left hemisphere failed to supplement the predominantly right-sided
“braking” system (Aron, Robbins, & Poldrack, 2014). Moreover, lower activations in the
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right paracentral lobule and inferior temporal region have both been implicated in the
motor (Zhang et al., 2015) and visual processing (Boehler et al., 2010) features of the
stop signal task. Taken together, these results suggest that a compromised network of
regions supporting inhibitory control constitutes a female-specific risk profile.
For males, the sole brain predictor was higher gray matter volume in the right
inferior temporal gyrus (Figure 5.4). As healthy neurodevelopment is characterized by
gray matter volume reduction over time (Giedd et al., 1999; Spear, 2000b), this effect
might suggest a neurodevelopmental delay at this region. The finding of lower stop
success activation in this same region for females might indicate that this delayed
neurodevelopmental process only manifests as a functional difference later in life. As
neurodevelopment begins sooner for females (Lenroot et al., 2007), this interpretation
may explain why males exhibit structural differences, whereas females exhibit functional
differences at this region during the age 14 scan. Future analyses could be conducted to
determine if this functional difference is observed in the male sample using the age 19
assessment of the IMAGEN study.
The post-hoc analyses suggested that the brain predictors from the random forest
analyses were the most robust predictors. For instance, for females, the highest ROC
AUC was found using the predictors from the random forest in a post-hoc decision tree
(ROC AUC=.83). Using the four female brain predictors identified from the random
forest to estimate a post-hoc logistic regression model returned superior prediction (ROC
AUC=.71) than using the single brain predictor identified from the logistic regression
analyses in a post-hoc logistic regression model (ROC AUC=.65). Therefore, using non186

linear analyses (random forest) to inform a post-hoc linear model (logistic regression)
was superior to a consistently linear model course of inquiry. These results indicate that
looking across the post-hoc results, the four stop task brain predictors are superior
predictors than the reward task predictor. And as the random forest analyses only
uncovered brain predictors passing threshold for males, it can be concluded that random
forests are better suited to identifying generalizable brain predictors.
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Tables
Table 5.1: Future Binge Drinking Levels For Each Starting Sample by Sex
Starting Samples to Later Match on Binge Drinking Levels
Males (N=315)

Females (N=270)

Binge
Drinking
Level

Future
Cannabis+Binge
Drinking
Group
(n=208)

Future Binge
Drinking
Only
Group
(n=107)

Future
Cannabis+Binge
Drinking
Group
(n=159)

Future Binge
Drinking
Only
Group
(n=111)

0
1-2x
3-5x
6-9x
10-19x
20-39x
40+

23
32
33
27
29
31
33

0
50
30
14
9
3
1

14
26
25
25
32
20
17

0
61
27
8
9
3
3

These data reflect the amount of binge drinking within the starting samples. All Future
Binge Drinking Only participants were cannabis naïve. Referencing these levels, two
subgroups for each sex were randomly selected for differential prediction analyses. First,
the 23 male and 14 female participants from the Future Cannabis+Binge Drinking sample
with a binge drinking level of zero were excluded. Then, within each use level, the larger
group was randomly subsampled to match the size of the smaller group (see Tables 5.2
and 5.3 for resulting analytic samples). See Figure 5.1 for graphical representation.
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Table 5.2: Demographic Information and Drug Use Levels for Male Analytic Samples
Males (N=178)
Measure

Age (M,SD)
Handedness (L, R)
PDS (M,SD)
Verbal IQ (M,SD)
Performance IQ
(M,SD)
SES (M,SD)
Drug Use Level
Binge Drinking by
Age 16
Cannabis Use by
Age 16

Future Cannabis+Binge
Drinking
Group
(n=89)
14.4, .45
13. 76
2.6, .49
114.3, 14.7

Future Binge Drinking Only
Group
(n=89)

p

14.5, .38
12, 77
2.5, .55
110.2, 13.8

.41
.83
.12
.06

108.5, 15.4

110.2, 13.8

.04

18.7, 4

17.9, 3.7

.16

1

2

3

4

5

6

1

2

3

4

5

6

32

30

14

9

3

1

32

30

14

9

3

1

1.0

39

10

8

6

9

17

0

0

0

0

0

0

.00

The two groups were pseudo-randomly selected from the starting sample (Table 5.1) to
be matched on binge drinking levels. P value reflects significant between-group
differences determined via chi-square (for handedness) and t-tests. All demographic
information measured at baseline, and were also included as candidate predictors in the
differential prediction analyses. PDS: Pubertal Development Scale (Carskadon and
Acebo, 1993). SES: Socioeconomic Status. Drug levels from the ESPAD and measured
on an ordinal scale (1=1–2x, 2=3–5x, 3=6-9x, 4=10-19x, 5=20-39x, 6=40+).

192

Table 5.3: Demographic Information and Drug Use Levels for Female Analytic Samples
Females (N=148)
Measure

Age (M,SD)
Handedness (L, R)
PDS (M,SD)
Verbal IQ (M,SD)
Performance IQ
(M,SD)
SES (M,SD)

Future Cannabis+Binge
Drinking
Group
(n=74)
14.5, .48
9, 65
3.2, .37
112.5, 11.8

Future Binge Drinking Only
Group
(n=74)

p

14.5, .47
5, 69
3.1, .42
108.5, 15.1

.70
.26
.20
.08

110.1, 12.6

105.8, 13.8

.06

19, 3.9

18, 3.7

.10

Drug Use Level

1

2

3

4

5

6

1

2

3

4

5

6

Binge Drinking by
Age 16

26

25

8

9

3

3

26

25

8

9

3

3

1.0

Cannabis Use by
Age 16

22

18

6

11

5

12

0

0

0

0

0

0

.00

The two groups were pseudo-randomly selected from the starting sample (Table 5.1) to
be matched on binge drinking levels. P value reflects significant between-group
differences determined via chi-square (for handedness) and t-tests. All demographic
information measured at baseline, and were also included as candidate predictors in the
differential prediction analyses. PDS: Pubertal Development Scale (Carskadon and
Acebo, 1993). SES: Socioeconomic Status. Drug levels from the ESPAD and measured
on an ordinal scale (1=1–2x, 2=3–5x, 3=6-9x, 4=10-19x, 5=20-39x, 6=40+).
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Table 5.4: Summary of SNP rs521674 distribution for Females
Females (N=148)

SNP

Major:
Minor
Alleles

rs521674

T:A

Future Cannabis+Binge
Drinking
Group
(n=74)
Hminor:HT:Hmajor
41: 27: 6

Future Binge
Drinking Only
Group
(n=74)
Hminor:HT:Hmajor
57: 0: 17

p
.001

Count of the number of risk alleles for the two groups. Hminor: Homozygote minor (high
risk alleles, A/A). HT:heterozygote major (A/T). Hmajor: Homozygote major (low risk
alleles, T/T). A higher number of risk alleles were present in the future binge drinking
only group. P-value derived from a chi-square analysis. SNP rs521674 located on
CHR10: 111075832, coding for the ADRA-2A receptor.

Table 5.5: Summary of Predictors Selected
Sex

Domain

Psychosocial

Predictor

Primary
Model

Lifetime Cigarettes
Feelings of Deviant Behaviors

RF & LR
LR

Secondary
Model
(Selection
Frequency)
RF (95)

L. Superior Cerebellum
R. Inferior Temporal Lobe
R. Paracentral Lobule
L. Middle Frontal Gyrus
L. Inferior Frontal Gyrus
rs521674

LR
RF
RF
RF
RF
LR

RF (91)
LR (0)
LR (43)
LR (1)
LR (0)
RF (11)

Lifetime Cigarettes
Feelings of Deviant Behaviors

RF & LR
RF

LR (64)

R. Inferior temporal lobe

RF

LR (71)

Brain
Females

Reward Outcome
Stop Success

Stop Failures
Genetic
Psychosocial
Males

Brain
Gray Matter Volume

The primary model denotes the model for which the predictor passed the initial threshold
for identification: 3 of 5 final models across all 100 runs. The secondary model denotes
the model for which the predictor did not pass the initial threshold, and the selection
frequency denotes the number of runs for which the predictor was selected by the
secondary model. RF: Random Forest. LR: Logistic Regression.
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Figure 5.1: Future Binge Drinking Levels in Starting Sample by Sex
A
60

Future Binge Drinking Levels in Starting Sample
for Males (N=315)

50

Count

40
30
20
10
0
0

1-2x

3-5x

6-9x

10-19x

20-39x

40+

Use Level
Cannabis+Binge Drinking (n=208)
Binge Drinking Only (n=107)

B
70

Future Binge Drinking Levels in Starting Sample
for Females (N=270)

60

Count

50
40
30
20
10
0
0

1-2x

3-5x

6-9x

10-19x

20-39x

40+

Use Level
Cananbis+Binge Drinking (n=159)
Binge Drinking Only (n=111)

A: Binge drinking levels by age 16 for starting sample of males. B: Binge drinking levels
by age 16 for starting sample of females.
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Figure 5.2: Future Binge Drinking Levels in Analytic Sample by Sex
A

Binge Drinking Levels in Matched
Samples of Males (N=178)

35
30
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5
0
1-2x

3-5x

6-9x

10-19x

20-39x

40+

Use Level
Future Cannabis+Binge (n=89)
Future Binge Only (n=89)

B

Binge Drinking Levels in Matched
Samples of Females (N=148)
30
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Count

20
15
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5
0
1-2x

3-5x
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20-39x

40+

Use Level
Future Cannabis+Binge (n=74)
Future Binge Only (n=74)

A: Binge drinking levels by age 16 for analytic sample of males. B: Binge drinking levels
by age 16 for analytic sample of females. Binge drinking levels were perfectly matched.
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Figure 5.3: Female Brain Predictors Identified for Each Model

Logistic Regression

Random Forest
Stop Success

Reward
Outcome

L

L

Cannabis+Binge > Binge Only

Stop Failure

R

Cannabis+Binge < Binge Only

For the logistic regression results, higher activations to reward outcomes in the left
superior cerebellum was identified as a differential predictor. For the random forest
results, lower activations in the left middle frontal gyrus, right inferior temporal gyrus,
and the right paracentral lobule during stop success, and lower activations in the left
inferior frontal gyrus during stop failure, were identified as differential predictors.
Figure 5.4: Male Brain Predictor Identified From the Random Forest.

Random Forest
Gray Matter
Volume

R

Cannabis+Binge > Binge Only

Only the random forest analysis identified a single predictor from the brain domain for
males. Higher gray matter volume in the right inferior temporal lobe was identified as a
differential predictor.
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CHAPTER 6: DISCUSSION & CONCLUSIONS
6.1: General Discussion
Overall Objectives
This dissertation identified a set of brain and behavioral features that
characterized cannabis use in adolescence. Findings were reported within the context of
prediction as age 14 data was used to predict cannabis initiation or level of cannabis use
two or five years later. And even though Chapter 2 contained a cross-sectional analysis,
Chapter 3 provided evidence that the observed amygdala hyperactivity is likely a preexisting difference.
Chapters 4 and 5 searched beyond the amygdala and identified a comprehensive
risk profile that contained predictors from the psychosocial and brain domains collected
prior to cannabis exposure. Therefore, this dissertation improves on the largely crosssectional body of work by uncovering sex- and drug-specific predictors that were
disentangled from any consequences of cannabis use. And although prediction was the
dominant theme throughout this dissertation, exploratory analyses also tested for changes
in amygdala reactivity and anxiety levels following an escalation of cannabis use from
age 14 to 19.
Results from these analyses are discussed here in terms of their utility in
stratifying risk and informing interventions. For risk stratification, these results help
gauge severity of risk for cannabis use by how closely an adolescent fits the identified
risk profiles. For instance, a female who drinks, smokes cigarettes, and exhibits a novelty
seeking personality may be considered more at risk than her peer who only drinks. The
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neurobiological predictors further aid in risk stratification if neuroimaging batteries ever
become commonly administered as a screening tool in behavioral health. Furthermore,
the identified predictors are discussed in terms of their ability to inform treatment
strategies. Those treatments are hypothesized to attenuate the likelihood of cannabis use
by altering the risk phenotypes for males and females.

Data Analysis Philosophy
Throughout this dissertation two lines of inquiry were pursued, hypothesis- and
data-driven (machine learning) analyses. Starting with the hypothesis-driven analyses, a
theoretical framework related to amygdala reactivity was used to characterize and predict
adolescent cannabis use. For the data-driven analyses, additional measures from the
IMAGEN study were explored without being limited by a specific theoretical framework
and uncovered a set sex-specific psychosocial and neurobiological predictors.
Hypothesis-driven studies have the advantage of being more transparent and may
lead to more interpretable findings guided by a theoretical framework. Alternatively,
data-driven studies provide a unique opportunity to make discoveries that were not
specifically theorized a-priori. This characteristic of data-driven studies was reflected by
the set of multimodal brain measures that predicted cannabis use by age 16. However,
only the hypothesis-driven line of inquiry yielded a brain measure that predicted cannabis
use by age 19. Therefore, both approaches can be used to make valuable insights into the
relationship between the brain to behavior.
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Moreover, these two lines of inquiry are not in opposition. This notion is
demonstrated by the post-hoc analyses in Chapters 4 & 5 that were informed by the datadriven analyses. Given the high-dimensionality of the brain data (1,946 ROIs; Table
4.1.3), it was impossible to theorize or test hypotheses related to each measure or
combination thereof. Instead, machine learning was required to identify the most robust
and generalizable brain features. Those results were then passed forward to test
hypotheses related to sex and drug-specificity. This approach embraced the highdimensionality of the brain data while employing a set of best practices (Whelan and
Garavan, 2014) that rigorously examined relationships between adolescent cannabis use
and the underlying neurobiology. Hence, this line of inquiry facilitated the discovery of
many novel neurobiological predictors of adolescent cannabis use.

6.2: Main Findings & Implications
Chapters 2 & 3 Findings
Chapters 2 & 3 together demonstrated that amygdala hyperactivity to angry faces
was likely a pre-existing difference that partially predicted the level of cannabis use five
years later. This dose-response prediction of cannabis use, and the lack of a significant
difference in amygdala reactivity at age 19, indicated that the amygdala is a predictive
biomarker, rather than a marker of a cannabis-related effect.
As the amygdala has been implicated in threat monitoring processes (Fox et al.,
2015; Mobbs et al., 2010), these results might suggest an exaggerated threat monitoring
system confers risk for cannabis use in adolescence. Chapter 3.2 attempted to confirm
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this by testing for associations between amygdala reactivity and anxiety levels. However,
this association was not confirmed and indicated that the DAWBA band score for
generalized anxiety is not a suitable measure to probe this construct for this sample.
For the anxiety level data, a significant main effect of time indicated that anxiety
levels increased from baseline into late adolescence. No main effect of group, or a groupby-time interaction was uncovered, which indicated cannabis use did not influence
symptoms of generalized anxiety. Instead, the main effect of time suggested it was
typical to report higher anxiety levels later at age 19. This pattern of results is consistent
with Van Oort and colleagues who previously reported that generalized anxiety disorder
symptom levels peaked in late adolescence (Van Oort et al., 2009). This phenomenon
might be due to the exploratory nature of early adolescence where lower anxiety levels
may be evolutionary beneficial to motivate autonomy (Spear, 2000b). These youths may
then experience more stress and uncertainty later in adolescence as they first become
independent outside of the household (i.e., for college, military, new careers, etc.).
Chapter 3.2 tested for changes in amygdala reactivity from age 14 to 19 with
chronic cannabis use. No significant differences were detected, although plotting the data
visually displayed a decrease in amygdala reactivity with chronic cannabis use (Figures
3.2.1-2). Despite the null statistical results, these analyses motivated a comparison of the
relatively large sample of typically developing (cannabis-naïve) adolescents. Those
analyses indicated healthy amygdala development was characterized by an increase in
activation from age 14 to 19. The observed pattern of amygdala reactivity might also be
characteristic of adolescence and early adulthood more generally. In tandem with the
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interpretation of the anxiety data, lower threat monitoring responses in adolescence might
facilitate exploration with novel environments and elevations in novelty seeking
personality, whereas a higher threat monitoring system in adulthood is beneficial to
maintain survival and independence (Spear, 2000b).

Chapters 2 & 3 Implications
The meaning of the amygdala findings were difficult to dissect. Considering the
role of the amygdala in threat monitoring (Fox et al., 2015), it is plausible that these data
reflected an attentional-bias to negative affect or an inability to suppress automatic threat
detection in favor of goal-directed behavior. However, it is difficult to make these
conclusions because the passive viewing face processing task did not have any task
performance measures.
Previous fMRI studies on adolescent psychopathology characterized both
generalized and social anxiety, as well as depression, in terms of amygdala hyperactivity
to evocative faces (Beesdo et al., 2009; Lau et al., 2009; Monk et al., 2008; Yang et al.,
2010). To better decompose this apparent lack of disorder specificity, van den Bulk and
colleagues correlated amygdala activations to faces with dimensional scores of anxiety
and depression in diagnosed children (DSM-IV) compared to controls (van den Bulk et
al., 2014). Results indicated that the right (but not left) amygdala activation to happy,
neutral, and angry faces significantly correlated with anxiety, but not depression scores.
Anxiety dimension scores explained 28% of the variance in right amygdala activations to
angry face within the clinical sample, but was not correlated in controls (van den Bulk et
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al., 2014). Although the cannabis users reported here were not selected for having an
anxiety disorder diagnosis, and their DAWBA band score levels did not differ from the
cannabis-naïve sample (Table 3.1.3), their pattern of amygdala reactivity were in line
with the papers above. And while that should not lead to the conclusion that the cannabis
users were an anxious sample, their similarities are worth considering. Nonetheless, the
lack of a correlation between anxiety scores and amygdala reactivity reported here was
consistent with the null effects reported by van den Bulk and colleagues for their control
sample (van den Bulk et al., 2014). Although, the van den Bulk report used a dimensional
measurement tool for anxiety (Revised Child Anxiety and Depression Scale) (Chorpita et
al., 2000) which was likely better suited to identify a linear relationship with amygdala
reactivity than the ordinal nature of the DAWBA band score.
Despite the lack of a suitable measure for anxiety, the baseline amygdala
reactivity may have signaled the child was under some level of distress more generally.
As these youths continued their cannabis use throughout the intervening five years, the
follow up amygdala reactivity indicated a visual decrease in activation relative to baseline
(Figure 3.2.1-2). Those findings were interpreted as broadly supporting a negative
reinforcement model of addiction, as proposed by Koob (Wise and Koob, 2014). While
this model asserts positive reinforcement is necessary for the initial repetition of drug
taking, it is the removal of distress that maintains and escalates drug use. Here, the
distress experienced by the individual, as reflected by heightened amygdala reactivity at
baseline, might be alleviated with cannabis use. This framework also accommodates the
dose-response relationship outlined in Chapter 3.1, as individuals with minor distress
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only required low levels of cannabis, whereas high distress necessitated frequent use.
This line of reasoning also supports the downward shift in amygdala reactivity as
repeated cannabis use may have lowered distress levels and amygdala reactivity.
Translating the findings of Chapters 2 & 3 into practice is difficult. As discussed
in Chapter 3, common antianxiety and antidepressant medications have been effective in
attenuating amygdala reactivity to angry faces. Therefore, pharmaceutical intervention
might be considered only for teens with especially high risk. On the other hand, it is
challenging to justify a treatment approach relative to the risks of cannabis use. If
schizophrenia is taken as the most functionally impairing or clinically relevant outcome
associated with adolescent use, it is worth noting that the lifetime prevalence rates of
schizophrenia is nearly 1% of the population (Simeone et al., 2015). And although a
recent meta-analyses indicated adolescent use of cannabis is associated with a four-fold
increase in the odds of receiving a schizophrenia or psychotic disorder diagnosis
(Marconi et al., 2016), those results should be interpreted in light of the very low base
rate. Moreover, the stepwise regression models indicated the right amygdala effect only
explained an extra 1% of the variance in cannabis use levels at age 19. Therefore, it is
unlikely that a clinically meaningful effect (i.e., lowering cannabis use) might be
achieved by pharmacologically targeting this biomarker.

Chapters 4 & 5 Findings
Chapters 4 & 5 outlined a series of sex-specific machine learning analyses that
uncovered risk profiles comprised of predictors from all data domains. The cross204

validated ROC AUCs indicated the models predicted future cannabis use well above
chance levels, with some caveats to be addressed.
Analyses failed to predict better than chance only for males when baseline
cigarettes were excluded for the differential prediction (Chapter 5), and predicting
cannabis initiation by age 19 (Chapter 4.2). These findings suggest the female prediction
analyses were more resilient to differences. This also highlights a theme throughout this
dissertation that females exhibit a more distinct predictive profile for cannabis use
relative to their male peers. Indeed, prediction accuracies for females were higher across
all prediction analyses regardless of the comparison sample (controls or binge drinkers),
machine learning algorithm (logistic regression or random forest), and age of initiation
(16 or 19). This finding was encouraging as it signaled that females are more accurately
predicted and may therefore be targeted more reliably for interventions than males.
Despite the finding that substance use disorders are generally higher in males (Kuhn,
2015), the superior prediction for females is consequential as the literature indicates that
females are more vulnerable to drug initiation (Anker and Carroll, 2010) and advance to
substance use disorders faster than males (Hernandez-Avila et al., 2004).
From Chapter 4.1, the predictive profiles contained six psychosocial predictors
that were shared across the sexes. Three of those predictors were related to other drugs,
namely higher baseline cigarette and alcohol use, and parental cannabis use. Of the
remaining three shared predictors, less negative feelings towards deviant behaviors, and
higher novelty seeking and disorderly personality were identified.
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Personality measures of the parent and child were frequently identified in
predicting cannabis use. Despite the differences in the exact personality measure
uncovered, all generally characterized a novelty seeking personality (see Figure 4.1.3 for
exact personality measures). Moreover, novelty seeking personality was the most robust
predictor of cannabis use by age 19 for females, and generalized to males in a post-hoc
fashion (Chapter 4.2). Therefore, this measure may be considered a trait-like feature that
predicts cannabis use regardless of the age of initiation or sex.
The identification of novelty seeking personality is consistent with the adolescent
and substance use literature. Researchers previously implicated this personality trait in
predicting cannabis use (Bidwell et al., 2015; Dugas et al., 2018), cigarette use (Hu et al.,
2008) and alcohol abuse (Boson et al., 2019). Animal studies concluded that animals
displaying more novelty seeking behaviors self-administered drugs like alcohol and
psychomotor stimulants at a higher rate than animals that did not display similar
behaviors (Belin and Deroche-Gamonet, 2012; Nadal et al., 2002; Suto et al., 2001).
Furthermore, animal (Adriani et al., 1998), and human studies (Spear, 2000b) reported
the novelty seeking personality phenotype peaks during adolescence. Together, these
findings suggest adolescents with higher novelty seeking personality traits than their
peers are at an even greater likelihood of drug initiation. This risk phenotype is therefore
an important target for intervention and will be discussed later.
Less negative feelings towards deviant behaviors was identified as a shared
predictor for males and females in Chapter 4.1, and also a shared differential predictor in
Chapter 5 (although from different algorithms). This feature asked the child to report how
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they would feel about engaging in deviant behaviors, so it was unclear if they reported
based on personal experience or a hypothetical cognitive appraisal. And although
IMAGEN did not collect measures on peer relationships, the literature suggests
adolescents are more likely to engage in delinquent behaviors with their peers (Haynie
and Osgood, 2005). Moreover, Van Ryzin & Dishion reported that cannabis use in young
adults is predicted by deviant peer group membership (Van Ryzin and Dishion, 2014).
Therefore, this effect might be characterizing the adolescents’ social network, although
the lack of other corroborating data does not support this interpretation.
Machine learning analyses also discovered many novel brain predictors of
cannabis use in adolescence. Starting with 1,946 brain measures, there were 22 brain
predictors identified for females (17 in Chapter 4, and five in Chapter 5), and nine brain
predictors identified for males (eight in Chapter 4, and one in Chapter 5). Despite this
profound data reduction, the results were complex given the differences in modality and
localization uncovered for each region of interest (ROI).
The brain predictors for males were related to the stop signal task and gray matter
volume, whereas all task modalities were identified for females. The presence of the stop
signal task ROIs highlights the utility of this task in capturing individual differences
related to cannabis use. Appendix 2 contains a review paper that highlights how
hypoactivations observed during this task relate to addictive behaviors (Spechler et al.,
2016). The findings reported here are in line with that pattern as the majority of the stop
task predictors for both sexes were hypoactivations relative to comparison samples
(Figure 4.1.3 & Figure 5.3).
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The anatomical locations of these hypoactivations are mostly in regions
previously implicated in response inhibition tasks. For instance, regions supporting motor
functioning like the cerebellum and thalamus (Ide and Li, 2011), and prefrontal regions
supporting executive control functioning like the inferior frontal gyrus (Garavan et al.,
1999) and orbital frontal cortex (OFC) (Whelan et al., 2012), were identified. A higher
impulsive personality was also identified as a female-specific psychosocial predictor
(Figure 4.1.3). Higher impulsivity and hypoactivations in the OFC have been reported to
predict drug use in adolescence (Whelan et al., 2012). All together, these results
suggested that deficits in the neurobiological systems supporting cognitive control
mechanisms confer an increase in risk for cannabis use in adolescence.
Work by Tapert and colleagues previously reported that cannabis users
demonstrated higher activations across prefrontal regions relative to controls following
one month monitored abstinence (Tapert et al., 2007b). As no behavioral differences
were observed, that study indicated more prefrontal processing resources are required for
cannabis users to execute inhibitory control behaviors at the same level as non-users.
Therefore, the predominant hypoactivations reported here may have facilitated drug
taking behaviors (Nigg et al., 2006). And while the Tapert report was cross-sectional,
those data contrast with the findings here and might imply prefrontal hyperactivations
arise following cannabis use.
Relative to the other tasks, the reward task was infrequently identified and was
also female-specific. Relative to controls, higher reward anticipation in the left middle
frontal gyrus was identified in Chapter 4.1, and higher reward outcome activation in the
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left superior cerebellum was identified in Chapter 5. The evident hyperactivations during
anticipation might signal a propensity to over-evaluate the incentive salience of rewards,
which generally aligns with the “wanting” component of the “wanting vs. liking” model
of addiction (Berridge and Robinson, 2016).
Finally, a set of face processing predictors was identified for males and females.
Lower neutral face reactivity appeared to be shared across the sexes, although in different
regions for males and females (Figure 4.1.3). Higher activation for angry faces was
identified for females only in the right ventromedial prefrontal cortex and possibly
signaled an emotion regulation strategy (Urry et al., 2006).
The face processing amygdala effects reported in Chapters 2 & 3 were not
reproduced in any of the data-driven analyses in Chapters 4 & 5. Reasons for this
discrepancy are likely due to differences in measurement and modeling. For
measurement, the ROI containing the amygdala in Chapters 2 & 3 were different from
that used in Chapters 4 & 5. The parcellation atlas used in Chapters 4 & 5 was
constructed using functional connectivity from resting state fMRI (Shen et al., 2013).
This atlas did not contain an ROI as specific to the amygdala as the anatomically defined
ROI used in Chapters 2 & 3. Upon visual inspection, the ROI covering the amygdala
used in Chapters 4 & 5 contained voxels from the anterior temporal lobe and
hippocampus. For modeling differences, Chapter 3 identified the right amygdala within
the context of a relatively large sample (n=525) collapsed across sex. This large sample
may have contributed to the statistical power necessary to detect a predictor that
explained 1% of the variance in future cannabis use. Chapters 4 & 5 analyses were
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executed separately for each sex for theoretical reasons, and also because sex was
consistently the most robust predictor when running preliminary analyses collapsed
across sex. Together, the reduction of statistical power and lack of amygdala ROI
specificity reduced the likelihood of the amygdala being reproduced in Chapters 4 & 5.
These fMRI results from Chapters 4 & 5 add to the very sparse literature using
fMRI to predict cannabis use in adolescence. There appeared to be only one study using
fMRI to predict cannabis use in adolescence. In that study, Tervo-Clemmens reported on
a visuospatial working memory task (Tervo-Clemmens et al., 2018). The results reported
here are not comparable to the Tervo-Clemmens data given the inconsistent task
modalities. Nonetheless, the results reported here add three more fMRI task modalities
related to different psychological constructs to the literature on cannabis prediction.
Lastly, the GMV results were modestly male-specific, although differences were
observed for females. Furthermore, the directions and locations were inconsistent within
each sex. For females, greater GMV in the right pre-SMA, and less GMV in the right
middle frontal gyrus (MFG) were identified (see Chapter 4.1). For males, greater GMV in
the right inferior temporal lobe was the sole brain predictor uncovered in Chapter 5,
whereas greater GMV in the right medial prefrontal cortex and less GMV in the left midcingulate cortex was uncovered in Chapter 4.1.
Medial temporal lobe differences were entirely absent from these structural results
despite previous literature pointing to an inverse relationship between cannabis use and
hippocampal and amygdalar brain volumes (Ashtari et al., 2011; Cousijn et al., 2012;
Yucel et al., 2008). However, those studies were cross-sectional, and might be more
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reflective of consequences of use given the animal studies that reported neurotoxicity of
cannabinoids on those structures (Lawston et al., 2000; Quinn et al., 2008b).
Two prospective structural studies by Cheetham and colleagues, and Jacobus and
colleagues, reported less brain volumes relative to controls across many prefrontal
regions like the OFC (Cheetham et al., 2012b) and precentral gyri (Jacobus et al., 2016).
Of note, Jacobus also reported less thickness in the right MFG predicted cannabis use,
which was reproduced here for females only. Therefore, these results add to the literature
by affirming less GMV in prefrontal regions predicts use, while the medial temporal lobe
regions are more likely to reflect differences following use.

Chapters 4 & 5 Implications
Chapters 4 & 5 demonstrate that a machine learning approach yielded strong
predictions and made novel discoveries that related the neurobiology to future cannabis
use in adolescence. These chapters advance the field of psychiatry more generally by
identifying sex- and drug-specific predictive biomarkers for cannabis use. Psychosocial
predictors were also identified and can be used to tailor intervention strategies. As large
neuroimaging studies like IMAGEN become more common, these approaches help
maximize the information gained from large datasets.
Starting with the prediction accuracies, the generally high ROC AUCs highlighted
the generalizability of the models. It is important to stress again that these prediction
models were all estimated within a cross-validation scheme and therefore addressed some
of the issues related to reproducibility in neuroimaging research (Poldrack et al., 2017).
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However, the gold standard remains to replicate findings in a completely external dataset.
Therefore, these prediction models could be tested on the forthcoming data releases of the
ABCD study, which is a population-level longitudinal study of development from
childhood to adulthood (www.abcdstudy.org).
Returning to the idea of risk-stratification, the post-hoc regressions from Chapters
4 & 5 demonstrate that the addition of predictors from a different feature domain
improves prediction accuracy. This finding is generally in line with prior “big data”
prediction studies that reported improvements with the addition of new modalities
(Jacobus et al., 2016; Whelan et al., 2014b). Therefore, adolescents can first be stratified
by how well they align with the psychosocial predictors. Following identification of these
profiles, the adolescent might be referred for a functional neuroimaging assessment.
Those who exhibit the structural and/or functional neurobiological differences could be
stratified again given their alignment with the neurobiological risk profiles. Although, at
this point in time, this scenario is likely not justifiable in light of the amount of time and
resources involved with functional neuroimaging assessments. Replication studies are
needed to ensure the brain predictors reported here generalize to other datasets. Also,
intervention studies informed by the neurobiological predictors are needed.
In terms of informing treatment interventions, it is challenging to recommend how
the brain findings inform interventions. This challenge is underscored by the quantity of
brain predictors uncovered from different modalities. To start, the functional tasks
broadly informed the psychological constructs that influenced cannabis use in
adolescence. For instance, exaggerated social threat processing can be inferred from
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Chapters 2 & 3. As inferred from Chapters 4 & 5, heightened reward evaluations might
be a female-specific construct, whereas poor response inhibition is a shared construct
across the sexes. Rather than directly targeting each brain predictor per se, targeting these
constructs might be a useful first step as a global approach.
Targeting a reduction in cigarette use is hypothesized to be most effective in
reducing cannabis use. In light of the clear predictive relationship between cigarette and
cannabis use reproduced here, special attention must be given to cigarette reduction
efforts as they are hypothesized to lower cannabis initiation rates. This idea is supported
by an epidemiological study that demonstrated a recent reduction in cigarette use likely
protected against an increase in cannabis use in youths (Miech et al., 2017). Nicotine is
also strongly implicated in alcohol use behaviors as both animal (Lê et al., 2003) and
human studies (Barrett et al., 2006) demonstrated that nicotine facilitated alcohol
consumption. In considering this pattern, a recent population level study indicated that
smoking cessation predicted a reduction in alcohol use (Brown et al., 2016). Given this
cross-drug reduction, and the pattern reported by Miech and colleagues, it is very likely
that cannabis use will decline by removing the influence of cigarettes.
Targeting personality features to inform substance use interventions is an ongoing
line of research by Conrod and colleagues (Conrod, 2016). As discussed in Chapter 4.2,
personality-targeted intervention programs have successfully lowered cannabis use in
adolescence (Mahu et al., 2015). The Mahu and colleagues intervention demonstrated
specific effects on cannabis use levels by targeting a sensation seeking personality
phenotype. Therefore, those findings are highly applicable to the novelty seeking
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personality elevations reported here. Altering the novelty seeking personality phenotype,
as demonstrated by Mahu, will likely be effective in lowering cannabis use.
A final set of psychosocial predictors to be considered is the influence of the
parent. The most robust predictor of use identified in Chapter 4 was parental cannabis use
(Figure 4.1.3). There are currently ten states in the US that legalized recreational cannabis
use, with commercial distribution approved in all but Vermont and the District of
Columbia (as of April 2019). Therefore, parents/guardians living in those states who use
legally (and other parents/guardians with illicit use) should be informed about the
influence their use might have on their child initiating cannabis (O’Loughlin et al., 2018;
Sokol et al., 2018), and the risks of adolescent use per se (Gobbi et al., 2019; Volkow et
al., 2016). On the other hand, the measure used here was for lifetime cannabis use,
therefore it is unknown if parental cannabis use was at all concurrent with the life of the
child. Nonetheless, it will be important to monitor how cannabis use patterns may change
in adolescents in states permitting recreational cannabis use for adults. Finally, as
parental personality measures also predicted use in the child (Figure 4.1.3), these findings
demonstrated that the parent should also be considered during risk-stratification and
possibly incorporated into interventions for their child when necessary.

Genetic Results
The genetic data used here were generally less predictive of cannabis use in
adolescence than data from other domains. Chapter 4 described how it was necessary to
collapse across sex to increase statistical power for the detection of eight predictive
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SNPs. And although Chapter 5 identified a single SNP implicated in the differential
prediction for females, it was determined that the frequency of the high-risk allele was
higher in the binge drinking only sample. This finding therefore may better characterize
the binge drinking only sample rather than the cannabis+binge drinking sample.
These findings add to the sparse literature relating genetic data to cannabis use.
And while most GWAS studies reported on clinical levels of cannabis use in adults
(Agrawal et al., 2011; Sherva et al., 2016), this study was unique in predicting cannabis
initiation in adolescence. The candidate gene approach used here helped conceptualize
neurobiological vulnerabilities to cannabis initiation as only SNPs related to
neurotransmitter receptors and cannabinoid pharmacology were included.
Genetic variation on genes coding for norepinephrine, dopamine, and opioid
(ADRA1b, ADRB2, DRD1, OPRM1) neurotransmitter receptors partially predicted
cannabis use in adolescence. The mechanisms by which these variations confered risk
need to be studied further. Nonetheless, these findings are in line with previous studies.
Animal models have implicated the role of norepinephrine and opioid pharmacology in
cannabis use. Work by Oropeza and colleagues, and Page and colleagues, demonstrated
that relative to vehicle, a cannabinoid agonist precipitated norepinephrine release in the
prefrontal cortex of rats (Oropeza et al., 2005; Page et al., 2008). Thus, individuals with
norepinephrine receptor variants might be more sensitive to the effects of cannabis due to
prefrontal activation differences. Ghozland and colleagues demonstrated specificity of the
mu-opioid receptor in THC-induced conditioned place preference (Ghozland et al., 2002)
thus implicating these receptors in the reinforcement properties of cannabis. And for
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dopamine, a human study by Ferri and colleagues reported more DRD1 risk alleles were
found in cigarette+cannabis smokers relative to cigarette only smokers (Ferri et al.,
2009). Therefore, the findings reported here are situated in the ongoing literature relating
these neurotransmitter systems to cannabis use.
The findings across all results suggest genetic variation on the SNPs used here
were modestly related to cannabis initiation. Instead, the psychosocial and brain
predictors were better suited to predict initiation and use levels. These findings motivate
the hypothesis that the SNPs are more relevant to the maintenance or escalation of
cannabis use following initiation. For instance, genetic variation on genes related to the
pharmacodynamic (CB1 receptors) and pharmacokinetic (FAAH) properties of cannabis
might only exert their influence on use behaviors following cannabis exposure. Future
directions testing these hypotheses are outlined below.

6.3: Limitations & Future Directions
This dissertation contained several important limitations to be discussed. To
begin, the IMAGEN study employed a convenient community sampling method
(Schumann et al., 2010). While the study contained a very large sample for a
neuroimaging project, the dataset is unable to make population level inferences. The
predominantly white European sampling also raises questions related to the
generalizability of these findings to other populations and settings. Cultural differences
were also apparent within the IMAGEN study. The Paris site covariate typically emerged
as a predictor of cannabis use due to the higher prevalence of cigarette use at that site.
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The IMAGEN study is also limited by the ESPAD drug use questionnaire. This
instrument contained poor drug use level quantification as exhibited by the ordinal level
(e.g., level 5=20-39x). It was also collected with poor temporal precision (age 14, 16, 19).
Additionally, there is no information about the route of administration (inhalation,
ingestion), drug preparation (plant matter, oils, etc.), or potency (THC composition).
These features may have different abuse liabilities and functional outcomes. Additionally,
the IMAGEN study did not collect any measures on social networks, peer drug use or
other peer influences. As these measures have previously predicted use (Ali et al., 2011),
their inclusion might have altered the prediction analyses reported here.
As a final limitation related to the data used here, Chapter 4.2 attempted to predict
the initiation of cannabis use by age 19 from data collected at age 14. Future studies
could incorporate measures collected at the age 16 assessment. The inclusion of data that
were more proximal in time to the outcome measure might improve prediction.
Moreover, the age 16 data could be used in reference to the age 14 data to determine if
any changes between the time points might improve the prediction of age 19 use.

Future Studies
The majority of the findings were discussed in their ability to inform treatment
interventions designed to alter a risk phenotype. Therefore, studies are needed to
demonstrate how effective those interventions might be on yielding reductions in
cannabis use. In doing so, those studies would also provide supporting evidence that the
predictors were causally related to cannabis use.
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As noted in discussion above related to the SNP results, genetic variation might
be related to cannabis maintenance or escalation, rather than initiation. Therefore, future
studies could test for linear associations (rather than the binary initiation association)
between the SNPs and future cannabis use level. Random forest analyses might also be
useful in identifying interactions between SNPs without having to explicitly model an
excessive number of interaction terms in a linear regression model. Alternatively, the
nine predictive SNPs from Chapters 4 & 5 could be selected to build interaction terms
with any combination of predictors. Along these lines, the nine SNPs could also be
selected for mediation analyses investigating how genetic variation relates to the
neurobiology. For example, modeling the SNPs as a mediator between cannabis use and
the brain data is hypothesized to inform the biological mechanisms of cannabisprecipitated brain changes.
The hypothesis-driven studies in Chapter 2 & 3 targeted the amygdala, in part,
due to the high density of CB1 receptors. Future studies could focus on other regions with
high CB1 densities like the hippocampus and cerebellum (Kawamura, 2006). Chapter 3
was also unique as it tested for consequences arising from cannabis use. As only the
amygdala was considered, future analyses could explore functional differences at the
whole-brain level. Moreover, all the brain data were analyzed within a mass univariate
framework. That is, each brain predictor reflected the mean activation level (or total
GMV) contained at that ROI. All ROIs were then modeled together as a collection of
independent variables. Moving forward, functional connectivity or graph theoretical
measures could be examined. Those measures, by design, estimate the inherent network
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structure of the neurobiology and might better characterize the relationship between the
brain and cannabis use beyond a mass univariate approach.
Connectivity measures have been previously used in addiction research to
characterize neurobiological differences related to drug cue-reactivity (Janes et al., 2012)
and craving (Janes et al., 2014). Previous studies have also successfully incorporated
functional connectivity metrics with machine learning algorithms to classify cigarette
smokers (Pariyadath et al., 2014), and predict treatment outcomes in individuals with
substance use disorders (Steele et al., 2018). Therefore, applying these techniques would
further illuminate the neurobiological mechanisms associated with cannabis use in
adolescence.
Finally, the IMAGEN study is just starting to release the age 23 assessments of
roughly 800 individuals. Future analyses examining how neurobiological trajectories
from early adolescence to early adulthood either predicts cannabis use or changes as a
consequence of use could be explored. Additionally, more clinically relevant prediction
analyses could be conducted on the individuals who might have met diagnostic criteria
for cannabis use disorder (DSM-5). A differential prediction analysis comparing
individuals with cannabis use vs. cannabis use disorder would better characterize
pathological use and stratify risk. A final clinical outcome to be predicted in these
samples is schizophrenia as this disorder is typically not diagnosed until late adolescence
into early adulthood (Gogtay et al., 2011). Those analyses would contribute to the debate
on cannabis-precipitated psychotic disorders (Volkow et al., 2016).
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Abstract
Historically, neuroscientific research into addiction has emphasized affective and
reinforcement mechanisms as the essential elements underlying the pursuit of drugs, their
abuse, and difficulties associated with abstinence. However, research over the last decade
or so has shown that cognitive control systems, associated largely but not exclusively
with the frontal lobes, are also important contributors to drug use behaviors. Here, we
focus on inhibitory control and its contribution to both current use and abstinence. A
body of evidence points to impaired inhibitory abilities across a range of drugs of abuse.
Typically, studies suggest that substance-abusing individuals are characterized by relative
hypoactivity in brain systems underlying inhibitory control. In contrast, abstinent users
tend to show either normal or supernormal levels of activity in the same systems attesting
to the importance of inhibitory control in suppressing the drug use urges that plague
attempts at abstinence. In this chapter, the brain and behavioral basis of response
inhibition will be reviewed, with a focus on neuroimaging studies of response inhibition
in current and abstinent drug abusers.
INTRODUCTION

A defining characteristic of addiction is the loss of control over one’s behavior. It
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is central to the diagnosis of a substance use disorder, it is characteristic of the alltoo common relapses of abstinent users attempting to stay clean, and it is apparent
when initial intentions to have just one drink escalate into a binge drinking session.
Although hedonic processes such as liking and craving may form the core motivation to
consume drugs, certain cognitive processes, such as attention and memory, likely
contribute to these drives whereas others, such as response inhibition, likely contribute to
the individual’s efforts to resist these drives. For instance, Bechara’s cognitive theory of
addiction posits that the augmented bottom-up signal of appetitive salience for drugs, in
part, attenuates top-down inhibitory control (Bechara, 2005).
Cognitive control processes, also commonly referred to as executive functions,
are attentionally demanding, and consciously available, volitional processes that initiate a
certain action or interrupt ongoing actions (Atkinson and Shiffrin, 1968; Schneider and
Shiffrin, 1977; Shiffrin and Schneider, 1977). Cognitive control takes on many forms,
including, but not limited to, attentional control and inhibitory control. Attentional
control involves the interaction between perceiving environmental cues and the allocation
of perceptual processing resources (Norman and Shallice, 1985) whereas inhibitory
control broadly refers to counteracting behaviors preceding, accompanying, or resulting
from cues. With regard to addiction, initiation of drug cravings may involve mechanisms
by which stimuli associated with previous drug use are detected and processed (Grant et
al., 1996; Hester et al., 2006), while the inhibition of behavior may involve mechanisms
related to monitoring and regulation (Forman et al., 2004; Kaufman et al., 2003). This
chapter will focus on inhibitory control, largely operationalized as response inhibition,
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and its contribution to substance abuse. Specifically, response inhibition will be
considered as a means to characterize substance use, abstinence, and recovery in
substance-dependent individuals.
RESPONSE INHIBITION TASKS
Inhibitory control is broadly conceptualized as the ability to suppress or
countermand a thought, action, or feeling. Many investigators study inhibitory control
using carefully designed tasks like the stop-signal task, or the go/no-go task, that measure
an individual’s ability to suppress a prepotent motor response. During the stop-signal
task, subjects perform a primary task such as identifying with button-press responses if a
visually presented arrow (the target stimulus) points to the left or the right. On a minority
of trials, often one quarter of trials, a unique auditory or visual stimulus (the stop-signal)
follows the target and instructs the subject to countermand their response. Task difficulty
is manipulated by varying the delay between the target and stop stimulus, such that the
longer the delay the more difficult it is to inhibit the response. By calculating how fast
subjects respond on trials without a stop-signal and the average stop-signal delay on trials
in which they successful inhibit 50% of the time, one can estimate the speed of the
response inhibition process known as the stop signal reaction time (SSRT) (Logan and
Cowan, 1984). During go/no-go tasks, subjects are presented with a continuous stream of
stimuli, the majority of which require a button-press response (go trial), and a minority
requiring no response (no-go trial) with the inhibitory demand being induced through the
prepotency to respond even on no-go trials. While both tasks are arguably very
rudimentary examples of inhibitory control, there is evidence, outlined below, that the
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neural circuitry subserving response inhibition is also involved in other types of cognitive
and emotional inhibition, thereby indicating that they may serve as reasonable probes for
more complex inhibitory demands, including those related to resisting drugs. As the
neural circuitry of response inhibition is relatively well understood and yields reliable and
sensitive behavioral measures of inhibitory ability, it has generated a significant number
of studies focused on the role of response inhibition in addiction (Luijten et al., 2014;
Smith et al., 2014).
THE NEUROBIOLOGY OF CONTROL
Neuroimaging research has identified the dorsolateral prefrontal cortex (dlPFC) as
a brain region critical for cognitive control. Evidence suggests the dlPFC is implicated
during dual-task coordination (D’Esposito et al., 1995; Mansouri et al., 2009), task
switching (Badre and Wagner, 2006; Dove et al., 2000; Sohn et al., 2000), memory
updating (Edin et al., 2009; Salmon et al., 1996), and response sequencing, monitoring,
and manipulation (Kim et al., 2013; Owen et al., 1996). This is consistent with the human
lesion literature implicating the frontal lobes in organizing, regulating, and producing
coherent behavior (Luria and Pribram, 1973; Stuss and Frank Benson, 1987). Frontal
lobe-damaged patients appear to lose important aspects of autonomous cognitive control
as evidenced by the loss of behavioral control to environmental contingencies (e.g.,
capture errors and utilization behaviors; Lhermitte, 1986). Although the focus of this
review will be on prefrontal systems mediating control, these systems operate in
conjunction with extensive parietal, premotor, cingulate, subcortical, and cerebellar
networks. Further, despite the evidence implicating the frontal lobes in cognitive control,
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the assignment of specific frontal loci to specific functions is far from resolved due,
perhaps, to one of the defining characteristics of the frontal lobes being their ability to
flexibly adapt to task demands. Dosenbach and colleagues suggest that different brain
networks are involved in distinct aspects of control with the frontoparietal cortex
implicated in initiating and adapting behavior, while sustained stable task performance is
associated with the anterior cingulate cortex (ACC), anterior insula, frontal operculum,
and anterior prefrontal cortex (Dosenbach et al., 2007).
With a specific focus on inhibitory control, a body of research (lesion, transcranial
magnetic stimulation (TMS), and fMRI methodologies) implicates the right inferior
frontal cortex (rIFC) in motor response inhibition (Aron et al., 2003; Chambers et al.,
2006; Garavan et al., 1999, 2006). More broadly, the rIFC is one node of a motor
inhibition network which also includes the pre-supplementary motor area (pre-SMA), and
subthalamic nucleus (STN) (Aron et al., 2014). It is unclear about the exact causal
pathways of these regions (Duann et al., 2009; Neubert et al., 2010; Swann et al., 2012),
but research proposes that the STN receives input from both the rIFC and pre-SMA, and
the STN inhibits motor activity at the basal ganglia (Aron and Poldrack, 2006; Schmidt et
al., 2013). Figure A2.1 shows a number of the main cortical areas activated during
response inhibition from the largest neuroimaging study of the STOP task (Whelan et al.,
2012). Human lesion studies provide converging evidence that lesions in the right preSMA (Floden and Stuss, 2006; Nachev et al., 2007) and the right inferior frontal gyrus
(IFG) subregion pars opercularis impair response inhibition (Aron et al., 2003, 2004,
2014). The first study using TMS found that temporary deactivation of the right IFG pars
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opercularis selectively impaired the ability to stop an already initiated action, whereas the
deactivation of the same region did not affect physiological arousal or the ability to
execute responses, confirming the important role of the IFG in the regulation of response
inhibition (Chambers et al., 2006). In addition, Cai and colleagues showed that
stimulation of the right pre-SMA slowed the implementation of stopping (measured via
SSRT) but had no influence on modulation of response tendencies and suggested that this
region impairs stopping behavior through a specific disruption of response inhibition (Cai
et al., 2012). These studies are supported by the temporal and spatial precision afforded
by electrocorticography studies, which have found the rIFC responds prior to successful
inhibition (Swann et al., 2009, 2012). Recent studies suggest that this may reflect a
broader role for this region in detecting attentionally salient events (Hampshire et al.,
2010), although it may be the case that in order to evoke right IFG activity, the salience
of these events must be relevant to response control (Dodds et al., 2011).
Although typically not activated in imaging studies of motor response inhibition,
there is considerable evidence of a role for the orbitofrontal cortex (OFC) in impulse
control. For example, OFC damage in a rodent model increases SSRT (Eagle et al.,
2008), while patients with lesion damage to the OFC show increased self-report and
cognitive measures of impulsivity and altered time perception relative to healthy controls
and non-OFC lesioned patients (Berlin et al., 2004). That said, many behaviors that
appear impulsive might not be driven by a deficit in impulsivity per se. For example,
Torregrossa and colleagues argue that the most robust deficit in OFC damaged animals is
in reversal learning. Seemingly impulsive behaviors, such as perseverative responding,
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and failure to alter responding when rewards for a learned behavior are devalued, may in
fact reflect impairment in the ability to update the value of an outcome, especially under
changing circumstances (Torregrossa et al., 2008).
There is evidence that regions implicated in motor inhibition and, in particular,
right frontal cortex, are involved in aspects of inhibitory control beyond response
inhibition. This includes the suppression of drug cravings elicited by a cocaine video:
brain activation in the rIFC was increased when inhibiting a craving response and was
negatively coupled with activation levels in the right nucleus accumbens (Volkow et al.,
2010). In a think/no-think paradigm, in which paired associates are actively suppressed,
activation in rIFC was associated with suppressing the sensory components of memories
(Depue et al., 2007). de Fockert and colleagues showed that increasing working memory
load increased activity levels in bilateral inferior and middle frontal gyri while
simultaneously increasing the distraction caused by (and sensory processing of) irrelevant
faces (de Fockert et al., 2001). Hester and colleagues modified this paradigm to show that
irrelevant drug stimuli produced heightened activity in visual cortex in cocaine users
relative to drug–na ̈ıve controls (Hester and Garavan, 2009). Critically, those users with
the greatest levels of activity in right prefrontal cortex showed the smallest behavioral
interference caused by the distracting drug stimuli. In a similar manner, a study of the
ability to ignore ecstasy-related stimuli produced greater occipital activation but reduced
right prefrontal activation in ecstasy users relative to controls (Roberts and Garavan,
2013). Tabibnia and colleagues identified the rIFC in a number of inhibitory deficits of
methamphetamine-dependent subjects (Tabibnia et al., 2011). Results indicated lower
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gray matter in the rIFC in dependent subjects relative to controls, and gray matter in this
region was correlated with drug craving, response inhibition performance, and a test of
affect regulation. Finally, Behan and colleagues have recently shown that the rIFC is
more active when subjects suppress reward anticipation (Behan et al., 2015). Here, a
novel task required subjects to prepare for either a target to which they must respond as
fast as possible to receive a reward, or, a stop-signal indicating they should make no
response. A psychophysiological interaction analysis suggested the possibility of having
to inhibit, rather than respond quickly, produced activity increases in the rIFC, which
were correlated with activity decreases in the ventral striatum. Further, the rIFC activity
was adjacent to a distinct rIFC region associated with motor inhibition. Combined, this
brief review suggests that the rIFC may have a broad role in inhibitory processes that
extend beyond motor inhibition. That said, there remains a lack of a comprehensive
theory relating the similarities and differences between the various types of inhibitory
control to their neurobiological and psychological overlap. Further research probing the
multiple types of inhibitory control in the same sample may be a valuable advance.
RESPONSE INHIBITION AND DRUGS OF ABUSE
Substance using populations are characterized by deficits in response inhibition.
A recent meta-analysis (Smith et al., 2014) of 97 studies found evidence for impaired
response inhibition among those dependent on alcohol, cocaine, methamphetamine,
tobacco, and MDMA.

Nicotine
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Although findings in the literature are mixed, a recent meta-analysis found a small
but significant effect relating cigarette smoking to response inhibition deficits (Smith et
al., 2014). Results from neuroimaging investigations have generally found alterations in
the neural circuitry associated with response inhibition in smokers compared to
nonsmoking controls (de Ruiter et al., 2012; Luijten et al., 2013; Nestor et al., 2011; but
see Galva ́n et al., 2011). For example, Nestor et al. (2011) found that smokers showed
reduced activation compared to nonsmokers in a widely distributed network including the
ACC, left IFG, bilateral inferior parietal lobules, and bilateral insula. This is similar to the
findings of de Ruiter et al. (2012) who found reduced activation of the rostral ACC
during inhibition in smokers.
One interesting line of research has examined the relationship between neural
activity during successful response inhibition and craving for cigarettes. Berkman et al.
(2011) demonstrated that subjects with greater task-related neural activity in nodes of the
response inhibition network (bilateral inferior frontal gyrus, SMA, putamen, and left
caudate) smoked less in response to subsequent, naturally occurring occasions of
cigarette craving. These results suggest that functioning in the circuitry underlying motor
inhibition translated to greater behavioral control in response to craving. Further, these
investigators found an inverse relationship between amygdala activation during response
inhibition and behavior, such that subjects with greater amygdala activation had a
stronger positive relationship between craving and smoking behavior. These findings link
altered patterns of neural activation with behavioral constructs known to be critical in
addiction. Further, as studies have reported hypoactivation in the neural circuitry for
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response inhibition without differences in task performance, this study underscores the
potential utility of neuroimaging as a sensitive measure of neurobiological alterations
related to impulsive behavior. Finally, there is considerable value in studies that link labbased measures of neurobiological function with assessments of inhibitory control in the
real world. Real-world behaviors as assessed, for example, by mobile technologies, open
up valuable opportunities to relate the neurobiology of inhibitory control to avoid drug
use in the natural environment, which in many cases is laden with cues to use.

Alcohol
Alcohol abusers have increased commission error rates compared to nondrinkers
or social drinkers on go/no-go tasks (Kamarajan et al., 2005; Murphy and Garavan,
2011), and longer SSRTs on the stop-signal task compared to controls (e.g., Goudriaan et
al., 2011; Lawrence et al., 2009; Rubio et al., 2007). However, mixed results have been
reported with a number of studies showing no difference in response inhibition related to
alcohol consumption (Li et al., 2009; Papachristou et al., 2013; Schmaal et al., 2013). It
has been suggested (Smith and Mattick, 2013) that this may relate to sex differences,
based on evidence that heavy drinking may be preferentially associated with impaired
response inhibition in females (Nederkoorn et al., 2009; Smith and Mattick, 2013;
Townshend and Duka, 2005). That said, few studies have been sufficiently powered to
specifically examine sex differences in response inhibition related to alcohol
consumption. Nonetheless, Smith and colleagues reported an overall impairment in
response inhibition in their meta-analysis and suggested that a dose response relationship
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may exist between impaired response inhibition and drinking patterns (Smith et al.,
2014). However, there have been no systematic studies addressing this possibility.
Studies using functional neuroimaging to examine response inhibition in problem
drinkers are limited. Li and colleagues found no performance differences on SSRT but
lower activation in left dlPFC in alcohol-dependent patients (Li et al., 2009). However,
these subjects were all successfully abstinent in alcohol treatment at the time of scanning,
making it difficult to determine if activation patterns were related to alcohol withdrawal
or early recovery from alcohol dependence. Recent findings have shown that alcohol-use
disorders are associated with lower activation in the IFG, insula, inferior parietal lobule,
and ACC compared to controls (Claus et al., 2013). When comparing heavy to light
alcohol consumption in college drinkers, the heavy drinkers showed impaired
performance and altered patterns of neural activity during response inhibition in areas
including the ACC, portions of the frontal lobe, hippocampus, and thalamus (Ahmadi et
al., 2013). Structural neuroimaging experiments have suggested that chronic alcohol
abuse is associated with global volume reduction, cortical and subcortical gray matter
reductions, and enlargement of the ventricles. The volume loss in frontal, cerebellar, and
subcortical regions are believed to play a critical role in individual differences related to
task performance (Chanraud et al., 2007; Scheurich, 2005; Sullivan, 2003). Therefore, as
the neural architecture supporting response inhibition deteriorates, behavioral inhibition
capacity is likely to suffer.

Cannabis
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Studies in both adolescent and adult cannabis users have found little evidence for
disrupted cognitive performance (Grant et al., 2012; Jager et al., 2010; Schweinsburg et
al., 2010; Tapert et al., 2007); however, see Moreno et al. (2012). Interestingly, several
studies have demonstrated that while there are inconsistent effects of cannabis use on
inhibitory performance, there are neural differences that can be detected via fMRI (Behan
et al., 2014; Hester et al., 2009; Roberts and Garavan, 2010; Schweinsburg et al., 2008;
Tapert et al., 2007). For example, Roberts and Garavan investigated neural activity using
fMRI during response inhibition in adolescent cannabis users and nondrug using controls.
While users had equal performance to control subjects, the users had increased activation
in frontal and parietal regions during successful inhibitions. This pattern of activation was
interpreted to indicate increased neural resources required of the users to achieve
performance levels comparable to controls (Roberts and Garavan, 2010). Similar results
were found in a study of college students (cannabis users compared to nondrug users)
where there was equal task performance but increased activation in the right inferior
parietal lobule, the right putamen, and the supplementary motor area in the users (Hester
et al., 2009).
It is notable that the pattern of effects in cannabis users (comparable performance
but greater activation relative to controls) differs from the hypoactivity associated with
other drugs of abuse. Some evidence suggests that heavier use, earlier onset, and greater
cumulative cannabis consumption is associated with smaller increases in activation in
frontal and parietal regions compared to lighter users or those who begin using later
(Schweinsburg et al., 2008, 2010). Such findings indicate that there may be an interaction
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of brain development and cannabis exposure on brain function and may additionally
suggest a compensatory mechanism in heavy cannabis users (Jacobus et al., 2009).
Another possibility is that the increased activation of cannabis users may compensate for
altered functional connectivity between regions. Recently, Orr and colleagues showed
increased intrahemispheric and decreased interhemispheric resting-state connectivity in
adolescent heavy cannabis users (Orr et al., 2013). The same sample of adolescent users,
when performing a go/no-go task showed impaired performance but no regional
activation differences relative to controls. Instead, the users showed increased
connectivity during the task between bilateral parietal lobes and left cerebellum, and
these same regions showed increased resting-state connectivity (Behan et al., 2014).
Although these results may suggest that atypical patterns of activation in cannabis users
may be related to differences in inter- and intrahemispheric connectivity, the full set of
results fails to offer a straightforward message. As cannabis is the most commonly used
illicit drug and the onset of use is common during the sensitive adolescent
neurodevelopmental period, it is important that the effects of cannabis on neurocognitive
function vis-à-vis inhibitory control be the subject of further inquiry.

Cocaine
There is strong evidence that cocaine users have poorer response inhibition than
nonusers. This is observed in studies using the stop-signal task (Colzato et al., 2007;
Fillmore and Craig, 2002; Li et al., 2006; Morie et al., 2014; but see Vonmoos et al.,
2013) and in go/no-go tasks (Ferna ́ndez-Serrano et al., 2011; Hester and Garavan, 2004;
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Hester et al., 2007; Kaufman et al., 2003; Lane et al., 2007). A review by Spronk and
colleagues calculated pooled effect sizes for both SSRT on the stop-signal task and errors
of commission on go/no-go tasks and found a moderate pooled effect size (0.50) of
cocaine user status on the stop-signal task and a moderate to large (0.64) pooled effect
size for errors of commission on the go/no-go task (Spronk et al., 2013). fMRI studies
have generally shown reduced neural activity in the PFC including rostral ACC and SMA
(Hester and Garavan, 2004; Kaufman et al., 2003; Li et al., 2007).
Using independent component analysis on a stop-signal task, Elton and colleagues
discriminated cocaine users from nonusers based on activity patterns decomposed into 11
components. Two of these components were specifically related to stop-signal success,
and cocaine users exhibited decreased activation in these networks compared to controls.
One network comprised the bilateral IFG, angular gyri, middle temporal, and posterior
parietal gyri, and the other network comprised the dlPFC, ventrolateral PFC, dorsomedial
PFC, anterior insula, and middle temporal gyrus (Elton et al., 2014).

MDMA/Ecstasy
A meta-analysis found that overall there is a small effect size on inhibitory errors
in heavy MDMA users compared to controls (Smith et al., 2014). Among individual
studies, there are several that reported no behavioral performance differences (von
Geusau et al. 2004; Quednow et al., 2006; Roberts et al., 2013; Roberts and Garavan,
2010). However, two of these studies used neuroimaging and found altered neural
processing in MDMA users. For example, Roberts and colleagues found that
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ecstasy/polydrug users showed altered EEG patterns suggestive of attentional or
inhibitory deficits (Roberts et al., 2013). Similarly, Roberts and Garavan (2010) found
intact performance but increased activation in the response inhibition network (right
DLPFC, inferior frontal gyrus, and parietal lobule) in recreational ecstasy users. Other
studies of current MDMA users have reported moderately impaired behavioral
performance in response inhibition (Hoshi et al., 2007). Taken together, the available
literature suggests a small impairment in response inhibition associated with MDMA use
and altered neural processing in users with intact behavioral performance.
RESPONSE INHIBITION AND ABSTINENCE
Relapse is, in many regards, a defining characteristic of drug dependence.
Successful abstinence might be viewed within a framework whereby prefrontal cognitive
systems seek to control biased attention and pathological behaviors. Hence, successful
abstinence may rest on the outcome of the antagonism between drug-wanting systems
driven, for example, by ventral striatally mediated salience attribution systems (Robinson
and Berridge, 2003), and drug-denying systems governed by the prefrontal cortex
(Goldstein and Volkow, 2002; Figure A2.2).
There is, however, relatively little empirical data on the neurobiology of
successful abstinence despite its potential value for informing therapeutic interventions.
The extant literature has typically investigated short-term abstinence and has revealed
many persistent deficits, which, for example, for cocaine users, are more pronounced in
heavy users in lateral and medial prefrontal regions associated with cognitive control
(Bolla et al., 2003, 2004). Abstinent cannabis users show a similar pattern of lateral and
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medial hypoactivity but have also been reported to show bilateral hippocampal
hyperactivity (Eldreth et al., 2004). There is, however, evidence to suggest that prolonged
abstinence will correct the general pattern of prefrontal hypoactivity in users (see below)
with, for example, cocaine abstinence reducing high-risk responses on a gambling task
(Bartzokis et al., 2000). Structural MRI studies have found reduced gray matter volume
in prefrontal, orbitofrontal, and cingulate regions in cocaine abstinent individuals (Fein et
al., 2002; Matochik et al., 2003), which, some argue, can last even with prolonged
abstinence (Tanabe et al., 2009). Interestingly, Connolly and colleagues found in a crosssectional analysis that cocaine abstinent individuals reached control-like levels of gray
matter volumes in the cingulate, insula, and dlPFC by 35 weeks of abstinence (Connolly
et al., 2013).
During abstinence, impulse control might be important for suppressing drugseeking behaviors and drug cravings. Although subjective reports of craving often prove
to be poor predictors of subsequent abstinence, cognitive and neuroimaging measures can
sometimes do better (Grüsser et al., 2004; Kosten et al., 2005). For example, higher
scores on a self-report measure of impulsivity (the Barratt Impulsiveness Scale) have
been shown to predict poorer treatment outcome (Moeller et al., 2001; Patkar et al.,
2004). With regard to brain predictors, unfortunately, the neuroimaging literature on
predicting relapse is small and has employed a variety of tasks that were not necessarily
designed to induce a craving response or to assess the user’s ability to exercise inhibitory
control over that response. Nonetheless, the existing results do identify prefrontal
systems, among other regions, as effective predictors of treatment outcome. For example,
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using a two-button prediction task, Paulus and colleagues showed activation levels in
prefrontal, temporal, and posterior cingulate regions early in abstinence to predict
subsequent relapse for methamphetamine users (Paulus et al., 2005). Grüsser et al. (2004)
found that activity in response to alcohol-related stimuli in the putamen, ACC, and
medial prefrontal cortex predicted relapse. In cocaine treatment-seeking individuals,
fMRI error-related processing (stop-error vs. stop-success) revealed blunted activity in
the dorsal ACC predicted relapse in both sexes, while females exhibited reduced thalamic
activity, and males exhibited reduced insular activity (Luo et al., 2013). Although it does
not follow from these findings that behavioral measures of impulse control should also
predict abstinence, the predictive value of prefrontal cortex suggests that regulatory
processes may be involved.
Given the important role that cognitive processes may play in avoiding relapse in
drug users and gamblers (Cox et al., 2002; Goudriaan et al., 2008; Passetti et al., 2008;
Waters et al., 2003), it may be the case that the best predictors of treatment outcome are
those that reflect cognitive control over drug urges rather than the drug urges themselves.
This is supported by a study by Brewer et al. (2008) who identified cognitive control
prefrontal regions, in addition to other subcortical and posterior cingulate regions, as
being the best predictors of treatment outcome in a treatment-receiving sample of cocaine
users. Further evidence for the assertion that impulse control might contribute to
successful abstinence arises from cross-sectional research of abstinent former users using
a go/no-go task. These studies show an apparent reversal in activation patterns, such that
prefrontal hypoactivity in current users is paired with prefrontal hyperactivity in abstinent
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users. For example, Connolly et al. (2012) showed that both short-term abstinent cocaine
users (1–5 weeks) and long-term abstinent users (4–24 months) present with fMRI
hyperactivity in cognitive control regions relative to drug–na ̈ıve controls. That is, the
brain regions involved in impulse control (e.g., right middle and rIFC), which are
consistently shown to be hypoactive in current users, show elevated activity in former
users compared to drug–na ̈ıve controls. Subsequent studies have shown former users to
be either comparable in performance, fMRI activation levels, and motor-inhibitionrelated ERP components to controls (Bell et al., 2014; Morie et al., 2014) or to show
elevated activation associated with successful inhibitions (Hester et al., 2013). The latter
study also revealed blunted activation in response to errors and punishments in the former
users suggesting some deficits may persist longer into abstinence.
Evidence for enhanced cognitive control contributing to successful abstinence is
also observed in former cigarette smokers (abstinent for 2 years). Using a go/no-go task,
current smokers showed reduced activity relative to controls in the dlPFC and the ACC
while the former smokers revealed greater inhibitionand error-related activation in the
ACC relative to the current smokers (Nestor et al., 2011). A recent study in cigarette
smokers highlighted behavioral effects of practicing self-control (i.e., small acts of
impulse control such as avoiding sweets were practiced over 2 weeks before quitting)
which significantly improved abstinence rates; 27% in the self-control group, relative to
12% in a control condition, were still abstinent 1 month after quitting (Muraven, 2010).
TMS and tDCS have shown some efficacy in enhancing cognitive control.
Jacobson and colleagues demonstrated faster SSRTs while stimulating the right inferior
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frontal gyrus (Jacobson et al., 2011). Applying this technique to substance-abusing
individuals may prove fruitful. One study in alcohol detoxification found a single session
of TMS over the rIFC facilitated cognitive control performance a week later (Herremans
et al., 2013). Similarly, pharmacological interventions targeting cognitive enhancement in
cigarette smokers have provided some support for the facilitation of abstinence. Focusing
on studies directly assessing response inhibition performance, galantamine, a
cholinesterase inhibitor, has reduced subjective craving for cigarettes, while improving
performance on a go/no-go task (Sofuoglu et al., 2012). Another study suggests that the
use of an NMDA partial agonist, D-cylcoserine, attenuates subjective ratings of cigarette
“stimulation” and “relaxation,” while improving performance on a go/no-go task (Nesic
et al., 2011). Lastly, in a combined fMRI-pharmacological study of guanfacine, a
noradrenergic agonist, smokers exhibited reduced cigarette consumption. While no effect
was found on task performance, the fMRI results indicate guanfacine attenuated dlPFC
responses. The authors interpret this finding as a possible guanfacine-related facilitation
of cognitive efficiency.
In summary, the extant literature suggests compromised inhibitory control in
active users and normalized or enhanced control in abstinent users. If inhibitory control is
shown to be an important contributor to abstinence then this raises exciting possibilities
for pharmacological or behavioral interventions. In time, neuroimaging measures may
enable us to predict who is most likely to abstain (e.g., related to the integrity of the
circuitry underlying inhibitory control) and, by tracking recovery in this circuitry, give
guidance on who is most at risk for subsequent relapse.
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CONCLUSION AND FUTURE DIRECTIONS
The preceding review suggests that deficits in inhibitory control characterize
substance dependence. There are, however, drug-specific effects that require further
elaboration (e.g., the mixed findings in cannabis users). The integration of functional
activation, functional connectivity, and brain structural data is important, but so too is a
much richer phenotypic characterization of the users including their drug use histories
(age of onset, polydrug use), mental health comorbidities, family and environmental
influences, and so on. In reviewing the literature, there persists a lack of a comprehensive
understanding on how the various types of inhibitory control relate to one another,
psychologically and neurobiologically. More assessments of drug use and other types of
inhibitory control (e.g., delaying gratification) or inhibitory control in reward-related
contexts may yield new insights. It is a conundrum that although different aspects of
inhibitory control appear to be uncorrelated with one another (e.g., self-report personality
measures, impulsive choice, and impulsive responding; Reynolds et al., 2006), drug users
score highly impulsive on all. Combining this with the evidence that inhibitory control is
related to reward processes such as drug-induced euphoria and drug self-administration
(Cervantes et al., 2013; Weafer and de Wit, 2013), suggests that more conceptual work is
required to integrate these constructs. Finally, as noted above, relating lab-based
measures of inhibitory control to drug urges and craving in the natural environment is an
important extension of the existing research.
With regard to abstinence, there are two questions of primary importance, and for
both, inhibitory control appears to be a central construct. First, to what extent does
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inhibitory control predicts abstinence? This is important clinically (i.e., identifying who is
most likely to relapse can help in allocating interventions and additional services) and
also theoretically (i.e., the predictors of relapse give good guidance on the mechanisms
that may contribute in a causal manner to abstinence; Garavan et al., 2013). Second, what
is the time-course of recovery of inhibitory control and other processes pertinent to
addiction? One speculation is that certain processes (e.g., the incentive salience attributed
to drugs and drug cues mediated by structures such as the ventral striatum) may persist
long after the cessation of use and may underlie relapse risk. It may be the case that
inhibitory control recovers to normal (or greater than normal) levels relatively early in
abstinence, and while inhibitory control exercised over drug cravings and behaviors is
essential to abstinence, relapse is highly likely when this regulatory function becomes
disrupted as happens, for example, under stressful situations. Large sample, longitudinal
studies of abstainers that assess multiple functions at multiple time-points are required to
fully elaborate the role that inhibitory control contributes to avoiding relapse.
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Figures
Figure A2.1: Response inhibition on the STOP task produces robust activation in parietal
and frontal cortex, including bilateral inferior frontal gyrus.

Figure A2.2: Stop Task Related Activity Hypotheses

We hypothesize that abstinence relies upon recovery of prefrontal systems involved in
inhibitory control (regions such as the right IFG and OFC shown on the left).
Vulnerability to relapse may be reflected in reinforcement or salience systems (involving
regions such as the ventral striatum shown on the right). We hypothesize that relapse may
arise from lapses in the prefrontal regulatory systems.
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APPENDIX 3: STRUCTURAL BRAIN CORRELATES OF ADOLESCENTS
WITH BEHAVIORAL AND EMOTIONAL DYSREGULATION
This Chapter has been previously published in the following format:
Spechler, P.A., Chaarani, B., Orr, C., Mackey, S., Higgins, S.T., … Garavan, H., Althoff,
R.R. & the IMAGEN consortium.. (2019). Neuroimaging evidence for right orbitofrontal
cortex differences in adolescents with emotional and behavioral dysregulation. Journal of
the American Academy of Child & Adolescent Psychiatry.
Abstract
Objective: To characterize the structural and functional neurobiology of a large group of
adolescents exhibiting a behaviorally and emotionally dysregulated phenotype.
Methods: Age 14 adolescents from the IMAGEN study were investigated. Latent class
analysis (LCA) on the Strengths and Difficulties Questionnaire (SDQ) was used to
identify a class of individuals with elevated behavioral and emotional difficulties
(“dysregulated”; n=233) who were compared to a matched sample from a low symptom
class (controls, n=233). Whole-brain gray matter volume (GMV) images were compared
using a general linear model with 10,000 random label permutations. Regional GMV
findings were then probed for functional differences from three fMRI tasks. Significant
brain features then informed mediation path models linking the likelihood of psychiatric
disorders (DSM-IV) with dysregulation.
Results: Whole-brain differences were found in the right orbitofrontal cortex (R.OFC;
p<.05; k=48), with dysregulated individuals exhibiting lower GMV. The dysregulated
group also exhibited higher activity in this region during successful inhibitory control
(F1,429=7.53, p<.05). Path analyses indicated significant direct effects between the
likelihood of psychopathologies and dysregulation. Modeling the R.OFC as a mediator
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returned modest partial effects, suggesting the path linking the likelihood of an anxiety or
conduct disorder diagnoses to dysregulation is partially explained by this anatomical
feature.
Conclusion: A large sample of dysregulated adolescents exhibited lower GMV in the
R.OFC relative to controls. Dysregulated individuals also exhibited higher regional
activations when exercising inhibitory control at performance levels comparable to
controls. These findings suggest a neurobiological marker of dysregulation, and highlight
the role of the R.OFC in impaired emotional and behavioral control.
Introduction
Adolescents exhibiting severe difficulties regulating behavior and emotion are
commonly referred for psychiatric evaluation but are difficult to classify into discrete
diagnostic categories, with “comorbidity” being the rule rather than the exception in child
psychiatry. Previous labels for these dysregulated children included severe mood
dysregulation (SMD) or irritability (Leibenluft, 2011) with the acknowledgement that
these individuals will likely meet diagnostic criteria for other disorders. Recently,
“disruptive mood dysregulation disorder” (DMDD) (American Psychiatric Association,
2013) was added to the DSM-5 to better classify dysregulated children. Research
indicates the prevalence of dysregulation is between 0.8 and 3.3%, with particularly high
co-occurrence with externalizing and internalizing disorders (Copeland et al.,
2013),(Dougherty et al., 2014). As individuals with a singular diagnosis may be thought
of as behaviorally or emotionally dysregulated, it is specifically the individuals with a set
of difficulties spanning both behavioral and emotional domains who need to be studied
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further. Considering the addition of this disorder into the DSM, and research showing the
functional outcomes of dysregulated youths are strikingly poor, (Copeland et al., 2014) it
is imperative to identify the neurobiological correlates of dysregulation. Characterizing
the pathophysiological substrates will help inform dysregulation nosology, provide
diagnostic biomarkers, and help inform targeted treatment methods.
The NIMH recently advocated the Research Domain Criteria (RDoc), which
hypothesizes psychiatric problems coexist on a spectrum of severity with symptoms that
cut across discrete diagnostic categories. Therefore, in this report using a large dataset of
adolescents (the IMAGEN study), (Schumann et al., 2010) we adopted a latent class
analysis

(LCA)

approach

to

the

Strengths

and

Difficulties

Questionnaire

(SDQ)(Goodman, 1997) to identify groups of individuals endorsing similar patterns of
behavioral and emotional problems. The result of an SDQ-LCA provides class groupings,
as well as dimensional characteristics of emotional and behavioral problems hypothesized
to contain varying patterns of symptomatology that resist discrete categorization. One
class is specifically hypothesized to comprise a profile analogous to DMDD. In other
words, in the absence of DMDD diagnoses, we hypothesized a class of individuals
exhibiting a profile in line with a dysregulation phenotype. Although measurement of a
dysregulation profile is a major challenge in the field, (Althoff et al., 2010a; Deutz et al.,
2016, 2018) the intent of our investigation is to characterize the neural correlates of
dysregulation as defined by one measurement method (among a suite of others). (Althoff
et al., 2010b; Jordan et al., 2016)
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Structural neuroimaging, and specifically, voxel-based morphometry (VBM), has
been used to study many psychiatric constructs across stages of development. VBM
allows the researcher to measure the volumes of the major tissue types of the brain,
(Ashburner and Friston, 2000) thus providing a neurobiological framework to closely
study a behavioral profile of interest. VBM has informed many adolescent psychiatric
disorders

related

to

dysregulation

including

anxiety,

(Radua

et

al.,

2010)

depression,(Bora et al., 2012) and conduct disorder. (Fairchild et al., 2011) Regarding
previous structural neuroimaging studies of dysregulation, Adleman and colleagues used
VBM to uncover differences among children with SMD, bipolar disorder (BP), and
controls, with the SMD group exhibiting the lowest gray matter volume (GMV) in
bilateral pre-supplemental motor area, right insula and dorsolateral prefrontal cortex.
(Adleman et al., 2012) Additionally, Gold and colleagues used VBM to study youths with
anxiety, BP, ADHD, and DMDD, compared to controls. Gold found GMV differences
specific to, and across psychiatric disorders, with dysregulated participants exhibiting
lower GMV in the right dorsolateral and superior frontal cortex. (Gold et al., 2016)
Therefore, for our primary analysis using whole-brain VBM data, we hypothesized
dysregulated individuals would exhibit lower GMV relative to controls in cortical regions
implicated in regulatory processes such as the bilateral insula, right-sided dorsolateral
prefrontal cortex, and ventromedial/orbitofrontal cortex. (Adleman et al., 2012; Rogers
and De Brito, 2016)
Regions uncovered from the primary anatomical analysis can be used as regions
of interest in post-hoc analyses on the fMRI data from the IMAGEN study. These post286

hoc analyses broadly test the hypothesis that differences in brain structure yields
differences in brain function. Interrogating both structure and function with the same
dataset maximizes the information gained about the neurobiological characteristics of
dysregulation, and captures the brain’s trait-like features measured via structural
neuroimaging, and state-like features measured during functional task demands. Followup analyses on neuroimaging data can also be used to explain the relationship between
candidate comorbidity diagnoses (Copeland et al., 2013) and dysregulation. For instance,
an identified neurobiological correlate of dysregulation can be modeled as a mediator in a
path analysis linking the likelihood of a psychiatric disorder to dysregulation. In doing so,
we test the hypothesis that the brain mediates the relationship between a disorder and
dysregulation in some linear fashion. As we only probe data from the age 14 assessment
of the IMAGEN study, these mediation models infer correlation and not causation.

Methods
Participants were drawn from the IMAGEN study of adolescent development.
(Schumann et al., 2010) Comprehensive study details are available in the online Standard
Operating Procedures (https://imagen-europe.com/). The IMAGEN study conformed to
the ethical standards outlined by the Declaration of Helsinki and was approved by ethics
committees at each site including King’s College, London; Central Institute of Mental
Health, Mannheim; Charite, Universitatsmedizin Berlin; University Medical Center
Hamburg-Eppendorf; University of Nottingham; Trinity College Dublin; Institut National
de la Sante et de la Recherche Medicale, Orsay. After description of the study to
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participants and their parents, written informed consent was obtained. Individuals who
provided assent were assessed at age 14. For this report, all data were taken from the
baseline assessment only (age 14). Participants with SDQ data (N=2,126) were used as
the starting sample of the analysis (Age M=14.56, SD=.44; Females=1,081, 51%).
Selected participants from the LCA analysis were then drawn from the sample who
received an anatomical scan with GMV images passing quality control (N=2,024).

Strengths and Difficulties Questionnaire
The SDQ is 25-item instrument designed to characterize children across five
domains including emotional symptoms, conduct problems, hyperactive behavior, peer
problems, and prosocial behaviors. (Goodman, 1997) Hence, the SDQ is especially suited
to capture both the behavioral and emotional features related to dysregulation.
Furthermore, the SDQ is widely used and has been shown to predict psychiatric
diagnoses later in life. (Goodman and Goodman, 2011) Data included in the analysis
were from the parent reporting on their child’s behavior in the past six months. SDQ data
from N=2,126 participants were used in the latent class analysis.
Each SDQ item is measured on an ordinal scale: 0=Not True, 1=Somewhat True,
2=Certainly True. While the majority of the instrument is negatively valenced (e.g.,
“Often unhappy”, “Often lies or cheats”), the few positively valenced items are reversed
coded with the exception of the entire prosocial domain. Therefore, higher values within
the emotional, conduct, hyperactive or peer domain reflect difficulties, whereas higher
values within the prosocial domain reflect strengths. For the input to the latent class
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analysis, positively valenced items from the prosocial domain were recoded to match the
overall pattern of the instrument.
Previous investigators have reported using the SDQ-Dysregulation Profile (SDQDP) to measure the dysregulation construct based on the sum of five proposed items.
(Holtmann et al., 2011) Rather than imposing the recommended SDQ-DP cutoff of scores
≥5 as dysregulated, we used a data driven approach to characterize individuals based on
patterns of similar problem behaviors. And while the SDQ-DP is based on five SDQ
items spanning behavioral and affective problems, youths who score high on only the
behavioral items may be categorized as dysregulated despite scoring low on the
emotional items. The use of latent class analysis is hypothesized to overcome this
limitation by identifying a class of individuals who are most likely to exhibit cooccurring behavioral and affective problems. Nonetheless, the SDQ-DP was calculated
and compared to the class probabilities returned from the latent class analysis.

Latent Class Analysis
Latent class analysis (LCA) is an example of a mixture model used to estimate
group membership of latent constructs. LCA is robust to the categorical data format of
the SDQ and assigns probability scores to each participant reflecting the likelihood of
class membership. Participants were categorized into the class with the highest
probability score.
Latent class models were estimated using the software Mplus via an EM
algorithm. Model comparison was performed on analyses returning 1-class through 7289

class solutions. The best-fitted model was identified using multiple measures of fit. The
Bayesian Information Criterion (BIC) is a goodness-of-fit index that penalizes models
with more classes. Lower BIC values indicate more parsimonious models. Because
standard loglikelihood tests are biased in this analytic environment, two other
examinations were used to compare a K class model to a K-1 class model, the Vuong-LoMendell-Rubin likelihood ratio test (VLMRT) and the bootstrap likelihood ratio test
(BLRT). In each case, significance comparing a K class model to a K-1 class model
indicates additional information is provided. If it is not significant, then the K-1 class
model can be accepted. In addition, models with higher entropy (closer to 1) indicate a
clearer delineation of classes. (Celeux and Soromenho, 1996) In this analysis, all indices
other than the BLRT (which was not discriminating) indicated a 5-class model fit (see
Table A3.1). These classes were then used to identify two groups of interest, a
dysregulated group, and a low symptom comparison group (controls). Group
identification was determined based on their respective patterns of item endorsement as
further explained below.

Structural Neuroimaging Methods
Across the eight acquisition sites, participants were scanned on 3T MRI scanners
from various manufacturers (Phillips, General Electric, Bruker, and Siemens).
Standardization and quality assurance efforts were made to insure all sites used the same
MRI acquisition parameters and yielded comparable data. High-resolution anatomical
magnetic resonance images were acquired, including a 3D T1-weighted magnetization
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prepared gradient echo sequence based on the ADNI protocol (http://adni.loni.usc.edu).
The structural image was collected for nine minutes using the following parameters:
TR=2300ms; TE=2.8ms; flip angle=8o; matrix size=240x256; voxel resolution=1.1mm3;
and 160 contiguous slices at a thickness of 1.1mm.
Whole-brain gray matter volume (GMV) images were generated using optimized
voxel-based morphometry procedures in SPM8. (Ashburner and Friston, 2000) Highresolution anatomical magnetic resonance images were acquired, including a 3D T1weighted magnetization prepared gradient echo sequence based on the ADNI protocol
(http://adni.loni.usc.edu). Structural MRI preprocessing included segmenting and
normalizing the images into Montreal Neurological Institute template space. The gray
matter segmentation images were then modulated to obtain volumetric images, rather
than tissue concentration images. N=2,024 participants received a structural MRI and had
GMV images passing quality control.
In preparation for the between-group GMV comparison, variables potentially
influencing adolescent GMV (age, sex, site of imaging acquisition, handedness, puberty
status, (Carskadon and Acebo, 1993) verbal and performance IQ, (Wechsler, 2003) and
total GMV) were partialled out of the images. To do so, all participants from the baseline
IMAGEN sample with preprocessed GMV images (N=2,024) were submitted to a
multiple regression with only the confounding variables included in the design matrix.
The residual GMV image for each participant was then used in the permutation test
described below. This procedure was used because including nuisance covariates in the
permutation analysis prohibitively increased computation time.
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In light of recent criticisms related to the proper correction for multiple
comparisons in neuroimaging research, (Eklund et al., 2016) permutation analyses have
been advocated as a non-parametric approach to closely control the number of falsepositives in a statistical analysis. (Winkler et al., 2014) Here, we used a random label
permutation test applied to the residual output of the aforementioned nuisance regression.
Each participant’s group membership was randomly shuffled and a whole-brain twogroup t-test using a general linear model was fitted to the residualized images. Random
label shuffling was repeated 10,000 times, thus building a null distribution at each voxel,
to which the originally labeled results were compared. Threshold-free cluster
enhancement correction (TFCE)(Smith and Nichols, 2009) was then used to control the
family-wise error rate for identifying clusters of residual gray matter that exhibit
significant group differences. Regions of interest (ROI) surviving a TFCE corrected α <
.05 were then probed for fMRI group differences, as well as being modeled as the
mediator in candidate path analyses linking the likelihood of psychopathology to
dysregulation. Permutation analyses were conducted using FSL’s Permutation Analysis
of Linear Models (Winkler et al., 2014) on the University of Vermont’s Advanced
Computing Core.

Functional Neuroimaging Methods
Three fMRI tasks commonly used in psychiatric neuroimaging were administered,
including the stop signal task, monetary-incentive delay task, and a face-processing task.
The stop signal (inhibitory control) task requires participants to inhibit a prepotent motor
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response. (Rubia et al., 2007) Motor inhibitory control performance during this task is
commonly measured using the stop signal reaction time (SSRT), an estimate of the speed
of the inhibitory process, calculated from the average latency period between the “go”
and “stop signal” during successful inhibition trials. (Logan and Cowan, 1984) The
monetary-incentive delay task measures the processing of both anticipation and receipt of
monetary rewards. (Knutson et al., 2000) The face-processing task involves the passive
viewing of angry faces, neutral faces, and control images. (Grosbras, 2005) See
Supplement 1, available online, for full details on the fMRI tasks.
All fMRI data were submitted to standard preprocessing methods and whole-brain
contrast images specific to each task were estimated using a general linear model (see
Supplement 1, available online, for fMRI processing details). Specifically, unsuccessful
and successful inhibitory control, monetary reward anticipation and receipt, angry faces,
neutral faces, and the differential activation for angry minus neutral faces, were each used
to explore any functional differences between the groups. For each contrast image, the
mean value within a region of interest (ROI) was extracted and analyzed using two-group
ANCOVA models with a Bonferroni corrected alpha based on the number of contrasts
tested for each task modality.

Likelihood of Psychiatric Diagnoses
Psychopathology was determined using the Developmental and Well-Being
Assessment (DAWBA; http://www.dawba.info/a0.html), a set of computer-administered
interviews, questionnaires, and ratings generating DSM-IV psychiatric diagnoses for ages
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5-17. Based on the child and parent responses, a computer algorithm generates scores to
predict the likelihood of meeting criteria for DSM-IV diagnoses (“band scores”). These
band scores range from 1 to 5, representing a probability of <0.1% to >70%. DAWBA
band scores have been shown to yield prevalence estimates that broadly compare to
clinician-rated diagnoses. (Goodman and Goodman, 2011)

Mediation Analyses
Mediation was conducted in Mplus using a robust weighted least squares
estimator to estimate direct and indirect effects, with bias-corrected 95% confidence
intervals generated from 1000 bootstrapped samples. The use of bootstrapping the
indirect effects is a more powerful method of inferring mediation compared to the
traditional five-step procedure. (Hayes, 2009) The independent variables for the five
separate mediation analyses included the full range of DAWBA band scores, representing
the likelihood of receiving a DSM-IV diagnosis for anxiety, depression, conduct disorder
(CD), oppositional defiance disorder (ODD), and attention deficit hyperactivity disorder
(ADHD). These five constructs were informed by Copeland and colleagues who assessed
the prevalence rates of DMDD comorbidity with these disorders. (Copeland et al., 2013)
Furthermore, these disorders broadly capture the co-occurring internalizing and
externalizing problems exhibited by dysregulated individuals.
The identified GMV features were modeled as a mediator between each band
score and the binary dysregulation status as the dependent variable. Hence, models were
constructed to test the hypothesis that the underlying neurobiology influences the
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relationship between a related psychiatric disorder and the dysregulated phenotype. As
the initial neuroimaging analysis here tests for a biomarker of dysregulation in isolation,
follow up path analyses assessed the involvement of brain structure with dysregulation in
the context of affiliated psychiatric diagnoses reported by Copeland and colleagues. Any
significant indirect effects uncovered by these path models provides evidence indicating
the correlation between the likelihood of a related disorder and being dysregulated is
driven, in part, through changes in focal brain structure.

Results
Latent Class Analysis Results
The best-fitting LCA model returned a five-class solution (see Table A3.1 for fit
statistics). Here, we describe each class and offer a label to characterize their profile.
Class 1, the “defiant class” (18% of the sample), contained individuals with low prosocial
traits and slightly elevated conduct problems and hyperactivity. Class 2, the “emotional
difficulties” class (16% of the sample), contained individuals with the highest emotional
difficulties. Class 3, the “dysregulated class” (12% of the sample), contained individuals
with very high levels of difficulties across all five domains. Class 4, the “hyperactive
class” (25% of the sample), contained individuals with elevated hyperactivity. Class 5,
the “low symptom class” (29% of the sample), contained individuals with very low levels
of problem behaviors across all domains. And while class 5 is labeled “low symptoms”,
we note that the defiant, emotional difficulties, and hyperactive classes also exhibit low
symptoms on domains outside of their problem areas. These findings are consistent with
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studies reporting high prevalence rates of any level of psychiatric symptomatology in
adolescence. (Copeland et al., 2011) See Figure A3.1 for the average item-endorsement
for each class and Table 2 for the five SDQ summary scores for each class.
While other classes exhibited elevations in a single domain (i.e., emotional
difficulties class; hyperactive class), the dysregulated class distinctly exhibited cooccurring behavioral and affective problems. These individuals exhibited the highest
probability of endorsing conduct problems, hyperactivity, peer problems, and the second
highest probability of endorsing emotional problems (closely following the emotional
difficulties class), and prosocial problems (closely following the defiant class). The low
symptom class (the largest sample) was selected as the comparison group as they
exhibited the lowest probability of endorsing all problematic behaviors. See Table S1,
available online, for comparison of the dysregulated class to the full sample on
descriptive characteristics.
Next, the SDQ-DP was calculated to compare to the LCA results using bivariate
correlations between the SDQ-DP sum score and the probability of each class
membership. Results indicated the SDQ-DP was most positively associated with the
dysregulated class (r2126=.61, p<.001) and most negatively associated with the low
symptom class (r2126=-.44, p<.001), thus providing support for the dysregulated
phenotype captured by class 3 and the low symptom group captured by class 5.
However, these correlations may be inflated as both measures were estimated from
similar items on the same dataset. Nonetheless, Holtmann and colleagues report
correlations between their SDQ-DP and Child Behavior Checklist-Dysregulation Profile
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(CBCL-DP) binary score at r=.45 and CBCL-DP sum score at r=.75. Therefore, the LCA
results reported here are in line with these other measurement instruments.
There were 184 participants included in the LCA who did not provide anatomical
scan data (for reasons including failing quality control, MRI safety issues, etc.).
However, chi-square tests indicated there was no difference in LCA class membership in
this subsample relative to the larger sample with anatomical scan data (Χ24,2126 =2.2,
p>.05). Thus, we do not believe there was any skew in the LCA class assignment by the
participants who did not provide anatomical scan data.

Neuroimaging Sample Characteristics
Of the 261 dysregulated and 613 low symptom comparison individuals identified
from the LCA, 233 dysregulated and 564 comparison individuals provided useable GMV
data. For the sample of 233 dysregulated individuals, an equal size subset of comparison
individuals was selected from the low symptom class. This control group was pseudorandomly selected so as to match to the dysregulated group by containing an equal
number of males and females who showed no differences on total GMV, pubertal
development, performance and verbal IQ, or age, and contained similar distributions for
handedness and site of acquisition (see Table S2, available online, for group
comparisons). And while site was included in the initial nuisance regression of the full
IMAGEN dataset, it is difficult to precisely account for site when there are unequal
representations at each site. Hence, a pseudo-random sampling of the two groups was
performed to identify a subsample of individuals with equal representations at each site.
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Results using this perfectly site-matched subsample were consistent with the main
findings reported below. See Supplement 1, available online, for more information.

Whole-brain Residual Gray Matter Volume Comparison
After running a two-sample t-test using a general linear model with 10,000
random label permutations, a single cluster survived TFCE-correction for multiple
comparisons (PFWE-corr<.05, k=48 voxels). This cluster was found in the right orbitofrontal
cortex (OFC), center of mass at (MNI: 24, 30, -16), spanning the orbital sulcus with
extent into the posterior orbital gyrus. In this region, dysregulated individuals exhibited
lower residual GMV relative to their peers with low symptoms (see Figure A3.2).

Laterality Test
As only one hemisphere survived strict correction, and there is growing interest in
prefrontal asymmetry, a contralateral region of interest analysis was performed post-hoc.
To perform this test, we translated the right-sided region of interest onto the left
hemisphere and extracted regional GMV for all subjects. Two-sample t-tests indicated the
left OFC ROI yielded significant differences (L.OFC: t462=-3.32, p<1.0x10-3), similar to
the findings in the right OFC, albeit at a relatively lower magnitude of effect (R.OFC:
t462=-4.40, p<1x10-4).

fMRI Comparisons
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The identified sample for GMV analyses (n=466) was selected on the basis of the
quality of their anatomical image, meaning some of these participants did not have fMRI
data available. See Table S3 and Supplement 1, available online, for full details regarding
these reduced samples, and reasons for missingness. In preparation for the ROI-level
between-group comparisons using the fMRI data, we first examined the amount of head
motion in the images. For each subject, the mean framewise displacement (mean FD) was
calculated for each of the three fMRI tasks. Based on prior developmental neuroimaging
studies,(Silvers et al., 2016) a head motion exclusionary criterion of mean FD > .9mm
was used. For the stop signal task, 3 dysregulated participants were excluded. For the
faces task, 1 dysregulated participant was excluded. For the MID task, 5 dysregulated and
1 low symptom participants were excluded. Importantly, these reduced samples for fMRI
comparisons retained critical between-group similarities as the starting samples for
anatomical comparisons. Chi-square (for categorical measures) and t-tests indicated that
after excluding subjects, the reduced samples retained their best-matched characteristics
and did not differ on age, sex, handedness, IQs, or total GMV (p> .05).
Data were then submitted to standard two-sample t-tests to determine any group
differences in head motion for a given task. Results indicated that while mean FD did not
exceed thresholds previously reported as problematic, (Power et al., 2012; Siegel et al.,
2014) the dysregulated sample exhibited significantly more head motion during each
fMRI acquisition (see Table S4, available online). Although participants’ head motion
parameters were included in the design matrix during their fMRI contrast estimation, we
also included mean FD as a covariate in the ROI-level between-group ANCOVA models.
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For the stop signal task, results indicated a significant between-group difference
during successful inhibitory control trials F1,377=5.61, pcorr<.05, such that the dysregulated
group showed higher activation (n=186, M=.15, SD=1.2) than the low symptom group
(n=194, M=-.09, SD=.92). To ensure these findings were not driven by the difference in
head motion, similar ANCOVA models were estimated on 5,000 pseudo-random
subsamples of the data matched on head motion. Results were consistent, leading to a
mean F1,307=4.9, p<.05, suggesting the between-group difference on successful inhibitory
control activations were not driven by head motion. See Supplement 1, available online,
for more information.
Due to problems with the behavioral task performance adaptive algorithm, stop
signal reaction time (SSRT) scores were available on only a subset of participants. A
between-group comparison on those individuals with useable SSRT behavioral data
(Dysregulated n=97; Controls n=107) yielded no significant differences on SSRT
(t202=0.38, p=.71). Given the reduced sample sizes of participants with SSRT data, no
imputations were performed for SSRT, and it is unknown the degree to which the effects
might generalize to the starting samples. No between-group activation differences were
detected for unsuccessful inhibitory control trials, or on any of the remaining fMRI
contrasts (reward and face processing tasks).

Mediation Analyses
The likelihood of having any of the five psychopathologies exhibited a significant
total and direct effect with dysregulation, substantiating their relationship with
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dysregulation. (Copeland et al., 2013) Bias-corrected confidence intervals around the
indirect effect of the right OFC GMV ROI indicated this region partially mediated the
likelihood of an anxiety disorder diagnosis (c=.023, 95% CI [0.003, 0.043]) or conduct
disorder diagnosis (c=.018, 95% CI [.003, .033]) to dysregulation status (see Figure
A3.3). No significant indirect effects were detected to link the brain between the
likelihood of depression, ODD, or ADHD with dysregulation. Additionally, regional
fMRI brain activation during successful inhibitory control did not yield any significant
mediation effects. See Table A3.3 for mediation model results.

Discussion
We report that emotionally and behaviorally dysregulated adolescents exhibited
lower GMV in the right OFC relative to their non-dysregulated peers. These findings
were identified by a conservative permutation analysis between two large samples of
closely matched groups. Secondary analyses indicated that within this same region, the
dysregulated group exhibited higher functional brain activation when executing
successful inhibitory control behaviors. These fMRI results provide some specificity on
the psychological correlates of the GMV effect, such that the anatomical difference
associated with dysregulation was related to inhibitory control but not to face or reward
processing. Taken together, these results suggest dysregulation is characterized by
differences in cortical regions involved with executive functioning. Lastly, the volume of
the right OFC region partially mediated relationships between the likelihoods of an
anxiety disorder and a conduct disorder diagnosis and dysregulation.
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It is interesting that the right OFC was uncovered from a conservative wholebrain analysis and also exhibited differences on the stop signal task, as there is a body of
research implicating the OFC in behavioral and emotional regulation. For example,
previous research on the IMAGEN sample identified this region as participating in a
network of brain activity during successful inhibitory control trials. (Whelan et al., 2012)
As the dysregulated and low symptoms groups exhibited similar task performance, the
greater activity in the right OFC of the dysregulated group may reflect greater effort or
cognitive resources needed to execute inhibitory behaviors equal to that of their peers.
Therefore, dysregulation may be partly dependent on a neurobiological inhibitory control
network compromised in its ability to efficiently regulate behavior.
The OFC is also putatively involved in integrating attention and emotion by
assigning a signal of affective value to stimuli. Previous work using event-related
potentials (ERP) during an affective go/no-go task was conducted on children with cooccuring internalizing and externalizing disorders. One set of results identified higher
ventral prefrontal activations during inhibitory control trials in children with poor selfregulatory abilities as measured via parent-child observations. (Granic et al., 2012) In a
related treatment study of similar children, treatment success was characterized by
attenuation of activation levels in the ventral prefrontal region during inhibitory control
trials. (Lewis et al., 2008) Hence, our findings are in line with these reports and suggest
the OFC as both a potential biomarker and candidate region for targeted clinical
interventions to help improve outcomes in children with dysregulated behavioral profiles.
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In terms of the mediation results, the investigated psychopathologies all exhibited
a significant and large total effect on dysregulation, indicating that the likelihood of
having an internalizing or externalizing disorder was associated with an increased
likelihood of being dysregulated. These findings are consistent with previous reports
identifying similar patterns of comorbidity from three datasets of child psychopathology.
(Copeland et al., 2013) Moreover, the direct effects were also large, accounting for nearly
98% of the total effect for all disorders (see Table A3.3). Given these relationships, the
significant partial mediation results are notable as little variance is left to be explained by
the indirect paths. Yet despite these relatively weak indirect effects, the significant
findings highlight the transdiagnostic nature of the right OFC region insofar as it is a
mediator to dysregulation for the likelihood of anxiety and conduct disorder. Although a
significant mediation was not observed for depression, ODD, or ADHD it would be
incautious to conclude that the mediation effect has specificity for anxiety and conduct
disorder as effects in similar directions were observed for depression (p=.065) and ODD
(p=.070; see Table A3.3). On the whole, the data suggest a small but potentially
important role for the OFC in linking internalizing and externalizing disorder to
dysregulation. Lastly, we reiterate the path models should not be misinterpreted as
implying the likelihood of an anxiety, conduct disorder, or the brain feature caused
dysregulation as the models are restricted to age 14 data only.
Limitations of this study include the lack of DSM-5 diagnostic measures, as it is
unclear if the individuals contained in the dysregulation group meet DMDD diagnostic
criteria. Future studies are needed to evaluate the degree to which the SDQ captures
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individuals who receive a DSM-5 DMDD diagnosis following a clinical interview.
Likewise, measurement studies are also needed to determine the correlation between
popular measurement methods like SDQ-LCA, SDQ-DP and CBCL-DP, and their
correlation with clinical ratings. Additionally, recent work taking a factor analytic
approach to the SDQ has identified a dysregulation factor using just three of the five
domains, omitting the prosocial and peer problem domains. (Deutz et al., 2018) However,
given that elevations in the CBCL Social Problems domain frequently accompany the
CBCL-DP, (Althoff et al., 2010a) this approach risks omitting relevant features of the
dysregulation construct.
In considering dysregulation measurement inconsistencies, differences in the
precise brain region uncovered here with the previous regions uncovered by Adleman and
by Gold and colleagues are likely attributed to differing measurement approaches.
Nonetheless, the right-sided prefrontal anatomical finding is broadly consistent with these
prior results. Although earlier fMRI studies of inhibitory control in dysregulation failed
to detect significant group differences (Deveney et al., 2012) this is likely due to our
fMRI analysis, by design, being restricted to a single anatomically defined region of
interest. Another important consideration in interpreting the present fMRI results and
integrating them with past findings is the potential confounding role of head motion.
Despite including mean framewise displacement as a covariate, ANCOVA models are
generally unable to completely control for a significant between-group difference in that
covariate. Confidence in our results comes from the 5,000 pseudo-random subsampling
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procedure in which the group differences were recapitulated with subsamples chosen not
to differ on head motion.
A caveat regarding the mediation results is that the path models were estimated
using DAWBA band scores. As the DAWBA contains many skip rules leading some
participants to “screen in” for extra items, these skips rules are sometimes related to high
SDQ domain scores. Estimating paths between band scores and a binary dysregulation
score determined via an SDQ-LCA consequently may contain a degree of circularity.
Another limitation of the present study is the use of single informant data, although
previous studies suggest agreements among multi-informants are generally low. (De Los
Reyes and Kazdin, 2005) Finally, given the neurodevelopmental changes underway at
age 14, it is unknown if the neuroanatomical difference identified here persists
throughout the lifespan. Future longitudinal studies on dysregulated individuals are
needed to determine the psychosocial and neurobiological antecedents of dysregulation,
as well as the developmental effect of neural maturation on the persistence of
dysregulation into late adolescence and adulthood.
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Tables
Table A3.1: Latent Class Analysis Model Fit Statistics
Fit Statistics
Number of
Classes
1
2
3
4
5
6
7

-2
loglikelihood

BIC

VLMR

BLRT

Entropy

-39030.3
-36850.3
-36188.3
-35664.2
-35252
-35067.2
-34893.2

78443.79
74474.39
73541.19
72883.75
72450.08
72471.34
72514.15

NA
<0.001
<0.001
0.0046
0.0028
0.3346
0.7601

NA
<0.001
<0.001
<0.001
<0.001
<0.001
<0.001

1
0.82
0.80
0.79
0.81
0.81
0.81

BIC = Bayesian Information Criterion; BLRT=Bootstrap Likelihood Ratio Test; NA=Not
Applicable; VLMR=Vuong-Lo-Mendell-Rubin Likelihood Ratio.

Table A3.2: Strengths and Difficulties Questionnaire Summary Scores For Each Latent
Class
Class (N)
1 (373)
2 (340)
3 (261)
4 (539)
5 (613)

Emotional
Symptoms
(M, SD)
1.36, 1.30
4.20, 1.76
4.15, 2.23
1.20, 1.10
0.88, 1.05

SDQ Summary Scores
Conduct
Hyperactive
Peer
Problems
Behavior
Problems
(M, SD)
(M, SD)
(M, SD)
1.98, 1.29
2.52, 1.51
1.66, 1.57
1.37, 1.19
3.16, 1.84
2.51, 1.71
4.32, 1.58
6.44, 1.98
2.91, 2.08
1.57, 1.17
3.99, 1.43
0.57, 0.80
0.64, 0.83
0.81, 0.87
0.89, 1.07

Prosocial
Behavior
(M, SD)
5.81, 1.36
8.99, 1.02
6.31, 1.97
8.59, 1.02
9.04, 1.03

Class 3 comprised the “dysregulated” group who exhibited highest levels of impairment
across all dimensions. Class 5 comprised the “low symptom” control group who
exhibited the lowest levels of impairment. Summary scores were calculated by the sum of
five items related to each dimension.(Goodman, 1997) Higher values signify more
difficulty except within the prosocial domain. M=Mean; SD=Standard Deviation; SDQ =
Strengths and Difficulties Questionnaire.
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Table A3.3: Summary of Mediation Models
Model

95% Bootstrapped
Confidence Interval
Lower
Upper

B

S.E.

p

Total Effect
Direct Effect
Indirect Effect

.690
.667
.023

.055
.058
.010

.001
.001
.025

.582
.554
.003

.799
.780
.043

Depression to Dysregulation
Total Effect
Direct Effect
Indirect Effect

.700
.683
.017

.044
.045
.009

.001
.001
.065

.613
.595
-.001

.788
.772
.035

Conduct Disorder to Dysregulation
Total Effect
Direct Effect
Indirect Effect

.780
.762
.018

.035
.036
.008

.001
.001
.022

.712
.692
.003

.848
.833
.033

.841
.826
.015

.024
.025
.008

.001
.001
.070

.794
.776
-.001

.888
.876
.031

.919
.909
.010

.019
.021
.006

.001
.001
.124

.882
.867
-.003

.957
.951
.023

Anxiety to Dysregulation

ODD to Dysregulation
Total Effect
Direct Effect
Indirect Effect
ADHD to Dysregulation
Total Effect
Direct Effect
Indirect Effect

Total effects reflect association between the likelihood of disorder and dysregulation.
Direct effects reflect the association between the likelihood of a disorder and
dysregulation while accounting for the GMV region of interest (mediator). Indirect
effects are the difference in betas, and reflect the magnitude of mediation through the
region of interest. Significant indirect effects (95%CI >0) in bold. ADHD=Attention
Deficit Hyperactivity Disorder; GMV=Gray Matter Volume; ODD=Oppositional Defiant
Disorder.

311

Figures
Figure A3.1: Average Strengths and Difficulties Questionnaire Item Endorsement for
Five Classes
Average SDQ Item Endorsement for Five Classes

1.8

Item Endorsement (0-2)

1.6
1.4
1.2

Class1

1

Class2

0.8

Class3

0.6

Class4

0.4

Class5

Emotional

Conduct

Hyperactive
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kind*

caring*
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considerate*

helpsout*

loner

adults better

bullied
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reflective*
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attentive*
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fidgets
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tantrum

lies

fights

afraid

clingy

somatic

worries

0

unhappy

0.2

Prosocial

Each SDQ item present on the x-axis, ordered by the five respective SDQ domains to aid
in interpretability. Average item endorsement on y-axis, from 0-2 (Not true, somewhat
true, certainly true). Items with asterisks indicate reverse coding. Dysregulated class (3)
in green line; low symptom class (5) in black line. SDQ=Strengths and Difficulties
Questionnaire.
Figure A3.2: Right Orbitofrontal Cortex Region of Interest

Cluster (k=48 voxels; center of mass MNI coordinates: 3), identified as passing TFCEcorrection (p < .05) from a two-sample residual gray matter volume permutation analysis.
This cluster was also present in a two-group permutation analysis estimated without
residualized images or nuisance covariates. MNI=Montreal Neurological Institute;
TFCE=Threshold-Free Cluster Enhancement.(Smith and Nichols, 2009)
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Figure A3.3: Mediation Models with Significant Indirect Effects
Right OFC
GMV ROI
a= -.189

Right OFC
GMV ROI
b=-.122

a= -.124

c’=.690
Dysregulation

Anxiety

b=-.143
c’=.780
Dysregulation

Conduct Disorder

c=.023

c=.018

Path models of the relationship between the likelihood of anxiety disorder (left), or,
conduct disorder (right), to dysregulation, mediated by the right orbitofrontal cortex gray
matter volume ROI. All coefficients are standardized and pass a null-hypothesis
significance test at p<.05. The indirect effects (dotted line, c paths) reflect the magnitude
of mediation through the ROI, with significance determined by 95% confidence intervals
generated from 1000 bootstrapped samples (see Table 3). Total effects (c’ paths) reflect
the bivariate correlation between a disorder and dysregulation when the mediator is
excluded. The negative parameter estimates for the paths into and out of the ROI (a and b
paths) are in line with the lower GMV exhibited by the dysregulated group. GMV=Gray
Matter Volume; ROI=Region of Interest.
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